{
  "questions": [
    {
      "id": "67e6cf2618b1e36f2e0000d0",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
        "http://www.ncbi.nlm.nih.gov/pubmed/19892633",
        "http://www.ncbi.nlm.nih.gov/pubmed/28496617",
        "http://www.ncbi.nlm.nih.gov/pubmed/22191982",
        "http://www.ncbi.nlm.nih.gov/pubmed/11975840",
        "http://www.ncbi.nlm.nih.gov/pubmed/19016570",
        "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
        "http://www.ncbi.nlm.nih.gov/pubmed/26961117",
        "http://www.ncbi.nlm.nih.gov/pubmed/34224023",
        "http://www.ncbi.nlm.nih.gov/pubmed/25156675"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 491,
          "offsetInEndSection": 684,
          "text": "However, ut should be stressed that the current experience with flumazenil is limited and that the effects of flumazenil on hepatic encephalopathy is not proven by randomized controlled studies"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 686,
          "offsetInEndSection": 747,
          "text": "Therefore, this drug should only be used in clinical studies."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 125,
          "offsetInEndSection": 233,
          "text": "In contrast to all other treatments used so far by flumazenil hepatic encephalopathy improves within minutes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 235,
          "offsetInEndSection": 379,
          "text": "Flumazenil is the first benzodiazepine antagonist which can be used in humans and is a well established for treatment of benzodiazepine overdose"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "For the first time a causal treatment of hepatic encephalopathy may be possible by the benzodiazepine antagonist flumazenil"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2575692",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 381,
          "offsetInEndSection": 489,
          "text": "For treatment of hepatic encephalopathy development of a new antagonist with a longer half-life is desirable"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19892633",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 238,
          "offsetInEndSection": 499,
          "text": "Women of childbearing age taking valproate should be warned of its teratogenicity and advised to plan pregnancies, take a higher dose of folate, discuss reducing the dose of valproate or changing the medication with their physician, and have antenatal screening"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19892633",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 501,
          "offsetInEndSection": 586,
          "text": "After birth, the infant should be examined for a wide range of reported abnormalities"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19892633",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 588,
          "offsetInEndSection": 654,
          "text": "Neurodevelopmental assessment should continue throughout childhood"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19892633",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 110,
          "offsetInEndSection": 236,
          "text": "It has traditionally been prescribed for epilepsy, but is increasingly used for such psychiatric conditions as bipolar disease"
        }
      ]
    },
    {
      "id": "680d5e47353a4a2e6b000005",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
        "http://www.ncbi.nlm.nih.gov/pubmed/313731",
        "http://www.ncbi.nlm.nih.gov/pubmed/17725169",
        "http://www.ncbi.nlm.nih.gov/pubmed/25207108",
        "http://www.ncbi.nlm.nih.gov/pubmed/22966723",
        "http://www.ncbi.nlm.nih.gov/pubmed/24730627",
        "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
        "http://www.ncbi.nlm.nih.gov/pubmed/22470757",
        "http://www.ncbi.nlm.nih.gov/pubmed/2644915",
        "http://www.ncbi.nlm.nih.gov/pubmed/16940490"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 144,
          "text": "Kartagener Syndrome is a rare autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis and situs inversus with dextrocardia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 146,
          "offsetInEndSection": 321,
          "text": "It is the subset of disorder called primary ciliary dyskinesia in which the cilia have abnormal structure and/or function resulting in multisystem diseases of various severity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 323,
          "offsetInEndSection": 462,
          "text": "Clinical manifestations include lifelong, chronic upper and lower respiratory tract diseases secondary to ineffective mucociliary clearance"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 464,
          "offsetInEndSection": 600,
          "text": "Early diagnosis and management of chest infections can prevent irreversible damage to lungs and prevent potential lifelong complications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 602,
          "offsetInEndSection": 757,
          "text": "This case report is on a patient who presented with long standing history of sinusitis, bronchiectasis and on examination situs inversus with dextrocardia."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/313731",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 170,
          "text": "A case of a nine year and eight months old child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis, bronchiectasis and \"situs inversus totalis\""
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/313731",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 172,
          "offsetInEndSection": 194,
          "text": "Literature is reviewed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/313731",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 196,
          "offsetInEndSection": 274,
          "text": "It is important to understand genetical and etiology aspects of bronchiectasis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/313731",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 276,
          "offsetInEndSection": 355,
          "text": "Diagnosis was considered on the basis of physical and radiographic examination."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17725169",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 207,
          "text": "Kartagener syndrome (a clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis, bronchiectasis and situs inversus with dextrocardia"
        }
      ]
    },
    {
      "id": "680f4a68353a4a2e6b000007",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
        "http://www.ncbi.nlm.nih.gov/pubmed/12853484",
        "http://www.ncbi.nlm.nih.gov/pubmed/19088202",
        "http://www.ncbi.nlm.nih.gov/pubmed/17517647",
        "http://www.ncbi.nlm.nih.gov/pubmed/24600235",
        "http://www.ncbi.nlm.nih.gov/pubmed/22220280",
        "http://www.ncbi.nlm.nih.gov/pubmed/22548175",
        "http://www.ncbi.nlm.nih.gov/pubmed/9177348",
        "http://www.ncbi.nlm.nih.gov/pubmed/7969211",
        "http://www.ncbi.nlm.nih.gov/pubmed/22649563"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 267,
          "offsetInEndSection": 414,
          "text": "Eptinezumab, delivered by intravenous (IV) administration, is being developed by Lundbeck Seattle BioPharmaceuticals for the prevention of migraine"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 191,
          "text": "Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti™) is a humanised monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 193,
          "offsetInEndSection": 265,
          "text": "CGRP is believed to play a major role in the pathophysiology of migraine"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 416,
          "offsetInEndSection": 520,
          "text": "In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 522,
          "offsetInEndSection": 626,
          "text": "This article summarizes the milestones in the development of eptinezumab leading to this first approval."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12853484",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 175,
          "text": "Silencing of the paternal allele of three imprinted genes (Igf2r, Slc22a2 and Slc22a3) requires cis expression of the Air RNA that overlaps the promoter of one of them (Igf2r)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12853484",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 177,
          "offsetInEndSection": 232,
          "text": "Air is a non-coding RNA whose mode of action is unknown"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12853484",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 234,
          "offsetInEndSection": 365,
          "text": "We tested the role of the Igf2r promoter and the role of transcriptional overlap between Igf2r and Air in silencing in this cluster"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12853484",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 367,
          "offsetInEndSection": 616,
          "text": "We analyzed imprinted expression in mice in which the Igf2r promoter is replaced by a thymidine kinase promoter that preserves a transcription overlap with Air, and in mice with a deleted Igf2r promoter that lack any transcriptional overlap with Air"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12853484",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 618,
          "offsetInEndSection": 767,
          "text": "Imprinted silencing of Air, Slc22a2 and Slc22a3 is maintained by the replacement promoter and also in the absence of transcriptional overlap with Air"
        }
      ]
    },
    {
      "id": "680a083218b1e36f2e00014d",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
        "http://www.ncbi.nlm.nih.gov/pubmed/28438613",
        "http://www.ncbi.nlm.nih.gov/pubmed/38036877",
        "http://www.ncbi.nlm.nih.gov/pubmed/37461668",
        "http://www.ncbi.nlm.nih.gov/pubmed/22138506",
        "http://www.ncbi.nlm.nih.gov/pubmed/29765840",
        "http://www.ncbi.nlm.nih.gov/pubmed/15935056",
        "http://www.ncbi.nlm.nih.gov/pubmed/10908612",
        "http://www.ncbi.nlm.nih.gov/pubmed/25130173",
        "http://www.ncbi.nlm.nih.gov/pubmed/27616979"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 150,
          "text": "With severe injury or disease, microglia become chronically activated and damage the local brain environment, likely contributing to cognitive decline"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 152,
          "offsetInEndSection": 464,
          "text": "We previously discovered that microglia are dependent on colony-stimulating factor 1 receptor (CSF1R) signaling for survival in the healthy adult brain, and we have exploited this dependence to determine whether such activated microglia contribute deleteriously to functional recovery following a neuronal lesion"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 466,
          "offsetInEndSection": 644,
          "text": "Here, we induced a hippocampal lesion in mice for 25 d via neuronal expression of diphtheria toxin A-chain, producing both a neuroinflammatory reaction and behavioral alterations"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 646,
          "offsetInEndSection": 748,
          "text": "Following the 25 d lesion, we administered PLX3397, a CSF1R inhibitor, for 30 d to eliminate microglia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 750,
          "offsetInEndSection": 1009,
          "text": "This post-lesion treatment paradigm improved functional recovery on elevated plus maze and Morris water maze, concomitant with reductions in elevated proinflammatory molecules, as well as normalization of lesion-induced alterations in synaptophysin and PSD-95"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1011,
          "offsetInEndSection": 1278,
          "text": "Further exploration of the effects of microglia on synapses in a second cohort of mice revealed that dendritic spine densities are increased with long-term microglial elimination, providing evidence that microglia shape the synaptic landscape in the adult mouse brain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1280,
          "offsetInEndSection": 1453,
          "text": "Furthermore, in these same animals, we determined that microglia play a protective role during lesioning, whereby neuronal loss was potentiated in the absence of these cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1455,
          "offsetInEndSection": 1766,
          "text": "Collectively, we demonstrate that microglia exert beneficial effects during a diphtheria toxin-induced neuronal lesion, but impede recovery following insult.\nIt remains unknown to what degree, and by what mechanisms, chronically activated microglia contribute to cognitive deficits associated with brain insults"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1768,
          "offsetInEndSection": 1935,
          "text": "We induced a genetic neuronal lesion in mice for 25 d and found activated microglia to increase inflammation, alter synaptic surrogates, and impede behavioral recovery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1937,
          "offsetInEndSection": 2143,
          "text": "These lesion-associated deficits were ameliorated with subsequent microglial elimination, underscoring the importance of developing therapeutics aimed at eliminating/modulating chronic microglial activation"
        }
      ]
    },
    {
      "id": "67e5557c18b1e36f2e0000ac",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
        "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
        "http://www.ncbi.nlm.nih.gov/pubmed/26140505",
        "http://www.ncbi.nlm.nih.gov/pubmed/28303677",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/16939780",
        "http://www.ncbi.nlm.nih.gov/pubmed/31314901",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
        "http://www.ncbi.nlm.nih.gov/pubmed/28991104",
        "http://www.ncbi.nlm.nih.gov/pubmed/28583723"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 154,
          "offsetInEndSection": 267,
          "text": "They can be separated from their target genes by large distances and are thus known as distal regulatory elements"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 269,
          "offsetInEndSection": 471,
          "text": "One consequence of the variability in the distance separating enhancers and their target promoters is that it is difficult to determine which elements are involved in the regulation of a particular gene"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 600,
          "offsetInEndSection": 688,
          "text": "However, little is known about how the individual elements contribute to gene expression"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 779,
          "offsetInEndSection": 914,
          "text": "Further, we discuss enhancer clusters and what is known about the contribution of individual elements to the regulation of target genes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 473,
          "offsetInEndSection": 598,
          "text": "Moreover, enhancers can be found in clusters in which multiple regulatory elements control expression of the same target gene"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Enhancers are short noncoding segments of DNA (100-1000 bp) that control the temporal and spatial activity of genes in an orientation-independent manner"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29583027",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 916,
          "offsetInEndSection": 1000,
          "text": "Finally, we examine the reliability of different methods used to identify enhancers."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 257,
          "offsetInEndSection": 368,
          "text": "It is still unclear what factors determine whether a target transcript is degraded or translationally repressed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 370,
          "offsetInEndSection": 612,
          "text": "In this study, we collected two classes of genes that are targeted by miR-1, miR-155, miR-16, miR-30a, and let-7b and built new computational models with machine-learning methods to predict the fates of target genes based on sequence features"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 820,
          "offsetInEndSection": 951,
          "text": "Further analysis shows that four out of the five studied miRNAs probably share similar regulatory mechanisms on their target genes."
        }
      ]
    },
    {
      "id": "6810fef8353a4a2e6b000016",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
        "http://www.ncbi.nlm.nih.gov/pubmed/10843242",
        "http://www.ncbi.nlm.nih.gov/pubmed/19317304",
        "http://www.ncbi.nlm.nih.gov/pubmed/31372118",
        "http://www.ncbi.nlm.nih.gov/pubmed/17235567",
        "http://www.ncbi.nlm.nih.gov/pubmed/20131283",
        "http://www.ncbi.nlm.nih.gov/pubmed/25005336",
        "http://www.ncbi.nlm.nih.gov/pubmed/8819627",
        "http://www.ncbi.nlm.nih.gov/pubmed/29274152",
        "http://www.ncbi.nlm.nih.gov/pubmed/27906102"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 134,
          "offsetInEndSection": 466,
          "text": "The purpose of the study was to estimate the complication rate of volar plating of DRF and its association with AO/OTA fracture type, surgeon experience and type of volar plate.\nRetrospectively, all patients treated with volar plating of a DRF between February 2009 and June 2013 at Aarhus University Hospital, Denmark were included"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 739,
          "offsetInEndSection": 871,
          "text": "78% (n=451) of the patients were treated with VariAx\nThe majority of DRF patients treated with a volar plate suffer no complications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 468,
          "offsetInEndSection": 655,
          "text": "AO/OTA fracture type, surgeon experience (1st year, 2nd-5th year resident or consultant), type of plate (VariAx\n576 patients with a median age of 63 years (min: 15; max: 87) were included"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 91,
          "offsetInEndSection": 132,
          "text": "The complication rates vary from 3 to 36%"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 873,
          "offsetInEndSection": 935,
          "text": "However, the overall complication rate of 14.6% is substantial"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 969,
          "offsetInEndSection": 1032,
          "text": "AO/OTA-type 23C1-3, had significantly higher complication rates"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1034,
          "offsetInEndSection": 1120,
          "text": "Neither surgeon experience, nor type of volar plate was able to predict complications."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "Volar plating of unstable distal radius fractures (DRF) has become the favoured treatment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28336098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 657,
          "offsetInEndSection": 737,
          "text": "78% were female and the mean observation time was 3.2 years (min: 2.0; max: 5.4)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10843242",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 294,
          "offsetInEndSection": 390,
          "text": "Thirty-nine patients with pregnancy-related ARF were treated between Jan 1, 1989 and Jan 1, 1999"
        }
      ]
    },
    {
      "id": "6810cb23353a4a2e6b000012",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23114244",
        "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
        "http://www.ncbi.nlm.nih.gov/pubmed/37743207",
        "http://www.ncbi.nlm.nih.gov/pubmed/23143331",
        "http://www.ncbi.nlm.nih.gov/pubmed/28813765",
        "http://www.ncbi.nlm.nih.gov/pubmed/26508190",
        "http://www.ncbi.nlm.nih.gov/pubmed/31639728",
        "http://www.ncbi.nlm.nih.gov/pubmed/23870040",
        "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
        "http://www.ncbi.nlm.nih.gov/pubmed/37972503"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 125,
          "offsetInEndSection": 474,
          "text": "There are no data on airway pressures generated and efficacy in bronchiolitis.\nThe objective of this study was to determine nasopharyngeal (NP) pressures generated with HHHFNC therapy in bronchiolitis.\nWe conducted a prospective, observational study to measure NP pressures at varying flow rates of HHHFNC therapy in moderate to severe bronchiolitis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 125,
          "offsetInEndSection": 648,
          "text": "There are no data on airway pressures generated and efficacy in bronchiolitis.\nThe objective of this study was to determine nasopharyngeal (NP) pressures generated with HHHFNC therapy in bronchiolitis.\nWe conducted a prospective, observational study to measure NP pressures at varying flow rates of HHHFNC therapy in moderate to severe bronchiolitis. Vital signs, bronchiolitis severity scores, and oxygen saturation were also noted.\nTwenty-five patients were enrolled (mean, 78.1 [SD, 30.9] days; weight, 5.3 [SD, 1.1] kg)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1478,
          "offsetInEndSection": 1571,
          "text": "Larger studies are needed to assess the clinical efficacy of HHHFNC therapy in bronchiolitis."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 792,
          "offsetInEndSection": 879,
          "text": "On average, NP pressure increased by 0.45 cm H2O for each 1-L/min increase in flow rate"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114244",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 881,
          "offsetInEndSection": 995,
          "text": "There were significant differences between pressures in open- and closed-mouth states for flow rates up to 6 L/min"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 267,
          "offsetInEndSection": 414,
          "text": "Eptinezumab, delivered by intravenous (IV) administration, is being developed by Lundbeck Seattle BioPharmaceuticals for the prevention of migraine"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 416,
          "offsetInEndSection": 520,
          "text": "In February 2020, eptinezumab was approved in the USA for the preventive treatment of migraine in adults"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37743207",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1257,
          "offsetInEndSection": 1667,
          "text": "In patients in whom palivizumab is currently indicated, its substitution by nirsevimab is recommended to reduce the burden of bronchiolitis.\nRoutine administration of nirsevimab to all infants aged less than 6 months born during the RSV season or aged less than 6 months at the start of the winter season is recommended to reduce the burden of disease and the frequency of hospitalization due to bronchiolitis."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37743207",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 401,
          "text": "Nirsevimab, a monoclonal antibody for the prevention of disease caused by respiratory syncytial virus (RSV), has recently been approved for use in Europe and Spain.\nTo provide recommendations for the administration of nirsevimab for prevention of RSV disease.\nThe approach chosen to develop these recommendations involved a critical review of the literature and the use of the Delphi and GRADE methods"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37743207",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 403,
          "offsetInEndSection": 429,
          "text": "An expert group was formed"
        }
      ]
    },
    {
      "id": "680bc7a718b1e36f2e000156",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
        "http://www.ncbi.nlm.nih.gov/pubmed/29295136",
        "http://www.ncbi.nlm.nih.gov/pubmed/20071548",
        "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
        "http://www.ncbi.nlm.nih.gov/pubmed/25130173",
        "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
        "http://www.ncbi.nlm.nih.gov/pubmed/27064462"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 227,
          "text": "Nanog is a stem cell transcription factor required for self-renewal and for maintaining pluripotency, and Nanog itself is regulated at least in part by leukaemia inhibitory factor (LIF)--a pluripotent cytokine of the IL6 family"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 229,
          "offsetInEndSection": 454,
          "text": "MARCH-7 is an E-3 ligase linked to regulation of the LIF-receptor in T lymphocytes and T cells from mice that lack expression of MARCH-7 are hyper-responsive to activation signals and show a five-fold increase in LIF activity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 456,
          "offsetInEndSection": 897,
          "text": "Here we ask, does MARCH-7 influence the expression profile of Nanog during the synchronized entry of T cells into the cell cycle? We discovered that lack of MARCH-7 was permissive for Nanog expression at both transcript and protein levels during G₁/S: moreover, addition of exogenous LIF to the MARCH-7 null cells caused a further 13-fold induction of Nanog; other measured transcripts including TGFβ, p53 and STAT3 were relatively unchanged"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 899,
          "offsetInEndSection": 1148,
          "text": "Since lack of MARCH-7 altered responsiveness to activation signals we sought evidence for pre-existing regulatory miR's that might correlate with MARCH-7 gene dose using head-to-head comparisons between MARCH-7 null, heterozygous and wt spleen cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1150,
          "offsetInEndSection": 1314,
          "text": "34 miRs were found including miR-346 that is known to target LIF transcripts and miR-346 is one of 16 miRs differentially expressed between hESCs and induced hiPSCs"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1399,
          "offsetInEndSection": 1525,
          "text": "In summary, in the absence of MARCH-7 a new signaling pathway is unmasked that involves Nanog expression in the T cell lineage"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1527,
          "offsetInEndSection": 1654,
          "text": "This is the first demonstration that T cells retain responsiveness to a LIF/Nanog axis and that this axis is linked to MARCH-7."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20962578",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1316,
          "offsetInEndSection": 1397,
          "text": "Of the 34 miRs, 12 were known to be temporally regulated in embryonic nerve cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 193,
          "text": "One of the most important protein complexes involved in maintaining correct RNA levels in eukaryotic cells is the exosome, a complex consisting almost exclusively of exoribonucleolytic proteins"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 195,
          "offsetInEndSection": 381,
          "text": "Since the identification of the exosome complex, seven years ago, much progress has been made in the characterization of its composition, structure and function in a variety of organisms"
        }
      ]
    },
    {
      "id": "67e56f2018b1e36f2e0000b0",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
        "http://www.ncbi.nlm.nih.gov/pubmed/20232113",
        "http://www.ncbi.nlm.nih.gov/pubmed/29140466",
        "http://www.ncbi.nlm.nih.gov/pubmed/29053785",
        "http://www.ncbi.nlm.nih.gov/pubmed/2534509",
        "http://www.ncbi.nlm.nih.gov/pubmed/15578997",
        "http://www.ncbi.nlm.nih.gov/pubmed/10481836",
        "http://www.ncbi.nlm.nih.gov/pubmed/23292513",
        "http://www.ncbi.nlm.nih.gov/pubmed/17420471",
        "http://www.ncbi.nlm.nih.gov/pubmed/18485618"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 87,
          "text": "Prostate cancer is the second leading cause of cancer death in men in the United States"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 89,
          "offsetInEndSection": 228,
          "text": "The disease is driven by androgen receptor (AR) signaling, and the majority of patients initially respond to androgen deprivation therapies"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 230,
          "offsetInEndSection": 429,
          "text": "The lethal form of this disease occurs when metastatic lesions progress in the setting of low testosterone levels, in what is conventionally referred to as castration-resistant prostate cancer (CRPC)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 431,
          "offsetInEndSection": 842,
          "text": "Recent insights suggest that CRPC continues to rely on an active AR pathway for cell survival and growth.\nThis review summarizes the rationale, mechanism of action and relevant clinical data of abiraterone acetate , an oral androgen biosynthesis inhibitor, in the management of CRPC.\nAbiraterone acetate is an oral, well-tolerated drug that targets a newly elucidated paradigm of continued AR activation in CRPC"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 844,
          "offsetInEndSection": 1027,
          "text": "Abiraterone acetate is approved in CRPC patients who have received docetaxel, and recent data suggest that the drug will also be effective and utilized in the pre-chemotherapy setting"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1029,
          "offsetInEndSection": 1143,
          "text": "Significant areas of scientific investigation remain in the optimization and further understanding of the therapy."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20232113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 241,
          "text": "Besides the well-characterized genomic action of thyroid hormone (TH), mediated by thyroid hormone receptors (TRs), accumulating data support the so-called non-genomic action of TH, which is often related to activation of signalling pathways"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20232113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 243,
          "offsetInEndSection": 483,
          "text": "In this study, we sought to determine whether TH activates intracellular signalling pathways in the adult cardiac myocytes and whether such activation modulates cell growth and the expression of target proteins important in cardiac function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20232113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 613,
          "offsetInEndSection": 848,
          "text": "This activation is inhibited by triiodothyroacetic acid (triac), which is a TH analogue known to displace the hormone from membrane bound receptors, indicating that this TH effect is mediated through a cell membrane-initiated mechanism"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20232113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 850,
          "offsetInEndSection": 1199,
          "text": "Furthermore, using specific inhibitors of the TH-activated kinases, we show that the long-term effects of TH on the expression of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA), alpha- and beta-myosin heavy chain (MHC) and cell growth are reverted, implying that what is initiated as a non-genomic action of the hormone interfaces with genomic effects"
        }
      ]
    },
    {
      "id": "67fe5f0918b1e36f2e000144",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15717219",
        "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
        "http://www.ncbi.nlm.nih.gov/pubmed/17868431",
        "http://www.ncbi.nlm.nih.gov/pubmed/26085906",
        "http://www.ncbi.nlm.nih.gov/pubmed/19282388",
        "http://www.ncbi.nlm.nih.gov/pubmed/19137372",
        "http://www.ncbi.nlm.nih.gov/pubmed/27722180",
        "http://www.ncbi.nlm.nih.gov/pubmed/24320032",
        "http://www.ncbi.nlm.nih.gov/pubmed/27709008",
        "http://www.ncbi.nlm.nih.gov/pubmed/18462375"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 195,
          "text": "Familial hypercholesterolemia (FH) is an autosomal dominant inherited metabolic disorder resulting in advanced vascular atherosclerosis and premature death, primarily from coronary artery disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 197,
          "offsetInEndSection": 320,
          "text": "The primary defect is a mutation in the gene encoding for the plasma LDL receptor located on the short arm of chromosome 19"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 322,
          "offsetInEndSection": 408,
          "text": "Liver transplantation is currently the most effective method of treating this disorder"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 410,
          "offsetInEndSection": 559,
          "text": "Living-related liver transplantation (LRLT) has become an excellent modality for treating children, including those with inherited metabolic diseases"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 561,
          "offsetInEndSection": 701,
          "text": "In this paper, we describe the first report of a LRLT for familial hypercholesterolemia and review FH and the role of liver transplantation."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 288,
          "text": "Today, the assessment of liver function in patients suffering from acute or chronic liver disease is based on liver biopsy and blood tests including synthetic function, liver enzymes and viral load, most of which provide only circumstantial evidence as to the degree of hepatic impairment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 290,
          "offsetInEndSection": 460,
          "text": "Most of these tests lack the degree of sensitivity to be useful for follow-up of these patients at the frequency that is needed for decision making in clinical hepatology"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 462,
          "offsetInEndSection": 712,
          "text": "Accurate assessment of liver function is essential to determine both short- and long-term prognosis, and for making decisions about liver and non-liver surgery, TIPS, chemoembolization or radiofrequency ablation in patients with chronic liver disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 714,
          "offsetInEndSection": 905,
          "text": "Liver function tests can serve as the basis for accurate decision-making regarding the need for liver transplantation in the setting of acute failure or in patients with chronic liver disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 907,
          "offsetInEndSection": 1031,
          "text": "The liver metabolic breath test relies on measuring exhaled (13) C tagged methacetin, which is metabolized only by the liver"
        }
      ]
    },
    {
      "id": "67fbe4d718b1e36f2e00011d",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8302780",
        "http://www.ncbi.nlm.nih.gov/pubmed/8873960",
        "http://www.ncbi.nlm.nih.gov/pubmed/23847260",
        "http://www.ncbi.nlm.nih.gov/pubmed/17534191",
        "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
        "http://www.ncbi.nlm.nih.gov/pubmed/22435808",
        "http://www.ncbi.nlm.nih.gov/pubmed/26140505",
        "http://www.ncbi.nlm.nih.gov/pubmed/21607086",
        "http://www.ncbi.nlm.nih.gov/pubmed/20386670",
        "http://www.ncbi.nlm.nih.gov/pubmed/16775366"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8302780",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "Contrary to what is observed in true hermaphroditism and in male pseudo-hermaphroditism, there is no erroneous transmission of the genetic gonadal differentiation programme in female pseudohermaphroditism"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8302780",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 206,
          "offsetInEndSection": 342,
          "text": "All that has happened is virilization of the urogenital sinus and external genitalia in a foetus exposed to exo- or endogenous androgens"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8302780",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 344,
          "offsetInEndSection": 598,
          "text": "In the absence of testis there is no production of anti-mullerian hormone, and for these reasons the uterus, the fallopian tubes and the vagina develop normally, whilst the wollfian ducts are regressed and there is no trace of male deep spermatic pathway"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8302780",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 600,
          "offsetInEndSection": 777,
          "text": "On the basis of recent acquisitions in biochemistry, endocrinology and embryogenesis, the authors compare the various degrees of virilization with the biochemical abnormalities."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8873960",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "Paget's disease is the most exaggerated example of bone remodeling in which abnormal osteoclastic bone resorption remains coupled to new bone formation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8873960",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 153,
          "offsetInEndSection": 314,
          "text": "There are abnormalities in the stages of osteoclast development, and studies in Paget's disease have suggested a major role for IL-6 in human osteoclast activity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8873960",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 316,
          "offsetInEndSection": 461,
          "text": "The pathophysiologic basis for these abnormalities is not clearly defined, except that the primary cellular abnormality resides in the osteoclast"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8873960",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 463,
          "offsetInEndSection": 1455,
          "text": "Many important questions about the pathophysiology of Paget's disease still remain to be answered, including: (1) What is the identity of the virus in pagetic osteoclasts?; (2) Are Paget's patients in different geographical locales harboring a similar virus in their osteoclasts, or can different paramyxoviruses induce Paget's disease?; (3) How is the virus maintained and propagated for many years, so that it can be expressed in the osteoclast, a cell with a finite lifespan?; and (4) Since Paget's disease has a very high familial tendency, with up to 40% of patients having an affected relative, what is the genetic locus associated with Paget's disease, and does this genotype result in an increased propensity for hematopoietic cells such as the osteoclast to harbor paramyxoviruses? The application of the techniques of molecular and cell biology to Paget's disease should provide answers to some of these questions and give important insights into the normal bone remodeling process."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23847260",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 179,
          "text": "In female mammals, the dosage difference in X-linked genes between XX females and XY males is compensated for by inactivating one of the two X chromosomes during early development"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23847260",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 181,
          "offsetInEndSection": 503,
          "text": "Since the discovery of the X inactive-specific transcript (XIST) gene in humans and its subsequent isolation of the mouse homolog, Xist, in the early 1990s, the molecular basis of X chromosome inactivation (X-inactivation) has been more fully elucidated using genetically manipulated mouse embryos and embryonic stem cells"
        }
      ]
    },
    {
      "id": "680a079718b1e36f2e000147",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29163501",
        "http://www.ncbi.nlm.nih.gov/pubmed/27467937",
        "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
        "http://www.ncbi.nlm.nih.gov/pubmed/29642292",
        "http://www.ncbi.nlm.nih.gov/pubmed/34535671",
        "http://www.ncbi.nlm.nih.gov/pubmed/27872101",
        "http://www.ncbi.nlm.nih.gov/pubmed/33468562",
        "http://www.ncbi.nlm.nih.gov/pubmed/28795321",
        "http://www.ncbi.nlm.nih.gov/pubmed/19056158",
        "http://www.ncbi.nlm.nih.gov/pubmed/33192571"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29163501",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 85,
          "offsetInEndSection": 238,
          "text": "The unique ability of natural killer (NK) cells to kill cancer cells independent of major histocompatibility requirement makes them suitable as ACT tools"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29163501",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "text": "Optimal adoptive cell therapy (ACT) should contribute to effective cancer treatment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29163501",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 240,
          "offsetInEndSection": 353,
          "text": "Herceptin, an antihuman epidermal growth factor receptor-2 (anti-HER2) monoclonal antibody, is used to treat HER2"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27467937",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 237,
          "offsetInEndSection": 351,
          "text": "Despite treatment with chemotherapeutic agents and advance disease, cancer patients remain sensitive to motolimod."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27467937",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 84,
          "offsetInEndSection": 235,
          "text": "Motolimod, a selective TLR8 agonist can act in concert with approved immunotherapies to sensitize T cells and augment natural killer (NK) cell function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27467937",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 82,
          "text": "A novel approach to immunotherapy is the activation of toll-like receptor 8 (TLR8)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 117,
          "offsetInEndSection": 269,
          "text": "They become educated by interacting with major histocompatibility antigen (MHC) class I molecules to gain function to kill targets and produce cytokines"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 728,
          "offsetInEndSection": 1013,
          "text": "Bispecific or trispecific killer engagers that target CD16 on NK cells to enhance recognition of tumor antigens, and desintegrin and metalloproteinase 17 (ADAM17) inhibition that prevents CD16 shedding after NK-cell activation should promote enhanced killing of cancer with specificity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 271,
          "offsetInEndSection": 355,
          "text": "In the clinic, haploidentical NK cells can be adoptively transferred to treat cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941379",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Natural killer (NK) cells recognize targets stressed by malignant transformation or infection and can be long-lived"
        }
      ]
    },
    {
      "id": "67e5749b18b1e36f2e0000b5",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
        "http://www.ncbi.nlm.nih.gov/pubmed/22391123",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/21429248",
        "http://www.ncbi.nlm.nih.gov/pubmed/21549021",
        "http://www.ncbi.nlm.nih.gov/pubmed/22717525",
        "http://www.ncbi.nlm.nih.gov/pubmed/23408854",
        "http://www.ncbi.nlm.nih.gov/pubmed/31633842",
        "http://www.ncbi.nlm.nih.gov/pubmed/23495208",
        "http://www.ncbi.nlm.nih.gov/pubmed/22548568"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 109,
          "offsetInEndSection": 400,
          "text": "We compare the national guidelines and the use of glucose lowering medication for type 2 diabetes (T2D) in Denmark, Finland, Norway and Sweden.\nWe compared how guidelines take comprehensive care into consideration, what treatment targets and what antihyperglycemic medication was recommended"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 571,
          "offsetInEndSection": 665,
          "text": "Individualized glycemic targets are emphasized especially in the Danish and Finnish guidelines"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1073,
          "offsetInEndSection": 1171,
          "text": "Danish and Finnish guidelines strongly underline the importance of individualized glycemic targets"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 107,
          "text": "Clinical guidelines form one of the cornerstones for providing high-quality care for patients with diabetes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 402,
          "offsetInEndSection": 569,
          "text": "The use of glucose-lowering medication was based on the sales of diabetes drugs in these countries.\nAll guidelines stress the importance of comprehensive diabetes care"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 667,
          "offsetInEndSection": 835,
          "text": "In 2013, sulfonylureas were the most common second-line treatment after metformin in Denmark, Norway and Sweden; in Finland, this position was taken by DPP-4 inhibitors"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 837,
          "offsetInEndSection": 926,
          "text": "Recommended initial insulin type for patients with T2D differs between the four countries"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1173,
          "offsetInEndSection": 1250,
          "text": "All guidelines recommend metformin as the initial oral antihyperglycemic drug"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1252,
          "offsetInEndSection": 1407,
          "text": "In relation to recommended second line drug therapy and initial insulin type for patients with T2D, the guidelines vary largely between the four countries."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26890317",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 928,
          "offsetInEndSection": 1071,
          "text": "Danish, Norwegian and Swedish guidelines also take economic aspects into account.\nAll guidelines stress regular and comprehensive diabetes care"
        }
      ]
    },
    {
      "id": "680d5f2a353a4a2e6b000006",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
        "http://www.ncbi.nlm.nih.gov/pubmed/19529061",
        "http://www.ncbi.nlm.nih.gov/pubmed/24730627",
        "http://www.ncbi.nlm.nih.gov/pubmed/25493340",
        "http://www.ncbi.nlm.nih.gov/pubmed/26627987",
        "http://www.ncbi.nlm.nih.gov/pubmed/313731",
        "http://www.ncbi.nlm.nih.gov/pubmed/33742041",
        "http://www.ncbi.nlm.nih.gov/pubmed/32897034",
        "http://www.ncbi.nlm.nih.gov/pubmed/22046001",
        "http://www.ncbi.nlm.nih.gov/pubmed/16940490"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "It is estimated that 1-13% of cases of bronchiectasis in adults globally are attributable to primary ciliary dyskinesia (PCD) but many adult patients with bronchiectasis have not been investigated for PCD"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 206,
          "offsetInEndSection": 346,
          "text": "PCD is a disorder caused by mutations in genes required for motile cilium structure or function, resulting in impaired mucociliary clearance"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 348,
          "offsetInEndSection": 498,
          "text": "Symptoms appear in infancy but diagnosis is often late or missed, often due to the lack of a \"gold standard\" diagnostic tool and non-specific symptoms"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 500,
          "offsetInEndSection": 915,
          "text": "Mutations in > 50 genes account for around 70% of cases, with additional genes, and non-coding, synonymous, missense changes or structural variants (SVs) in known genes presumed to account for the missing heritability.\nUK patients with no identified genetic confirmation for the cause of their PCD or bronchiectasis were eligible for whole genome sequencing (WGS) in the Genomics England Ltd 100,000 Genomes Project"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 917,
          "offsetInEndSection": 1042,
          "text": "21 PCD probands and 52 non-cystic fibrosis (CF) bronchiectasis probands were recruited in Wessex Genome Medicine Centre (GMC)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1044,
          "offsetInEndSection": 1368,
          "text": "We carried out analysis of single nucleotide variants (SNVs) and SVs in all families recruited in Wessex GMC.\n16/21 probands in the PCD cohort received confirmed (n = 9), probable (n = 4) or possible (n = 3) diagnosis from WGS, although 13/16 of these could have been picked up by current standard of care gene panel testing"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1370,
          "offsetInEndSection": 1444,
          "text": "In the other cases, SVs were identified which were missed by panel testing"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1549,
          "offsetInEndSection": 1664,
          "text": "3/52 probands in the non-CF bronchiectasis cohort received a confirmed (n = 2) or possible (n = 1) diagnosis of PCD"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1666,
          "offsetInEndSection": 1905,
          "text": "We identified variants in novel PCD candidate genes (CFAP53 and CEP164) in 2 further probands in the non-CF bronchiectasis cohort.\nGenetic testing is an important component of diagnosing PCD, especially in cases of atypical disease history"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34556108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1907,
          "offsetInEndSection": 2015,
          "text": "WGS is effective in cases where prior gene panel testing has found no variants or only heterozygous variants"
        }
      ]
    },
    {
      "id": "6810f6f0353a4a2e6b000015",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
        "http://www.ncbi.nlm.nih.gov/pubmed/24567800",
        "http://www.ncbi.nlm.nih.gov/pubmed/18840004",
        "http://www.ncbi.nlm.nih.gov/pubmed/32730231",
        "http://www.ncbi.nlm.nih.gov/pubmed/26694823",
        "http://www.ncbi.nlm.nih.gov/pubmed/31796986",
        "http://www.ncbi.nlm.nih.gov/pubmed/37086147",
        "http://www.ncbi.nlm.nih.gov/pubmed/26770990",
        "http://www.ncbi.nlm.nih.gov/pubmed/27835045",
        "http://www.ncbi.nlm.nih.gov/pubmed/34819089"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 394,
          "offsetInEndSection": 682,
          "text": "Baseline regimens (prior to IDegLira treatment) were categorized as: multiple daily insulin injections (MDI; 28%); glucagon-like peptide-1 (GLP-1) receptor agonists in combination with insulin (24%); basal insulin (19%); GLP-1 receptor agonists (10%); and non-injectable medications (19%)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1197,
          "offsetInEndSection": 1414,
          "text": "IDegLira reduced direct medical costs versus GLP-1 receptor agonists in combination with insulin, and versus GLP-1 receptor agonist therapy, and was therefore considered dominant (cost saving while improving outcomes)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 392,
          "text": "To evaluate the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus comparator regimens for type 2 diabetes in Spain, based on real-world evidence.\nClinical data were taken from the European Xultophy Treatment Retrospective Audit (EXTRA) real-world evidence study in which patients failing to meet glycaemic targets were switched to IDegLira"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 935,
          "offsetInEndSection": 1195,
          "text": "Future costs and clinical benefits were discounted at 3% annually and sensitivity analyses were performed.\nIDegLira was projected to reduce the incidence of diabetes-related complications and improve quality-adjusted life expectancy versus all four comparators"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1416,
          "offsetInEndSection": 1861,
          "text": "IDegLira was found to be cost-effective versus MDI and basal insulin with incremental cost-effectiveness ratios of EUR 3013 per quality-adjusted life-year (QALY) gained and EUR 6890 per QALY gained, respectively.\nLong-term projections based on real-world evidence indicated that IDegLira is likely to improve clinical outcomes and reduce costs or be cost-effective compared with other injectable regimens in people with type 2 diabetes in Spain."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30740861",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 684,
          "offsetInEndSection": 861,
          "text": "The IQVIA CORE Diabetes Model was used to project long-term outcomes for patients switching to IDegLira or continuing their baseline regimens (excluding non-injectable regimens)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24567800",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 224,
          "text": "There are many advantages of combining incretin therapy [glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors] with insulin therapy as a glucose-lowering strategy in type 2 diabetes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24567800",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 451,
          "offsetInEndSection": 778,
          "text": "Several clinical trials have studied the addition of GLP-1 receptor agonists [exenatide BID (twice daily), lixisenatide, albiglutide] or DPP-4 inhibitors (vildagliptin, sitagliptin, saxagliptin, alogliptin, linagliptin) to ongoing insulin therapy or adding insulin to ongoing therapy with a GLP-1 receptor agonist (liraglutide)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24567800",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 226,
          "offsetInEndSection": 333,
          "text": "One important advantage is the complementary mode of the mechanistic action of incretin and insulin therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24567800",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 335,
          "offsetInEndSection": 449,
          "text": "Another advantage is the reduction in risk of hypoglycemia and weight gain when adding incretin therapy to insulin"
        }
      ]
    },
    {
      "id": "680a237618b1e36f2e000152",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
        "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
        "http://www.ncbi.nlm.nih.gov/pubmed/22736234",
        "http://www.ncbi.nlm.nih.gov/pubmed/25201633",
        "http://www.ncbi.nlm.nih.gov/pubmed/26420896",
        "http://www.ncbi.nlm.nih.gov/pubmed/26692525",
        "http://www.ncbi.nlm.nih.gov/pubmed/28960585",
        "http://www.ncbi.nlm.nih.gov/pubmed/21983866",
        "http://www.ncbi.nlm.nih.gov/pubmed/21390826",
        "http://www.ncbi.nlm.nih.gov/pubmed/28259301"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 12,
          "offsetInEndSection": 179,
          "text": "The Rockall, Glasgow-Blatchford, and AIMS65 are useful and validated scoring systems for predicting the outcomes of patients with nonvariceal gastrointestinal bleeding"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1196,
          "offsetInEndSection": 1297,
          "text": "Other scoring systems might be useful for predicting significant clinical outcomes in these patients."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 181,
          "offsetInEndSection": 277,
          "text": "However, there are no validated evidence for using them to predict outcomes on variceal bleeding"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 279,
          "offsetInEndSection": 558,
          "text": "The aim of this study was to evaluate and compare the prognostic accuracy of different nonvariceal bleeding scores with other liver-specific scoring systems in cirrhotic patients.\nA retrospective multicenter study that included 160 cirrhotic patients with acute variceal bleeding"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 560,
          "offsetInEndSection": 752,
          "text": "The AUROC's to predict in-hospital mortality, and rebleeding, were analyzed for each scoring system.\nOverall in-hospital mortality occurred in 13% and in-hospital rebleeding in 12% of patients"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 754,
          "offsetInEndSection": 894,
          "text": "The systems with the best AUROC value for predicting mortality were MELD (0.828; 95% CI 0.748-0.909), and AIMS65 (0.817; 95% CI 0.724-0.909)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27740523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 896,
          "offsetInEndSection": 1194,
          "text": "The best score systems for predicting rebleeding were Glasgow-Blatchford (0.756; 95% CI 0.640- 0.827), and Rockall (0.691; 95% CI 0.580-0.802).\nIn addition to liver-specific scores, the AIMS65 score is accurate for predicting in-hospital mortality in cirrhotic patients with acute variceal bleeding"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 141,
          "text": "Brain metastasis velocity (BMV) predicts outcomes after initial distant brain failure (DBF) following upfront stereotactic radiosurgery (SRS)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 143,
          "offsetInEndSection": 435,
          "text": "We developed an integrated model of clinical predictors and pre-SRS MRI-derived radiomic scores (R-scores) to identify high-BMV (BMV-H) patients upon initial identification of brain metastases (BMs).\nIn total, 256 patients with BMs treated with upfront SRS alone were retrospectively included"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33817641",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 437,
          "offsetInEndSection": 646,
          "text": "R-scores were built from 1246 radiomic features in 2 target volumes by using the Extreme Gradient Boosting algorithm to predict BMV-H groups, as defined by BMV at least 4 or leptomeningeal disease at first DBF"
        }
      ]
    },
    {
      "id": "68110110353a4a2e6b000018",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
        "http://www.ncbi.nlm.nih.gov/pubmed/1354979",
        "http://www.ncbi.nlm.nih.gov/pubmed/34261138",
        "http://www.ncbi.nlm.nih.gov/pubmed/30602365",
        "http://www.ncbi.nlm.nih.gov/pubmed/12856055",
        "http://www.ncbi.nlm.nih.gov/pubmed/34318916",
        "http://www.ncbi.nlm.nih.gov/pubmed/26016316",
        "http://www.ncbi.nlm.nih.gov/pubmed/20973886",
        "http://www.ncbi.nlm.nih.gov/pubmed/24157119",
        "http://www.ncbi.nlm.nih.gov/pubmed/19837254"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Acetaminophen (APAP) overdose is the leading cause of acute liver failure (ALF) with limited treatment options"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 218,
          "offsetInEndSection": 490,
          "text": "Previous studies from our laboratory using an incremental dose model involving a regenerating (300 mg/kg, APAP300) and a nonregenerating (600 mg/kg, APAP600) dose of APAP in mice have revealed several proregenerative pathways that regulate regeneration after APAP overdose"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 492,
          "offsetInEndSection": 610,
          "text": "Here we report that DNA damage and repair mechanisms regulate initiation of liver regeneration following APAP overdose"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1283,
          "offsetInEndSection": 1526,
          "text": "Taken together, these data show that massive DNA DSB occurs in high-dose APAP toxicity, and lack of prompt DSB repair after APAP overdose leads to prolonged growth arrest and proliferative senescence, resulting in inhibited liver regeneration."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 112,
          "offsetInEndSection": 216,
          "text": "It is known that liver regeneration following APAP-induced ALF is a deciding factor in the final outcome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 612,
          "offsetInEndSection": 765,
          "text": "Mice treated with nonregenerating APAP600 dose showed prolonged expression of pH2AX, a marker of the DNA double-strand break (DSB), compared with APAP300"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 767,
          "offsetInEndSection": 883,
          "text": "In regenerating APAP300 dose-treated mice, H2AX was rapidly dephosphorylated at Tyr142, indicating timely DNA repair"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 885,
          "offsetInEndSection": 963,
          "text": "Expression of several DNA repair proteins was substantially lower with APAP600"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 965,
          "offsetInEndSection": 1111,
          "text": "Poly(ADP) ribose polymerase (PARP) activation, involved in DNA repair, was significantly higher in the APAP300 group compared to the APAP600 group"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29540258",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1113,
          "offsetInEndSection": 1281,
          "text": "Activation of p53, the major cell cycle checkpoint protein, was significantly higher with APAP600 as demonstrated by substantially higher expression of its target genes"
        }
      ]
    },
    {
      "id": "680f4c63353a4a2e6b00000d",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
        "http://www.ncbi.nlm.nih.gov/pubmed/23700068",
        "http://www.ncbi.nlm.nih.gov/pubmed/23687004",
        "http://www.ncbi.nlm.nih.gov/pubmed/32243020",
        "http://www.ncbi.nlm.nih.gov/pubmed/6945487",
        "http://www.ncbi.nlm.nih.gov/pubmed/15233598",
        "http://www.ncbi.nlm.nih.gov/pubmed/23259418",
        "http://www.ncbi.nlm.nih.gov/pubmed/20127218",
        "http://www.ncbi.nlm.nih.gov/pubmed/29351538",
        "http://www.ncbi.nlm.nih.gov/pubmed/2644915"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 48,
          "text": "Obesity is associated with multiple health risks"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 50,
          "offsetInEndSection": 155,
          "text": "Bariatric surgery is a treatment for clinically severe obesity and is known to increase urolithiasis risk"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 157,
          "offsetInEndSection": 217,
          "text": "However, trends in risk over time are not well characterized"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 302,
          "offsetInEndSection": 535,
          "text": "A comparison of urinary risk of urolithiasis after the Roux-en-Y and gastric banding procedures was performed.\nWe evaluated 24-hour urine collections from 39 subjects (11 male and 28 female, mean age 51 years) after bariatric surgery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1254,
          "offsetInEndSection": 1523,
          "text": "Dietary intake of high oxalate foods did not correlate with urinary oxalate excretion or with hyperoxaluria.\nOur study confirms the risk of urinary stones following the Roux-en-Y gastric bypass procedure as a result of hyperoxaluria, low urine volume and hypocitraturia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1585,
          "offsetInEndSection": 1733,
          "text": "Future studies should elucidate the effect of nutrition and/or pharmacological therapy on stone risk of both surgeries as their incidence increases."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 814,
          "offsetInEndSection": 952,
          "text": "Urinary calcium excretion was lower (p = 0.001) in the Roux-en-Y gastric bypass (100 mg daily) vs the gastric banding group (191 mg daily)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 954,
          "offsetInEndSection": 1079,
          "text": "After Roux-en-Y gastric bypass surgery 48% had a urinary oxalate of 45 mg daily or more compared to 25% after gastric banding"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1081,
          "offsetInEndSection": 1206,
          "text": "Urinary citrate was less than 370 mg daily for 14 subjects in the Roux-en-Y gastric bypass and 1 in the gastric banding group"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 537,
          "offsetInEndSection": 630,
          "text": "Of these subjects 27 underwent Roux-en-Y gastric bypass and 12 had gastric banding procedures"
        }
      ]
    },
    {
      "id": "680a087218b1e36f2e00014f",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
        "http://www.ncbi.nlm.nih.gov/pubmed/29359419",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/21246178",
        "http://www.ncbi.nlm.nih.gov/pubmed/30626381",
        "http://www.ncbi.nlm.nih.gov/pubmed/21645191",
        "http://www.ncbi.nlm.nih.gov/pubmed/31633842",
        "http://www.ncbi.nlm.nih.gov/pubmed/25753522",
        "http://www.ncbi.nlm.nih.gov/pubmed/34807422",
        "http://www.ncbi.nlm.nih.gov/pubmed/7607795"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 43,
          "offsetInEndSection": 180,
          "text": "They vary greatly in terms of associated regulatory elements, sequence motifs, the choice of transcription start sites and other features"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 182,
          "offsetInEndSection": 423,
          "text": "Several technologies that harness next-generation sequencing have enabled recent advances in identifying promoters and their features, helping researchers who are investigating functional categories of promoters and their modes of regulation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 425,
          "offsetInEndSection": 594,
          "text": "Additional features of promoters that are being characterized include types of histone modifications, nucleosome positioning, RNA polymerase pausing and novel small RNAs"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 596,
          "offsetInEndSection": 770,
          "text": "In this Review, we discuss recent findings relating to metazoan promoters and how these findings are leading to a revised picture of what a gene promoter is and how it works."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 41,
          "text": "Promoters are crucial for gene regulation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29359419",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 127,
          "text": "Pluripotency denotes the flexible capacity of single cells to give rise to all somatic lineages and typically also the germline"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29359419",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 252,
          "offsetInEndSection": 317,
          "text": "These two in vitro stem cell types have divergent characteristics"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29359419",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 319,
          "offsetInEndSection": 444,
          "text": "They are considered as representative of distinct developmental stages, distinguished by using the terms \"naïve\" and \"primed\""
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29359419",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 446,
          "offsetInEndSection": 501,
          "text": "A binary description is an over-simplification, however"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29359419",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 503,
          "offsetInEndSection": 582,
          "text": "Here, we discuss an intermediate stage of pluripotency that we term \"formative\""
        }
      ]
    },
    {
      "id": "6810daad353a4a2e6b000013",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
        "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
        "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
        "http://www.ncbi.nlm.nih.gov/pubmed/26068773",
        "http://www.ncbi.nlm.nih.gov/pubmed/24440934",
        "http://www.ncbi.nlm.nih.gov/pubmed/11033584",
        "http://www.ncbi.nlm.nih.gov/pubmed/24672652",
        "http://www.ncbi.nlm.nih.gov/pubmed/11863113",
        "http://www.ncbi.nlm.nih.gov/pubmed/26204547",
        "http://www.ncbi.nlm.nih.gov/pubmed/24818516"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 199,
          "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 201,
          "offsetInEndSection": 331,
          "text": "But variability in fecal bacterial communities-believed to be the therapeutic agent-can complicate or undermine treatment efficacy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 333,
          "offsetInEndSection": 678,
          "text": "To understand the effects of transplant preparation methods on living fecal microbial communities, we applied a DNA-sequencing method (PMA-seq) that uses propidium monoazide (PMA) to differentiate between living and dead fecal microbes, and we created an analysis pipeline to identify individual bacteria that change in abundance between samples"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 680,
          "offsetInEndSection": 864,
          "text": "We found that oxygen exposure degraded fecal bacterial communities, whereas freeze-thaw cycles and lag time between donor defecation and transplant preparation had much smaller effects"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1048,
          "offsetInEndSection": 1312,
          "text": "Our results indicate that some current practices for preparing microbiota transplant material adversely affect living fecal microbial content and highlight PMA-seq as a valuable tool to inform best practices and evaluate the suitability of clinical fecal material."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 866,
          "offsetInEndSection": 1046,
          "text": "Notably, the abundance of Faecalibacterium prausnitzii-an anti-inflammatory commensal bacterium whose absence is linked to inflammatory bowel disease-decreased with oxygen exposure"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 148,
          "offsetInEndSection": 332,
          "text": "A 61-year-old man with ulcerative pancolitis was diagnosed with a third recurrence of Clostridium difficile infection, previously treated with metronidazole, vancomycin and fidaxomicin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 334,
          "offsetInEndSection": 429,
          "text": "Fecal microbiota transplantation of an unrelated healthy donor was performed by the lower route"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 586,
          "offsetInEndSection": 816,
          "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure."
        }
      ]
    },
    {
      "id": "6810c27b353a4a2e6b000010",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
        "http://www.ncbi.nlm.nih.gov/pubmed/16310120",
        "http://www.ncbi.nlm.nih.gov/pubmed/15076016",
        "http://www.ncbi.nlm.nih.gov/pubmed/21907533",
        "http://www.ncbi.nlm.nih.gov/pubmed/28130396",
        "http://www.ncbi.nlm.nih.gov/pubmed/23567018",
        "http://www.ncbi.nlm.nih.gov/pubmed/25732238",
        "http://www.ncbi.nlm.nih.gov/pubmed/9381720",
        "http://www.ncbi.nlm.nih.gov/pubmed/35043116",
        "http://www.ncbi.nlm.nih.gov/pubmed/14564166"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 674,
          "offsetInEndSection": 847,
          "text": "There were 11 children who were treated with sertraline, and these patients were retrospectively compared to 34 children who were not treated with sertraline by chart review"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1039,
          "offsetInEndSection": 1222,
          "text": "Mean rate of improvement in both expressive and receptive language development was significantly higher in the group who was treated with sertraline (P < 0.0001 and P = 0.0071, resp.)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1224,
          "offsetInEndSection": 1326,
          "text": "This data supports the need for a controlled trial of sertraline treatment in young children with FXS."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 258,
          "offsetInEndSection": 432,
          "text": "We examined data through a chart review for 45 children with FXS, 12-50 months old, using the Mullen Scales of Early Learning (MSEL) for baseline and longitudinal assessments"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 434,
          "offsetInEndSection": 600,
          "text": "All children had clinical level of anxiety, language delays based on MSEL scores, and similar early learning composite (ELC) scores at their first visit to our clinic"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 602,
          "offsetInEndSection": 672,
          "text": "Incidence of autism spectrum disorder (ASD) was similar in both groups"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 849,
          "offsetInEndSection": 1037,
          "text": "The baseline assessments were done at ages ranging from 18 to 44 months (mean 26.9, SD 7.99) and from 12 to 50 months (mean 29.94, SD 8.64) for treated and not treated groups, respectively"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 136,
          "offsetInEndSection": 256,
          "text": "However, there are no medication recommendations with documented efficacy for children under 5 years old of age with FXS"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22934167",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 134,
          "text": "Young children with fragile X syndrome (FXS) often experience anxiety, irritability, and hyperactivity related to sensory hyperarousal"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16310120",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1143,
          "offsetInEndSection": 1409,
          "text": "The use of sertraline increased by 62% to 345,576 visits and paroxetine by 269% to 279,275 visits.\nWe observed a declining trend in the provision of psychotherapy/mental health counseling during outpatient visits by children and adolescents diagnosed with depression"
        }
      ]
    },
    {
      "id": "680a07a418b1e36f2e000148",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23719940",
        "http://www.ncbi.nlm.nih.gov/pubmed/22789131",
        "http://www.ncbi.nlm.nih.gov/pubmed/24325394",
        "http://www.ncbi.nlm.nih.gov/pubmed/29515123",
        "http://www.ncbi.nlm.nih.gov/pubmed/16221071",
        "http://www.ncbi.nlm.nih.gov/pubmed/14727085",
        "http://www.ncbi.nlm.nih.gov/pubmed/21507353",
        "http://www.ncbi.nlm.nih.gov/pubmed/20458667",
        "http://www.ncbi.nlm.nih.gov/pubmed/22374445",
        "http://www.ncbi.nlm.nih.gov/pubmed/22613852"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23719940",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 469,
          "offsetInEndSection": 687,
          "text": "Dendritic cells (DCs), the most potent professional antigen-presenting leukocytes of the immune system, release relatively high levels of exosomes and also interact with free exosomes present in the extracellular space"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23719940",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 158,
          "text": "Exosomes are extremely small (<100 nm) membrane vesicles, generated in the endocytic compartment that are released to the extracellular milieu by living cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23719940",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 689,
          "offsetInEndSection": 817,
          "text": "Therefore, DCs constitute a good model for the analysis of exosome-shuttle miRNAs and their horizontal propagation between cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23719940",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 160,
          "offsetInEndSection": 467,
          "text": "Although the biological function of exosomes in vivo remains unclear, they seem to function as mechanisms of cell-to-cell communication for horizontal transfer of proteins, antigens, prions, morphogens, mRNA, and noncoding regulatory RNAs, including microRNAs (miRNAs) (also known as exosome-shuttle miRNAs)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23719940",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 819,
          "offsetInEndSection": 1069,
          "text": "This chapter provides basic protocols for purification of exosomes released by mouse bone marrow-derived DCs, analysis of their miRNA content, and assessment of the function of exosome-shuttle miRNAs, once they are transferred to target/acceptor DCs."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 771,
          "offsetInEndSection": 1005,
          "text": "CD28SupA treatment led to a significant reduction in mechanical pain hypersensitivity, alongside a decrease in the numbers of infiltrating T cells, macrophages, and antigen-presenting cells in the sciatic nerve and dorsal root ganglia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1176,
          "offsetInEndSection": 1410,
          "text": "This was associated with a reduction in the numbers of T cells, macrophages, and antigen-presenting cells in the sciatic nerve and dorsal root ganglia, and reduced activation of microglia and infiltration of T cells in the spinal cord"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 121,
          "offsetInEndSection": 268,
          "text": "CD4+CD25+Foxp3+ regulatory T cells (Tregs) are endogenous immune suppressors, reducing T-cell proliferation and proinflammatory cytokine production"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 270,
          "offsetInEndSection": 329,
          "text": "Currently, the role of Tregs in neuropathic pain is unknown"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 331,
          "offsetInEndSection": 547,
          "text": "In this study, we tested the effects of expanding Tregs on pain hypersensitivity and neuroinflammation in 2 models of neuropathy; sciatic nerve chronic constriction injury and experimental autoimmune neuritis in rats"
        }
      ]
    },
    {
      "id": "67fbd58c18b1e36f2e00010e",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
        "http://www.ncbi.nlm.nih.gov/pubmed/30113005",
        "http://www.ncbi.nlm.nih.gov/pubmed/19444607",
        "http://www.ncbi.nlm.nih.gov/pubmed/28751258",
        "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
        "http://www.ncbi.nlm.nih.gov/pubmed/14502650",
        "http://www.ncbi.nlm.nih.gov/pubmed/25768905",
        "http://www.ncbi.nlm.nih.gov/pubmed/29974096",
        "http://www.ncbi.nlm.nih.gov/pubmed/21238939",
        "http://www.ncbi.nlm.nih.gov/pubmed/26303227"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 137,
          "text": "Alzheimer's disease (AD) is characterized by accumulation of two misfolded and aggregated proteins, β-amyloid and hyperphosphorylated tau"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 139,
          "offsetInEndSection": 384,
          "text": "Both cellular systems responsible for clearance of misfolded and aggregated proteins, the lysosomal and the proteasomal, have been shown to be malfunctioning in the aged brain and more so in patients with neurodegenerative diseases, including AD"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 956,
          "offsetInEndSection": 1176,
          "text": "Furthermore, reduced proteasome activity activated several proteins implicated in tau phosphorylation and AD pathology, including c-Jun N-terminal kinase, c-Jun and extracellular signal-regulated protein kinase (ERK) 1/2"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 386,
          "offsetInEndSection": 505,
          "text": "This malfunction could be contributing to β-amyloid and tau accumulation, eventually aggregating in plaques and tangles"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 507,
          "offsetInEndSection": 644,
          "text": "We have investigated the impact of decreased proteasome activity on tau phosphorylation as well as on microtubule stability and transport"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 646,
          "offsetInEndSection": 793,
          "text": "To do this, we used our recently developed neuronal model where human SH-SY5Y cells obtain neuronal morphology and function through differentiation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 795,
          "offsetInEndSection": 954,
          "text": "We found that exposure to low doses of the proteasome inhibitor MG-115 caused tau phosphorylation, microtubule destabilization and disturbed neuritic transport"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1178,
          "offsetInEndSection": 1382,
          "text": "Restoration of the microtubule transport was achieved by inhibiting ERK 1/2 activation, and simultaneous inhibition of both ERK 1/2 and c-Jun reversed the proteasome inhibition-induced tau phosphorylation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1384,
          "offsetInEndSection": 1567,
          "text": "Taken together, this study suggests that a decrease in proteasome activity can, through activation of c-Jun and ERK 1/2, result in several events related to neurodegenerative diseases"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24270002",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1569,
          "offsetInEndSection": 1731,
          "text": "Restoration of proteasome activity or modulation of ERK 1/2 and c-Jun function can open new treatment possibilities against neurodegenerative diseases such as AD."
        }
      ]
    },
    {
      "id": "67fbe10618b1e36f2e000111",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
        "http://www.ncbi.nlm.nih.gov/pubmed/29795071",
        "http://www.ncbi.nlm.nih.gov/pubmed/21571763",
        "http://www.ncbi.nlm.nih.gov/pubmed/23413037",
        "http://www.ncbi.nlm.nih.gov/pubmed/23516405",
        "http://www.ncbi.nlm.nih.gov/pubmed/25200592",
        "http://www.ncbi.nlm.nih.gov/pubmed/24201088",
        "http://www.ncbi.nlm.nih.gov/pubmed/30127341",
        "http://www.ncbi.nlm.nih.gov/pubmed/18432151",
        "http://www.ncbi.nlm.nih.gov/pubmed/22964266"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 754,
          "text": "To study the association between parental depression and maternal antidepressant use during pregnancy with autism spectrum disorders in offspring.\nPopulation based nested case-control study.\nStockholm County, Sweden, 2001-07.\n4429 cases of autism spectrum disorder (1828 with and 2601 without intellectual disability) and 43,277 age and sex matched controls in the full sample (1679 cases of autism spectrum disorder and 16,845 controls with data on maternal antidepressant use nested within a cohort (n=589,114) of young people aged 0-17 years.\nA diagnosis of autism spectrum disorder, with or without intellectual disability.\nParental depression and other characteristics prospectively recorded in administrative registers before the birth of the child"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 756,
          "offsetInEndSection": 1073,
          "text": "Maternal antidepressant use, recorded at the first antenatal interview, was available for children born from 1995 onwards.\nA history of maternal (adjusted odds ratio 1.49, 95% confidence interval 1.08 to 2.08) but not paternal depression was associated with an increased risk of autism spectrum disorders in offspring"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1075,
          "offsetInEndSection": 1370,
          "text": "In the subsample with available data on drugs, this association was confined to women reporting antidepressant use during pregnancy (3.34, 1.50 to 7.47, P=0.003), irrespective of whether selective serotonin reuptake inhibitors (SSRIs) or non-selective monoamine reuptake inhibitors were reported"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1372,
          "offsetInEndSection": 1536,
          "text": "All associations were higher in cases of autism without intellectual disability, there being no evidence of an increased risk of autism with intellectual disability"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1538,
          "offsetInEndSection": 1897,
          "text": "Assuming an unconfounded, causal association, antidepressant use during pregnancy explained 0.6% of the cases of autism spectrum disorder.\nIn utero exposure to both SSRIs and non-selective monoamine reuptake inhibitors (tricyclic antidepressants) was associated with an increased risk of autism spectrum disorders, particularly without intellectual disability"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1899,
          "offsetInEndSection": 2030,
          "text": "Whether this association is causal or reflects the risk of autism with severe depression during pregnancy requires further research"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23604083",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 2032,
          "offsetInEndSection": 2263,
          "text": "However, assuming causality, antidepressant use during pregnancy is unlikely to have contributed significantly towards the dramatic increase in observed prevalence of autism spectrum disorders as it explained less than 1% of cases."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29795071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Duchenne muscular dystrophy (DMD) is the most frequent and severe form of the dystrophinopathies"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29795071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 98,
          "offsetInEndSection": 181,
          "text": "The literature shows that about 30-40% of DMD subjects have intellectual disability"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29795071",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 488,
          "offsetInEndSection": 655,
          "text": "The aim of the present study was to describe a case series of children with Duchenne muscular dystrophy that have also the presence of autism spectrum disorders (ASDs)"
        }
      ]
    },
    {
      "id": "680fcb72353a4a2e6b00000e",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
        "http://www.ncbi.nlm.nih.gov/pubmed/30233361",
        "http://www.ncbi.nlm.nih.gov/pubmed/17489689",
        "http://www.ncbi.nlm.nih.gov/pubmed/23394539",
        "http://www.ncbi.nlm.nih.gov/pubmed/23020586",
        "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
        "http://www.ncbi.nlm.nih.gov/pubmed/24183081",
        "http://www.ncbi.nlm.nih.gov/pubmed/17997835",
        "http://www.ncbi.nlm.nih.gov/pubmed/20061809",
        "http://www.ncbi.nlm.nih.gov/pubmed/22937989"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "The field of non-coding RNA (ncRNA) has expanded over the last decade following the discoveries of several new classes of regulatory ncRNA"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 371,
          "offsetInEndSection": 580,
          "text": "Although this area of research is only in its infancy, this article focuses on several classes of regulatory ncRNA (i.e., miRNA, lncRNA, and circRNA), while summarizing their activities in mammalian heat shock"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 704,
          "offsetInEndSection": 894,
          "text": "Our model expands on the mechanisms for efficient execution of the stress response, while offering a more comprehensive summary of the major regulators and responders in heat shock signaling"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 140,
          "offsetInEndSection": 258,
          "text": "A growing amount of evidence now indicates that ncRNAs are involved even in the most fundamental of cellular processes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 260,
          "offsetInEndSection": 369,
          "text": "The heat shock response is no exception as ncRNAs are being identified as integral components of this process"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 582,
          "offsetInEndSection": 702,
          "text": "We also present an updated model integrating the traditional heat shock response with the activities of regulatory ncRNA"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24002685",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 896,
          "offsetInEndSection": 1031,
          "text": "It is our hope that much of what is discussed herein may help researchers in integrating the fields of heat shock and ncRNA in mammals."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30233361",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 69,
          "text": "The origins of the major classes of current anti-emetics are examined"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30233361",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 337,
          "offsetInEndSection": 369,
          "text": "Major drug classes include: (i)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30233361",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 71,
          "offsetInEndSection": 217,
          "text": "Serendipity is a recurrent theme in discovery of their anti-emetic properties and repurposing from one indication to another is a continuing trend"
        }
      ]
    },
    {
      "id": "6805568118b1e36f2e000145",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26798032",
        "http://www.ncbi.nlm.nih.gov/pubmed/24942635",
        "http://www.ncbi.nlm.nih.gov/pubmed/20694403",
        "http://www.ncbi.nlm.nih.gov/pubmed/25276464",
        "http://www.ncbi.nlm.nih.gov/pubmed/18315779",
        "http://www.ncbi.nlm.nih.gov/pubmed/33196758",
        "http://www.ncbi.nlm.nih.gov/pubmed/15296954",
        "http://www.ncbi.nlm.nih.gov/pubmed/23470070",
        "http://www.ncbi.nlm.nih.gov/pubmed/25314315",
        "http://www.ncbi.nlm.nih.gov/pubmed/23282091"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26798032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 219,
          "offsetInEndSection": 422,
          "text": "However, in September 2014, the World Health Organization inventoried and has since regularly updated a list of potential drug candidates with demonstrated antiviral efficacy in in vitro or animal models"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26798032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 137,
          "text": "The 2014-2015 outbreak of Ebola virus disease is the largest epidemic to date in terms of the number of cases, deaths, and affected areas"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26798032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 424,
          "offsetInEndSection": 689,
          "text": "This includes agents belonging to various therapeutic classes, namely direct antiviral agents (favipiravir and BCX4430), a combination of antibodies (ZMapp), type I interferons, RNA interference-based drugs (TKM-Ebola and AVI-7537), and anticoagulant drugs (rNAPc2)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26798032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 691,
          "offsetInEndSection": 939,
          "text": "Here, we review the pharmacokinetic and pharmacodynamic information presently available for these drugs, using data obtained in healthy volunteers for pharmacokinetics and data obtained in human clinical trials or animal models for pharmacodynamics"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26798032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 941,
          "offsetInEndSection": 1130,
          "text": "Future studies evaluating these drugs in clinical trials are critical to confirm their efficacy in humans, propose appropriate doses, and evaluate the possibility of treatment combinations."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 787,
          "offsetInEndSection": 959,
          "text": "However, it has not yet been demonstrated whether the dual orexin receptor antagonists (DORAs) under development for insomnia are ideal drugs for the treatment of addiction"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 961,
          "offsetInEndSection": 1194,
          "text": "The question of whether to use a DORA or single orexin receptor antagonist (SORA) for the treatment of addiction is a key question that will need to be answered in order to maximize the clinical utility of orexin receptor antagonists"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 116,
          "offsetInEndSection": 295,
          "text": "The orexin/hypocretin system is an attractive potential therapeutic target as demonstrated by the successful clinical trials of antagonist medications like Suvorexant for insomnia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 540,
          "offsetInEndSection": 785,
          "text": "The orexins have been shown to have a role in mediating the effects of several drugs of abuse, such as cocaine, morphine and alcohol via projections to key brain regions such as the ventral tegmental area, nucleus accumbens and prefrontal cortex"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1196,
          "offsetInEndSection": 1440,
          "text": "This review will examine the role of the orexin/hypocretin system in addiction, orexin-based pharmacotherapies under development and factors affecting the selection of one or both orexin receptors as drug targets for the treatment of addiction."
        }
      ]
    },
    {
      "id": "67e26b0b18b1e36f2e000073",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28967342",
        "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
        "http://www.ncbi.nlm.nih.gov/pubmed/35198223",
        "http://www.ncbi.nlm.nih.gov/pubmed/31818146",
        "http://www.ncbi.nlm.nih.gov/pubmed/21919012",
        "http://www.ncbi.nlm.nih.gov/pubmed/32693809",
        "http://www.ncbi.nlm.nih.gov/pubmed/18688681",
        "http://www.ncbi.nlm.nih.gov/pubmed/38090463",
        "http://www.ncbi.nlm.nih.gov/pubmed/27638018",
        "http://www.ncbi.nlm.nih.gov/pubmed/31752657"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28967342",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 206,
          "offsetInEndSection": 388,
          "text": "Takotsubo cardiomyopathy is an increasingly recognized syndrome characterized by transient and reversible systolic dysfunction of the apical and middle segments of the left ventricle"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28967342",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 390,
          "offsetInEndSection": 493,
          "text": "This syndrome resembles acute myocardial infarction in the absence of evident coronary artery occlusion"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28967342",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 495,
          "offsetInEndSection": 1235,
          "text": "Although the precise pathophysiology of takotsubo cardiomyopathy is still unknown, it seems that it is associated with excessive sympathetic stimulation, microvascular dysfunction, coronary artery vasospasm, and abnormal myocardial tissue metabolism.\nHerein, we sought to recognize and summarize the available literature data on Takotsubo cardiomyopathy regarding solid-organ transplant, in an attempt to provide the demographic and morphologic functional characteristics of patients with Takotsubo cardiomyopathy and related clinical implications.\nTransplant surgeons should maintain a high index of clinical suspicion and never underestimate takotsubo cardiomyopathy as a potential cause of heart failure following solid-organ transplant."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28967342",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "Takotsubo cardiomyopathy, also known as \"broken heart syndrome,\" \"apical ballooning syndrome,\" and \"stress-induced cardiomyopathy,\" was first des cribed in Japanese patients in 1990 by Sato and colleagues"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "text": "Takotsubo cardiomyopathy is a transient type of acute heart failure with distinct wall motion abnormalities and unclear pathophysiology"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 137,
          "offsetInEndSection": 421,
          "text": "This review focuses on the proposed pathophysiological mechanisms that could be involved in the occurrence takotsubo cardiomyopathy.\nAcute stress and subsequent excessive activation of the sympathetic nervous system are major factors in the pathophysiology of takotsubo cardiomyopathy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1048,
          "offsetInEndSection": 1458,
          "text": "Chronic stress is also linked to this complex mechanism by accelerating cripple of endocrinal hypothalamic-pituitary-adrenal axis activity, which influences the cortisol effect on releasing catecholamine, which is directly related to the pathogenesis of takotsubo cardiomyopathy.\nThe excessive activation of the sympathetic nervous system and subsequent high levels of catecholamines could initiate the process"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 582,
          "offsetInEndSection": 847,
          "text": "The incidence of Takotsubo cardiomyopathy has increased following COVID-19 infection and vaccination, which suggests that neurohormonal and psychological factors (i.e., fear and anxiety of infection or vaccination) may have an additional role in the pathophysiology"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 849,
          "offsetInEndSection": 1046,
          "text": "In addition, inflammatory state, cytokine storm, augmented sympathetic activity, and endothelial dysfunction during the acute phase of COVID-19 infection may participate in Takotsubo cardiomyopathy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36268377",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 423,
          "offsetInEndSection": 580,
          "text": "The high levels of catecholamine work in a triggering manner, generate reactive oxygen species, release inflammatory cytokines, and induce endothelial injury"
        }
      ]
    },
    {
      "id": "680a080b18b1e36f2e00014b",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
        "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
        "http://www.ncbi.nlm.nih.gov/pubmed/20071548",
        "http://www.ncbi.nlm.nih.gov/pubmed/29295136",
        "http://www.ncbi.nlm.nih.gov/pubmed/25130173",
        "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
        "http://www.ncbi.nlm.nih.gov/pubmed/23145817",
        "http://www.ncbi.nlm.nih.gov/pubmed/36572998"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 153,
          "text": "canSAR (http://cansar.icr.ac.uk) is a public integrative cancer-focused knowledgebase for the support of cancer translational research and drug discovery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 155,
          "offsetInEndSection": 884,
          "text": "Through the integration of biological, pharmacological, chemical, structural biology and protein network data, it provides a single information portal to answer complex multidisciplinary questions including--among many others--what is known about a protein, in which cancers is it expressed or mutated, and what chemical tools and cell line models can be used to experimentally probe its activity? What is known about a drug, its cellular sensitivity profile and what proteins is it known to bind that may explain unusual bioactivity? Here we describe major enhancements to canSAR including new data, improved search and browsing capabilities and new target, cancer cell line, protein family and 3D structure summaries and tools."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "This article explains what methicillin-resistant Staphylococcus aureus (MRSA) is, how it is spread and what the real challenges are in healthcare settings in the UK"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 262,
          "offsetInEndSection": 317,
          "text": "It is intended to be a reference source for all nurses."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 193,
          "text": "One of the most important protein complexes involved in maintaining correct RNA levels in eukaryotic cells is the exosome, a complex consisting almost exclusively of exoribonucleolytic proteins"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 195,
          "offsetInEndSection": 381,
          "text": "Since the identification of the exosome complex, seven years ago, much progress has been made in the characterization of its composition, structure and function in a variety of organisms"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 383,
          "offsetInEndSection": 528,
          "text": "Although the exosome seems to accumulate in the nucleolus, it has been clearly established that it is also localized in cytoplasm and nucleoplasm"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 530,
          "offsetInEndSection": 680,
          "text": "In accordance with its widespread intracellular distribution, the exosome has been implicated in a variety of RNA processing and degradation processes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 736,
          "offsetInEndSection": 1394,
          "text": "What are the factors that regulate the activity of the exosome? How and where is the complex assembled? What are the differences in the composition of the nuclear and cytoplasmic exosome? What is the detailed structure of exosome subunits? What are the mechanisms by which the exosome is recruited to substrate RNAs? Here, we summarize the current knowledge on the composition and architecture of this complex, explain its role in both the production and degradation of various types of RNA molecules and discuss the implications of recent research developments that shed some light on the questions above and the mechanisms that are controlling the exosome."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "What is the function of the Hox genes? At first glance, it is a curious question"
        }
      ]
    },
    {
      "id": "6810db0a353a4a2e6b000014",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
        "http://www.ncbi.nlm.nih.gov/pubmed/27064462",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/26123398",
        "http://www.ncbi.nlm.nih.gov/pubmed/14647535",
        "http://www.ncbi.nlm.nih.gov/pubmed/16775366",
        "http://www.ncbi.nlm.nih.gov/pubmed/23199349",
        "http://www.ncbi.nlm.nih.gov/pubmed/33338197",
        "http://www.ncbi.nlm.nih.gov/pubmed/17241784",
        "http://www.ncbi.nlm.nih.gov/pubmed/34560767"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "Prader-Willi syndrome is a rare neurogenetic disorder, which is evidence of genomic imprinting in undercentromeric region of chromosome 15"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 202,
          "offsetInEndSection": 230,
          "text": "PWS is an incurable disorder"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 232,
          "offsetInEndSection": 290,
          "text": "Nevertheless a diagnosis based on DNA analysis is possible"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 292,
          "offsetInEndSection": 468,
          "text": "Molecular diagnostic research includes DNA methylation analysis in the 15q11-q13 region, the gene dosage analysis of the SNRPN gene and the microsatellite polymorphism analysis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 470,
          "offsetInEndSection": 550,
          "text": "The result of DNA analysis is the base of verification of the clinical diagnosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 552,
          "offsetInEndSection": 693,
          "text": "It also enables to determine the type of molecular defect, from which a genetic risk is depended and what is the base of genetic counselling."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10910667",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 140,
          "offsetInEndSection": 200,
          "text": "Defects of the SNRPN gene are the main cause of the syndrome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27064462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 66,
          "text": "Blepharospasm (BSP) is a rather distressing form of focal dystonia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27064462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 68,
          "offsetInEndSection": 213,
          "text": "Although many aspects of its pathophysiological mechanisms are already known, we lack fundamental evidence on etiology, prevention, and treatment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27064462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 215,
          "offsetInEndSection": 371,
          "text": "To advance in our knowledge, we need to review what is already known in various aspects of the disorder and use these bases to find future lines of interest"
        }
      ]
    },
    {
      "id": "67e2cfcf18b1e36f2e00009a",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
        "http://www.ncbi.nlm.nih.gov/pubmed/18044180",
        "http://www.ncbi.nlm.nih.gov/pubmed/12373918",
        "http://www.ncbi.nlm.nih.gov/pubmed/24109197",
        "http://www.ncbi.nlm.nih.gov/pubmed/26289836",
        "http://www.ncbi.nlm.nih.gov/pubmed/10819845",
        "http://www.ncbi.nlm.nih.gov/pubmed/23062036",
        "http://www.ncbi.nlm.nih.gov/pubmed/24126422",
        "http://www.ncbi.nlm.nih.gov/pubmed/22716221",
        "http://www.ncbi.nlm.nih.gov/pubmed/23203733"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 190,
          "offsetInEndSection": 360,
          "text": "This article reviews lasofoxifene, a new-generation SERM that has completed phase III development for the prevention and treatment of osteoporosis in postmenopausal women"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 362,
          "offsetInEndSection": 626,
          "text": "Consistent with preclinical observations, this new SERM demonstrated improved skeletal efficacy over raloxifene and at an oral dose of 0.5 mg/day was effective in the prevention of both vertebral and nonvertebral fractures in postmenopausal women with osteoporosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 883,
          "offsetInEndSection": 1139,
          "text": "With its increased efficacy on the prevention of nonvertebral fractures than current available SERMs and its positive effects on the vagina, this new compound may represent an alternative and cost-effective therapy for osteoporosis in postmenopausal women."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 188,
          "text": "Selective estrogen receptor modulators (SERMs) represent a class with a growing number of compounds that act as either estrogen receptor agonists or antagonists in a tissue-specific manner"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 628,
          "offsetInEndSection": 881,
          "text": "At the same dosage, lasofoxifene treatment also reduced estrogen receptor-positive breast cancer risk and the occurrence of vaginal atrophy, but, like the other SERMs, was associated with hot flushes and an increased risk of venous thromboembolic events"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20169039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 190,
          "offsetInEndSection": 626,
          "text": "This article reviews lasofoxifene, a new-generation SERM that has completed phase III development for the prevention and treatment of osteoporosis in postmenopausal women. Consistent with preclinical observations, this new SERM demonstrated improved skeletal efficacy over raloxifene and at an oral dose of 0.5 mg/day was effective in the prevention of both vertebral and nonvertebral fractures in postmenopausal women with osteoporosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18044180",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18044180",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 274,
          "offsetInEndSection": 380,
          "text": "For this reason, ongoing research continues to search for more effective and tolerable osteoporosis agents"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18044180",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 382,
          "offsetInEndSection": 511,
          "text": "Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention and treatment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18044180",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 513,
          "offsetInEndSection": 618,
          "text": "A new drug application (NDA) for postmenopausal osteoporosis prevention was recently submitted to the FDA"
        }
      ]
    },
    {
      "id": "680a081d18b1e36f2e00014c",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
        "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
        "http://www.ncbi.nlm.nih.gov/pubmed/24677511",
        "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
        "http://www.ncbi.nlm.nih.gov/pubmed/26067407",
        "http://www.ncbi.nlm.nih.gov/pubmed/23022892",
        "http://www.ncbi.nlm.nih.gov/pubmed/3359982",
        "http://www.ncbi.nlm.nih.gov/pubmed/23283699",
        "http://www.ncbi.nlm.nih.gov/pubmed/21138990",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "Astrocytes express voltage-gated calcium channels (VGCCs) that are upregulated in the context of the reactive astrogliosis occurring in several CNS pathologies"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 309,
          "offsetInEndSection": 396,
          "text": "However, the functions and regulation of VGCC in astrocytes are still poorly understood"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 398,
          "offsetInEndSection": 593,
          "text": "Interestingly, protein kinase C epsilon (PKCepsilon), one of the known regulators of VGCC in several cell types, induces in astrocytes a stellated morphology similar to that associated to gliosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 595,
          "offsetInEndSection": 703,
          "text": "Thereby, here we explored the possible regulation of VGCC by adenovirally expressed PKCepsilon in astrocytes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 963,
          "offsetInEndSection": 1185,
          "text": "Moreover, the new calcium channels formed as a consequence of PKCepsilon activation are functional, since overexpression of constitutively-active PKCepsilon increased significantly the calcium current density in astrocytes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 161,
          "offsetInEndSection": 307,
          "text": "Moreover, the ability of selective calcium channel blockers to inhibit reactive astrogliosis has been revealed in a variety of experimental models"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 705,
          "offsetInEndSection": 874,
          "text": "We found that PKCepsilon potently increases the mRNA levels of two different calcium channel alpha(1) subunits, Ca(V)1.2 (L-type channel) and Ca(V)2.1 (P/Q-type channel)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 876,
          "offsetInEndSection": 961,
          "text": "The mRNA upregulation was followed by a robust increase in the corresponding peptides"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1256,
          "offsetInEndSection": 1428,
          "text": "However, the effect on the P/Q-type channel was more prominent since an increase of the relative contribution of this channel to the whole cell calcium current was observed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17676593",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1430,
          "offsetInEndSection": 1669,
          "text": "Finally, we found that PKCepsilon-induced stellation was significantly reduced by the specific L-type channel blocker nifedipine, indicating that calcium influx through VGCC mediates the change in astrocyte morphology induced by PKCepsilon"
        }
      ]
    },
    {
      "id": "6810ff8f353a4a2e6b000017",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18072276",
        "http://www.ncbi.nlm.nih.gov/pubmed/2694348",
        "http://www.ncbi.nlm.nih.gov/pubmed/25077096",
        "http://www.ncbi.nlm.nih.gov/pubmed/19343179",
        "http://www.ncbi.nlm.nih.gov/pubmed/16813956",
        "http://www.ncbi.nlm.nih.gov/pubmed/36780037",
        "http://www.ncbi.nlm.nih.gov/pubmed/32116320",
        "http://www.ncbi.nlm.nih.gov/pubmed/32601779",
        "http://www.ncbi.nlm.nih.gov/pubmed/18314594",
        "http://www.ncbi.nlm.nih.gov/pubmed/21865362"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 187,
          "offsetInEndSection": 569,
          "text": "Accomplishments include the benefit of tamoxifen therapy for early stage invasive and noninvasive breast cancer, the benefit of raloxifene and tamoxifen for prevention of breast cancer, the improved efficacy of tamoxifen after chemotherapy as opposed to concurrent administration, and the ability of letrozole administered after 5 years of tamoxifen to improve disease-free survival"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 571,
          "offsetInEndSection": 774,
          "text": "Most recently, Cooperative Group studies have contributed to the development of a molecular profiling test, Oncotype Dx, which identifies women who have an excellent prognosis with hormonal therapy alone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 776,
          "offsetInEndSection": 1625,
          "text": "Ongoing phase 3 clinical trials address the following questions: Is prolonged duration of aromatase inhibitor (AI) therapy beneficial? What is the efficacy and toxicity of steroidal versus nonsteroidal AIs in adjuvant treatment? Is combination hormonal therapy with an estrogen receptor down-regulator (fulvestrant) and an AI superior to an AI alone in the treatment of metastatic breast cancer? Does ovarian suppression offer superior benefit to standard therapy in the treatment of premenopausal breast cancer? What is the role of chemotherapy for early stage breast cancer selected via molecular profiling analysis? How can targeted therapies be used effectively in combination? Studies in subsets of patients defined by molecular profiling will be necessary to fully define breast cancer subtypes and realize the promise of personalized medicine"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1627,
          "offsetInEndSection": 1773,
          "text": "Close research partnerships that promote large-scale translational research are essential to the continuation of rapid achievements in this field."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18072276",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 185,
          "text": "Over several decades, investigators working through National Cancer Institute-sponsored Cooperative Groups have contributed to major advances in the endocrine treatment of breast cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2694348",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "It is important to know the risk of cancer in inflammatory bowel disease and to know the magnitude of the problem"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2694348",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 196,
          "offsetInEndSection": 551,
          "text": "It is useful to have a surveillance procedure and follow all patients considered at risk of developing cancer? Should prophylactic surgery be recommended for all patients with long-standing extensive disease, and what will be its impact on the quality of life? There is a wide range of reported incidence of colorectal cancer in inflammatory bowel disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2694348",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 553,
          "offsetInEndSection": 724,
          "text": "This is likely to be due to selection bias and problems with generalization and validity of the results rather than any real differences in the underlying cancer incidence"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2694348",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 726,
          "offsetInEndSection": 831,
          "text": "Rigorous methodologic standards must be used to measure the risk of cancer in inflammatory bowel disease."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2694348",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 115,
          "offsetInEndSection": 194,
          "text": "It then becomes possible to answer some questions on the management of patients"
        }
      ]
    },
    {
      "id": "67fbe21818b1e36f2e000113",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
        "http://www.ncbi.nlm.nih.gov/pubmed/22560341",
        "http://www.ncbi.nlm.nih.gov/pubmed/15860414",
        "http://www.ncbi.nlm.nih.gov/pubmed/22498583",
        "http://www.ncbi.nlm.nih.gov/pubmed/9092799",
        "http://www.ncbi.nlm.nih.gov/pubmed/23406027",
        "http://www.ncbi.nlm.nih.gov/pubmed/1422238",
        "http://www.ncbi.nlm.nih.gov/pubmed/8421095",
        "http://www.ncbi.nlm.nih.gov/pubmed/22497336",
        "http://www.ncbi.nlm.nih.gov/pubmed/36632846"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 91,
          "text": "Thyroid hormones are involved in developmental and homeostatic processes in several tissues"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 279,
          "offsetInEndSection": 473,
          "text": "It is largely documented that thyroid hormones act via nuclear receptors, the TRs, which are transcription factors and whose activity can be modulated by the local availability of the hormone T3"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 880,
          "offsetInEndSection": 1169,
          "text": "Here, we summarize these data and propose a new and intriguing role for thyroid hormones in two selected examples.\nIn the intestinal epithelium and the retina, TRα1 and TRβ2 are expressed at the level of the precursors where they induce cell proliferation and differentiation, respectively"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1607,
          "offsetInEndSection": 1683,
          "text": "This article is part of a Special Issue entitled Thyroid hormone signalling."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 475,
          "offsetInEndSection": 878,
          "text": "In the \"classical view\", the T3-induced physiological response depends on the expression of specific TR isoforms and the iodothyronine deiodinase selenoenzymes that control the local level of T3, thus TR activity.\nRecent data have clearly established that the functionality of TRs is coordinated and integrated with other signaling pathways, specifically at the level of stem/progenitor cell populations"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1171,
          "offsetInEndSection": 1605,
          "text": "Moreover, these different functions result from the integration of the hormone signal with other intrinsic pathways, which play a fundamental role in progenitor/stem cell physiology.\nTaken together, the interaction of TRs with other signaling pathways, specifically in stem/progenitor cells, is a new concept that may have biological relevance in therapeutic approaches aimed to target stem cells such as tissue engineering and cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 206,
          "offsetInEndSection": 277,
          "text": "Interestingly, their pleiotropic roles are conserved across vertebrates"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22890105",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1171,
          "offsetInEndSection": 1683,
          "text": "Moreover, these different functions result from the integration of the hormone signal with other intrinsic pathways, which play a fundamental role in progenitor/stem cell physiology.\nTaken together, the interaction of TRs with other signaling pathways, specifically in stem/progenitor cells, is a new concept that may have biological relevance in therapeutic approaches aimed to target stem cells such as tissue engineering and cancer. This article is part of a Special Issue entitled Thyroid hormone signalling."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22560341",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 84,
          "text": "Epidemiological studies suggest an important link between obesity and thyroid cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22560341",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 86,
          "offsetInEndSection": 210,
          "text": "The adipose tissue-derived polypeptide leptin acting via leptin receptor may modulate cell migration of thyroid cancer cells"
        }
      ]
    },
    {
      "id": "67fc20ee18b1e36f2e00012a",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2544511",
        "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
        "http://www.ncbi.nlm.nih.gov/pubmed/22693659",
        "http://www.ncbi.nlm.nih.gov/pubmed/22033613",
        "http://www.ncbi.nlm.nih.gov/pubmed/21390826",
        "http://www.ncbi.nlm.nih.gov/pubmed/32998960",
        "http://www.ncbi.nlm.nih.gov/pubmed/31733287",
        "http://www.ncbi.nlm.nih.gov/pubmed/16960645",
        "http://www.ncbi.nlm.nih.gov/pubmed/23119205",
        "http://www.ncbi.nlm.nih.gov/pubmed/31970486"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2544511",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 153,
          "offsetInEndSection": 290,
          "text": "Polymorphic chromosome 10 markers were used to screen paired tumor and lymphocyte DNA samples in 13 patients with glioblastoma multiforme"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2544511",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 372,
          "offsetInEndSection": 499,
          "text": "This finding suggests that a recessive gene involved in the development of glioblastoma multiforme is present on chromosome 10."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2544511",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "Recessive mutations, revealed by loss of the wild-type allele, have been associated with the development of a variety of cancers in children and adults"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2544511",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 292,
          "offsetInEndSection": 370,
          "text": "Ten patients showed loss of constitutional heterozygosity in the tumor samples"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 153,
          "offsetInEndSection": 411,
          "text": "The tumor family history of a patient with cafè-au-lait spots (CALS) and early onset adenomas, duodenal cancer, and glioblastoma was positive for colonic adenoma (mother), jejunal (maternal grandfather), lung (father), and colorectal (paternal uncle) cancers"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 697,
          "offsetInEndSection": 962,
          "text": "Our findings point out the association between PMS2 and TS, and support the hypothesis that patients with a few polyps, small bowel tumors with a very early onset, glioblastoma, and CALS should be considered as a variant of hereditary nonpolyposis colorectal cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 516,
          "offsetInEndSection": 612,
          "text": "PMS2 expression was absent in the proband's duodenal cancer with high microsatellite instability"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "We report the clinicopathological, genetic, and immunohistochemical characterization of an atypical Turcot syndrome (TS) family with small bowel cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 413,
          "offsetInEndSection": 514,
          "text": "PMS2 genetic testing identified the nonsense 1951C>T (Q643X) and the missense 161C>T (S46I) mutations"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16144131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 614,
          "offsetInEndSection": 695,
          "text": "The normal cells also displayed no PMS2 expression and some degree of instability"
        }
      ]
    },
    {
      "id": "67f8527318b1e36f2e000104",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
        "http://www.ncbi.nlm.nih.gov/pubmed/36389300",
        "http://www.ncbi.nlm.nih.gov/pubmed/25010615",
        "http://www.ncbi.nlm.nih.gov/pubmed/21172808",
        "http://www.ncbi.nlm.nih.gov/pubmed/26176336",
        "http://www.ncbi.nlm.nih.gov/pubmed/32100250",
        "http://www.ncbi.nlm.nih.gov/pubmed/16867087",
        "http://www.ncbi.nlm.nih.gov/pubmed/27388852",
        "http://www.ncbi.nlm.nih.gov/pubmed/32472305",
        "http://www.ncbi.nlm.nih.gov/pubmed/23254906"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "We report a case of successful fiberoptic tracheal intubation through the supraglottic airway device air-Q in a 14-year-old boy in whom intubation was difficult because of Shprintzen-Goldberg syndrome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 403,
          "offsetInEndSection": 574,
          "text": "After induction of general anesthesia, both attempts of laryngoscope-guided and AirwayScope -guided tracheal intubation failed, but a size-2 air-Q could be easily inserted"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 576,
          "offsetInEndSection": 725,
          "text": "Fiberoptic tracheal intubation through the air-Q was successfully performed without any difficulty and was safe for his weak airway connective tissue"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 727,
          "offsetInEndSection": 930,
          "text": "Supraglottic airway air-Q is a useful conduit for fiberoptic tracheal intubation under general anesthesia, especially in the case of a patient with weak connective tissue in whom intubation is difficult."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 283,
          "offsetInEndSection": 401,
          "text": "The patient showed dysmorphic facies and weakness of connective tissue, and was scheduled to undergo abdominal surgery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23984569",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 202,
          "offsetInEndSection": 281,
          "text": "Shprintzen-Goldberg syndrome is a rare congenital disorder of connective tissue"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36389300",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "Thoracoscopic-assisted Nuss repair is a commonly used method for treating pectus excavatum, which has always been performed under tracheal intubation and general anesthesia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36389300",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 174,
          "offsetInEndSection": 295,
          "text": "However, general anesthesia with endotracheal intubation can produce intubation and anesthetic drug related complications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36389300",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 297,
          "offsetInEndSection": 453,
          "text": "In non-intubation anesthesia, laryngeal mask is used instead of tracheal intubation without muscle relaxants and small doses of sedative and analgesic drugs"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36389300",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 455,
          "offsetInEndSection": 552,
          "text": "Therefore, non-intubation anesthesia can reduce complications and speed up postoperative recovery"
        }
      ]
    },
    {
      "id": "680f4ae9353a4a2e6b000009",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21429248",
        "http://www.ncbi.nlm.nih.gov/pubmed/21549021",
        "http://www.ncbi.nlm.nih.gov/pubmed/27559188",
        "http://www.ncbi.nlm.nih.gov/pubmed/15554782",
        "http://www.ncbi.nlm.nih.gov/pubmed/37919834",
        "http://www.ncbi.nlm.nih.gov/pubmed/23438422",
        "http://www.ncbi.nlm.nih.gov/pubmed/27100513",
        "http://www.ncbi.nlm.nih.gov/pubmed/24471476",
        "http://www.ncbi.nlm.nih.gov/pubmed/20583541",
        "http://www.ncbi.nlm.nih.gov/pubmed/17429407"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21429248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 981,
          "text": "About 3% of people will be diagnosed with epilepsy during their lifetime, but about 70% of people with epilepsy eventually go into remission.\nWe conducted a systematic review and aimed to answer the following clinical questions: What are the effects of starting antiepileptic drug treatment following a single seizure? What are the effects of drug monotherapy in people with partial epilepsy? What are the effects of additional drug treatments in people with drug-resistant partial epilepsy? What is the risk of relapse in people in remission when withdrawing antiepileptic drugs? What are the effects of behavioural and psychological treatments for people with epilepsy? What are the effects of surgery in people with drug-resistant temporal lobe epilepsy? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2009 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21429248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 983,
          "offsetInEndSection": 1251,
          "text": "We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).\nWe found 83 systematic reviews, RCTs, or observational studies that met our inclusion criteria"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21429248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1253,
          "offsetInEndSection": 2373,
          "text": "We performed a GRADE evaluation of the quality of evidence for interventions.\nIn this systematic review we present information relating to the effectiveness and safety of the following interventions: antiepileptic drugs after a single seizure; monotherapy for partial epilepsy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs for drug-resistant partial epilepsy (allopurinol, eslicarbazepine, gabapentin, lacosamide, lamotrigine, levetiracetam, losigamone, oxcarbazepine, retigabine, tiagabine, topiramate, vigabatrin, or zonisamide); antiepileptic drug withdrawal for people with partial or generalised epilepsy who are in remission; behavioural and psychological treatments for partial or generalised epilepsy (biofeedback, cognitive behavioural therapy (CBT), educational programmes, family counselling, relaxation therapy (alone or plus behavioural modification therapy, yoga); and surgery for drug-resistant temporal lobe epilepsy ( lesionectomy, temporal lobectomy, vagus nerve stimulation as adjunctive therapy)."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549021",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 981,
          "text": "About 3% of people will be diagnosed with epilepsy during their lifetime, but about 70% of people with epilepsy eventually go into remission.\nWe conducted a systematic review and aimed to answer the following clinical questions: What are the effects of starting antiepileptic drug treatment following a single seizure? What are the effects of drug monotherapy in people with partial epilepsy? What are the effects of additional drug treatments in people with drug-resistant partial epilepsy? What is the risk of relapse in people in remission when withdrawing antiepileptic drugs? What are the effects of behavioural and psychological treatments for people with epilepsy? What are the effects of surgery in people with drug-resistant temporal lobe epilepsy? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2009 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549021",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 983,
          "offsetInEndSection": 1251,
          "text": "We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).\nWe found 83 systematic reviews, RCTs, or observational studies that met our inclusion criteria"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549021",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1253,
          "offsetInEndSection": 2373,
          "text": "We performed a GRADE evaluation of the quality of evidence for interventions.\nIn this systematic review we present information relating to the effectiveness and safety of the following interventions: antiepileptic drugs after a single seizure; monotherapy for partial epilepsy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs for drug-resistant partial epilepsy (allopurinol, eslicarbazepine, gabapentin, lacosamide, lamotrigine, levetiracetam, losigamone, oxcarbazepine, retigabine, tiagabine, topiramate, vigabatrin, or zonisamide); antiepileptic drug withdrawal for people with partial or generalised epilepsy who are in remission; behavioural and psychological treatments for partial or generalised epilepsy (biofeedback, cognitive behavioural therapy (CBT), educational programmes, family counselling, relaxation therapy (alone or plus behavioural modification therapy, yoga); and surgery for drug-resistant temporal lobe epilepsy ( lesionectomy, temporal lobectomy, vagus nerve stimulation as adjunctive therapy)."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27559188",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 134,
          "text": "Gaucher disease is a rare lysosomal storage disease resulting from a deficiency or reduced activity in the acid β-glucocosidase enzyme"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27559188",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 136,
          "offsetInEndSection": 668,
          "text": "Only 1 treatment option was available for 15 years, but several new treatment options have come to market since 2003.\nThe article will detail the pathophysiology and review current therapies in the literature for all 3 major clinical types of Gaucher disease, with a focus on considerations for selecting therapy in type 1 disease.\nExtracted and summarized applicable studies and reviews from Cochrane Review, ClinicalTrials.gov, CINAHL, IPA, and PubMed.\nEnzyme replacement therapy is preferred for the management of Gaucher disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27559188",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 749,
          "offsetInEndSection": 886,
          "text": "However, velaglucerase alfa and taliglucerase alfa theoretically have a lower risk of immunogenicity reactions compared with imiglucerase"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27559188",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 888,
          "offsetInEndSection": 1139,
          "text": "Alternative treatments for type 1 disease include substrate reduction therapy; however, these treatments require evaluation of patient-specific variables (eg, genotype evaluation, renal function) and consideration of adverse effect and dosing profiles"
        }
      ]
    },
    {
      "id": "67fd922518b1e36f2e000143",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
        "http://www.ncbi.nlm.nih.gov/pubmed/29730267",
        "http://www.ncbi.nlm.nih.gov/pubmed/34847253",
        "http://www.ncbi.nlm.nih.gov/pubmed/25319955",
        "http://www.ncbi.nlm.nih.gov/pubmed/23963646",
        "http://www.ncbi.nlm.nih.gov/pubmed/17644068",
        "http://www.ncbi.nlm.nih.gov/pubmed/33468562",
        "http://www.ncbi.nlm.nih.gov/pubmed/33279177",
        "http://www.ncbi.nlm.nih.gov/pubmed/35502476",
        "http://www.ncbi.nlm.nih.gov/pubmed/25130173"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 132,
          "text": "Mechanistic/mammalian target of rapamycin complex 1 (mTORC1) is a serine/threonine kinase that plays a major role in cell metabolism"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 134,
          "offsetInEndSection": 261,
          "text": "Although mTORC1 inhibitors are known to exert immunosuppressive effects, their effects on immune cells are not fully understood"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 263,
          "offsetInEndSection": 549,
          "text": "In the present study, we examined the involvement of mTORC1 in the differentiation and functions of macrophages using THP-1 cells, which are derived from human monocytic leukemia and differentiate into macrophage-like cells upon treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 551,
          "offsetInEndSection": 656,
          "text": "We also examined the effects of two mTOR inhibitors, Torin 1 and rapamycin, on TPA-stimulated THP-1 cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 658,
          "offsetInEndSection": 838,
          "text": "Although mTORC1 activation was observed upon TPA stimulation, mTOR inhibitors did not affect TPA-induced morphological changes or expression of the general macrophage marker, CD11b"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 840,
          "offsetInEndSection": 938,
          "text": "In contrast, phagocytosis and fluid endocytosis were significantly impaired by the mTOR inhibitors"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 940,
          "offsetInEndSection": 1154,
          "text": "Endocytosis suppression was observed when mTOR inhibitors were added during differentiation, but not before or after differentiation, suggesting that endocytosis suppression altered the direction of differentiation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1156,
          "offsetInEndSection": 1237,
          "text": "Furthermore, mTOR inhibitors altered the expression of M1/M2 polarization markers"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37225457",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1239,
          "offsetInEndSection": 1409,
          "text": "These results suggest that the immunosuppressive effects of mTOR inhibitors may involve the suppression of macrophage endocytosis caused by abnormal cell differentiation."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29730267",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 266,
          "text": "Although M2-like tumor-associated macrophages (TAMs) have been considered as a vital therapeutic target in cancer therapy due to their role in promoting tumor progression and metastasis, very few compounds have been identified to inhibit M2-like polarization of TAMs"
        }
      ]
    },
    {
      "id": "67fc1a3818b1e36f2e000129",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
        "http://www.ncbi.nlm.nih.gov/pubmed/23237251",
        "http://www.ncbi.nlm.nih.gov/pubmed/23814607",
        "http://www.ncbi.nlm.nih.gov/pubmed/25012804",
        "http://www.ncbi.nlm.nih.gov/pubmed/25264655",
        "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
        "http://www.ncbi.nlm.nih.gov/pubmed/15828301",
        "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 104,
          "text": "Achalasia is a rare disorder in children who are commonly treated by laparoscopic Heller's myotomy (LHM)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 263,
          "offsetInEndSection": 613,
          "text": "The aim of the study is to appraise the results of LHM based on a systematic literature review.\nMEDLINE search of the English literature was performed for \"achalasia,\" \"children,\" \"laparoscopy,\" \"Heller,\" \"myotomy,\" and \"cardiomyotomy.\" Frequency of postoperative symptoms was grouped to calculate the percentage of patients with symptoms improvement"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 615,
          "offsetInEndSection": 790,
          "text": "Incidence of postoperative gastro-esophageal reflux (GER) and dysphagia between patients with and without fundoplication at the time of LHM was compared by Fisher's Exact Test"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1089,
          "offsetInEndSection": 1219,
          "text": "Fundoplication was performed in 271 (82%): Dor (n = 205, 76%), Toupet (n = 49, 18%), Thal (n = 13, 4.5%), and Nissen (n = 4, 1.5%)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1336,
          "offsetInEndSection": 1557,
          "text": "Forty-nine (15%) required re-intervention: pneumatic dilatations (n = 30, 9%), redo-surgery (n = 23, 7%), botox injection (n = 1, 0.3%), and medical therapy (n = 5, 1.5%).\nLHM for achalasia is effective in 85% of children"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1559,
          "offsetInEndSection": 1593,
          "text": "Revision surgery is required in 7%"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1595,
          "offsetInEndSection": 1700,
          "text": "There is no difference in incidence of GER and dysphagia between patients with and without fundoplication"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 106,
          "offsetInEndSection": 261,
          "text": "However, there are no large studies evaluating the results of LHM in the pediatric population, and the need of a concomitant fundoplication remains unclear"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1221,
          "offsetInEndSection": 1334,
          "text": "Incidence of postoperative GER and dysphagia was similar between children with and without fundoplication (P = 1)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27901639",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1702,
          "offsetInEndSection": 1769,
          "text": "Routine use of an additional fundoplication might not be justified."
        }
      ]
    },
    {
      "id": "67e285b018b1e36f2e00007b",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
        "http://www.ncbi.nlm.nih.gov/pubmed/30127341",
        "http://www.ncbi.nlm.nih.gov/pubmed/19450321",
        "http://www.ncbi.nlm.nih.gov/pubmed/21418666",
        "http://www.ncbi.nlm.nih.gov/pubmed/20017317",
        "http://www.ncbi.nlm.nih.gov/pubmed/19909521",
        "http://www.ncbi.nlm.nih.gov/pubmed/29150909",
        "http://www.ncbi.nlm.nih.gov/pubmed/36272567",
        "http://www.ncbi.nlm.nih.gov/pubmed/21285074",
        "http://www.ncbi.nlm.nih.gov/pubmed/20122165"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Turner syndrome is a chromosomal abnormality in which there is complete or partial absence of the X chromosome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 112,
          "offsetInEndSection": 163,
          "text": "Turner syndrome effects 1 in every 2000 live births"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 165,
          "offsetInEndSection": 282,
          "text": "Short stature is a cardinal feature of Turner Syndrome and the standard treatment is recombinant human growth hormone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 457,
          "offsetInEndSection": 633,
          "text": "Adjuvant therapy with oxandrolone is used but there is no consensus on the optimal timing of treatment, the duration of treatment and the long term adverse effects of treatment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 635,
          "offsetInEndSection": 788,
          "text": "The objective of this review and meta-analysis is to examine the effect of oxandrolone on adult height in growth hormone treated Turner syndrome patients"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 790,
          "offsetInEndSection": 890,
          "text": "Eligible trials were identified by a literature search using the terms: Turner syndrome, oxandrolone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 976,
          "offsetInEndSection": 1053,
          "text": "Twenty-six articles were reviewed and four were included in the meta-analysis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1055,
          "offsetInEndSection": 1138,
          "text": "A random effects model was used to calculate an effect size and confidence interval"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1140,
          "offsetInEndSection": 1325,
          "text": "The pooled effect size of 2.0759 (95 % CI 0.0988 to 4.0529) indicates that oxandrolone has a positive effect on adult height in Turner syndrome when combined with growth hormone therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26322078",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1327,
          "offsetInEndSection": 1467,
          "text": "In conclusion, the addition of oxandrolone to growth hormone therapy for treatment of short stature in Turner syndrome improves adult height"
        }
      ]
    },
    {
      "id": "680a07f918b1e36f2e00014a",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30867380",
        "http://www.ncbi.nlm.nih.gov/pubmed/21871892",
        "http://www.ncbi.nlm.nih.gov/pubmed/8385108",
        "http://www.ncbi.nlm.nih.gov/pubmed/16423829",
        "http://www.ncbi.nlm.nih.gov/pubmed/24694658",
        "http://www.ncbi.nlm.nih.gov/pubmed/24642372",
        "http://www.ncbi.nlm.nih.gov/pubmed/10944589",
        "http://www.ncbi.nlm.nih.gov/pubmed/25007779",
        "http://www.ncbi.nlm.nih.gov/pubmed/9817749",
        "http://www.ncbi.nlm.nih.gov/pubmed/10416608"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30867380",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 66,
          "text": "Primary cilium is a membrane-protruding immotile sensory organelle"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30867380",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 146,
          "offsetInEndSection": 291,
          "text": "However, recent studies have uncovered that the cilium is dynamically organized organelle in a cell cycle-dependent manner; it is formed during G"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30867380",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 68,
          "offsetInEndSection": 144,
          "text": "It had been supposed that the cilium was a static organelle for long periods"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21871892",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "The endoplasmic reticulum (ER) is responsible for folding and delivery of secretory proteins to their site of action"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21871892",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 118,
          "offsetInEndSection": 194,
          "text": "One major modification proteins undergo in this organelle is N-glycosylation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21871892",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 376,
          "offsetInEndSection": 539,
          "text": "The lectin Yos9 recognizes the N-glycan signal of misfolded proteins and acts as a gatekeeper for the delivery of these substrates to the cytoplasm for degradation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21871892",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 323,
          "offsetInEndSection": 374,
          "text": "Processing of N-glycans generates a signal for ERAD"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8385108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "text": "The erd2 protein is the receptor responsible for recycling proteins bearing the carboxyl-terminal sequence KDEL (single-letter amino acid code) to the endoplasmic reticulum, following their loss from that organelle by the process of forward transport"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8385108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 372,
          "offsetInEndSection": 502,
          "text": "Binding in vitro exhibits the same sequence specificity as retention of lumenal proteins in vivo and is strikingly sensitive to pH"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8385108",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 504,
          "offsetInEndSection": 691,
          "text": "Our results raise the possibility that erd2p-mediated sorting of lumenal endoplasmic reticulum proteins is facilitated by the pH differences between compartments of the secretory pathway."
        }
      ]
    },
    {
      "id": "67cdc78381b102733300001a",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
        "http://www.ncbi.nlm.nih.gov/pubmed/12297829",
        "http://www.ncbi.nlm.nih.gov/pubmed/21498981",
        "http://www.ncbi.nlm.nih.gov/pubmed/27579812",
        "http://www.ncbi.nlm.nih.gov/pubmed/37417206",
        "http://www.ncbi.nlm.nih.gov/pubmed/22577917",
        "http://www.ncbi.nlm.nih.gov/pubmed/29504325",
        "http://www.ncbi.nlm.nih.gov/pubmed/34507998",
        "http://www.ncbi.nlm.nih.gov/pubmed/3653618",
        "http://www.ncbi.nlm.nih.gov/pubmed/27406083"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "text": "Major papilla pancreatic sphincter dysfunction, a variant of sphincter of Oddi dysfunction, causes pancreatitis and pancreatic-type pain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 138,
          "offsetInEndSection": 282,
          "text": "The gold standard for diagnosis is sphincter of Oddi manometry, most commonly performed at endoscopic retrograde cholangiopancreatography (ERCP)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 284,
          "offsetInEndSection": 464,
          "text": "Noninvasive testing, such as secretin-stimulated transabdominal or endoscopic ultrasound assessment of pancreatic duct diameter, is less reliable and has relatively low sensitivity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 722,
          "offsetInEndSection": 916,
          "text": "Patients with sphincter of Oddi dysfunction may respond to biliary sphincterotomy alone, but evaluation of their pancreatic sphincter is warranted if symptoms persist after biliary therapy alone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 918,
          "offsetInEndSection": 1025,
          "text": "Whether both biliary and pancreatic sphincters should be treated at the first ERCP session is controversial"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1027,
          "offsetInEndSection": 1225,
          "text": "Biliary and pancreatic endoscopic sphincterotomies are associated with two- to fourfold increased incidence of pancreatitis following the procedure in patients with pancreatic sphincter hypertension"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1227,
          "offsetInEndSection": 1337,
          "text": "Prophylactic pancreatic duct stenting reduces the frequency and severity of complications by greater than 50%."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 466,
          "offsetInEndSection": 581,
          "text": "Two thirds of patients with biliary sphincter of Oddi dysfunction have elevated pancreatic basal sphincter pressure"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11900681",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 583,
          "offsetInEndSection": 720,
          "text": "To maximize the diagnostic yield of sphincter of Oddi dysfunction, both the biliary and pancreatic sphincter pressures should be measured"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297829",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "Receptor-mediated endocytosis is one of the major mechanisms for uptake of lipoprotein cholesterol in the liver"
        }
      ]
    },
    {
      "id": "67d7ff2c18b1e36f2e000049",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12485471",
        "http://www.ncbi.nlm.nih.gov/pubmed/12459520",
        "http://www.ncbi.nlm.nih.gov/pubmed/23767452",
        "http://www.ncbi.nlm.nih.gov/pubmed/21159258",
        "http://www.ncbi.nlm.nih.gov/pubmed/3804022",
        "http://www.ncbi.nlm.nih.gov/pubmed/2438879",
        "http://www.ncbi.nlm.nih.gov/pubmed/15981987",
        "http://www.ncbi.nlm.nih.gov/pubmed/6742871",
        "http://www.ncbi.nlm.nih.gov/pubmed/7549032",
        "http://www.ncbi.nlm.nih.gov/pubmed/15489956"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12485471",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Gluten sensitive enteropathy has various manifestations, of which the two major forms are classical coeliac disease (cCD) and dermatitis herpetiformis (DH)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12485471",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1158,
          "offsetInEndSection": 1261,
          "text": "The non-HLA DR;DQ factors are critical for the different clinical manifestations of gluten sensitivity."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12485471",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 415,
          "offsetInEndSection": 594,
          "text": "In the present report we evaluated the role of the major genetic susceptibility locus, HLA DQ, in 25 families, in which both forms of the disease, cCD and DH, occurred in siblings"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12485471",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 849,
          "offsetInEndSection": 1156,
          "text": "Results from the Finnish family material with 25 discordant and 85 concordant sib pairs, and from additional case-control material comprising 71 unrelated Hungarian DH and 68 cCD patients, together indicated that the HLA DQ locus did not differ between the two major outcomes of gluten sensitive enteropathy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12485471",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 290,
          "offsetInEndSection": 347,
          "text": "The symptoms in both forms are dependent on gluten intake"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12459520",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 150,
          "text": "Dermatitis herpetiformis (DH) is an IgA mediated blistering skin disease characterized by the presence of granular deposits of IgA in papillary dermis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12459520",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 152,
          "offsetInEndSection": 329,
          "text": "The major significant advances in our understanding of DH have been the demonstration that DH patients also have coeliac diseases (CD) and that the rash is also gluten dependent"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12459520",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 416,
          "offsetInEndSection": 552,
          "text": "The other major significant finding has been the presence of IgA in the uninvolved, now used as the diagnostic criterion for the disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12459520",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 554,
          "offsetInEndSection": 754,
          "text": "Despite the fact that it has been known for over fifty years that gluten causes the enteropathy of CD, and for over thirty years the rash of DH, it is still not known how gluten produces these effects"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12459520",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 756,
          "offsetInEndSection": 883,
          "text": "Future immunological studies may look at ways of inducing tolerance to gluten peptides once the toxic ones have been identified"
        }
      ]
    },
    {
      "id": "680a084018b1e36f2e00014e",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
        "http://www.ncbi.nlm.nih.gov/pubmed/25199710",
        "http://www.ncbi.nlm.nih.gov/pubmed/17368474",
        "http://www.ncbi.nlm.nih.gov/pubmed/25752977",
        "http://www.ncbi.nlm.nih.gov/pubmed/26984631",
        "http://www.ncbi.nlm.nih.gov/pubmed/25640666",
        "http://www.ncbi.nlm.nih.gov/pubmed/31856298",
        "http://www.ncbi.nlm.nih.gov/pubmed/29686426",
        "http://www.ncbi.nlm.nih.gov/pubmed/11994452",
        "http://www.ncbi.nlm.nih.gov/pubmed/34583974"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "B cells are increasingly regarded as integral to the pathogenesis of multiple sclerosis, in part as a result of the success of B cell-depletion therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 153,
          "offsetInEndSection": 376,
          "text": "Multiple B cell-dependent mechanisms contributing to inflammatory demyelination of the CNS have been explored using experimental autoimmune encephalomyelitis (EAE), a CD4 T cell-dependent animal model for multiple sclerosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 378,
          "offsetInEndSection": 585,
          "text": "Although B cell Ag presentation was suggested to regulate CNS inflammation during EAE, direct evidence that B cells can independently support Ag-specific autoimmune responses by CD4 T cells in EAE is lacking"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 587,
          "offsetInEndSection": 791,
          "text": "Using a newly developed murine model of in vivo conditional expression of MHC class II, we reported previously that encephalitogenic CD4 T cells are incapable of inducing EAE when B cells are the sole APC"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 793,
          "offsetInEndSection": 953,
          "text": "In this study, we find that B cells cooperate with dendritic cells to enhance EAE severity resulting from myelin oligodendrocyte glycoprotein (MOG) immunization"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 955,
          "offsetInEndSection": 1141,
          "text": "Further, increasing the precursor frequency of MOG-specific B cells, but not the addition of soluble MOG-specific Ab, is sufficient to drive EAE in mice expressing MHCII by B cells alone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895531",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1143,
          "offsetInEndSection": 1383,
          "text": "These data support a model in which expansion of Ag-specific B cells during CNS autoimmunity amplifies cognate interactions between B and CD4 T cells and have the capacity to independently drive neuroinflammation at later stages of disease."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25199710",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 264,
          "text": "Immune cell infiltration to the brain's territory was considered for decades to reflect a pathological process in which immune cells attack the central nervous system (CNS); such a process is observed in the inflammatory autoimmune disease, multiple sclerosis (MS)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25199710",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 266,
          "offsetInEndSection": 611,
          "text": "As neuroinflammatory processes within the CNS parenchyma are also common to other CNS pathologies, regardless of their etiology, including neurodegenerative disorders such as Alzheimer's disease (AD) and Amyotrophic lateral sclerosis (ALS), these pathologies have often been compared to MS, a disease that benefits from immunosuppressive therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25199710",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 613,
          "offsetInEndSection": 756,
          "text": "Yet, over the last decade, it became clear that autoimmunity has a bright side, and that it plays a pivotal role in CNS repair following damage"
        }
      ]
    },
    {
      "id": "67cde41a81b102733300001d",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
        "http://www.ncbi.nlm.nih.gov/pubmed/19762051",
        "http://www.ncbi.nlm.nih.gov/pubmed/23265597",
        "http://www.ncbi.nlm.nih.gov/pubmed/22857835",
        "http://www.ncbi.nlm.nih.gov/pubmed/29336855",
        "http://www.ncbi.nlm.nih.gov/pubmed/22745925",
        "http://www.ncbi.nlm.nih.gov/pubmed/21926430",
        "http://www.ncbi.nlm.nih.gov/pubmed/29623269",
        "http://www.ncbi.nlm.nih.gov/pubmed/19325171",
        "http://www.ncbi.nlm.nih.gov/pubmed/26090646"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Central retinal artery occlusion (CRAO) is an ocular emergency and is the ocular analogue of cerebral stroke"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 110,
          "offsetInEndSection": 220,
          "text": "It results in profound, usually monocular vision loss, and is associated with significant functional morbidity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 222,
          "offsetInEndSection": 321,
          "text": "The risk factors for CRAO are the same atherosclerotic risk factors as for stroke and heart disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 323,
          "offsetInEndSection": 423,
          "text": "As such, individuals with CRAO may be at risk of ischemic end organ damage such as a cerebral stroke"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 425,
          "offsetInEndSection": 576,
          "text": "Therefore, the management of CRAO is not only to restore vision, but at the same time to manage risk factors that may lead to other vascular conditions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 667,
          "offsetInEndSection": 830,
          "text": "These include carbogen inhalation, acetazolamide infusion, ocular massage and paracentesis, as well as various vasodilators such as intravenous glyceryl trinitrate"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 832,
          "offsetInEndSection": 932,
          "text": "None of these \"standard agents\" have been shown to alter the natural history of disease definitively"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 934,
          "offsetInEndSection": 1108,
          "text": "There has been recent interest shown in the use of thrombolytic therapy, delivered either intravenously or intra-arterially by direct catheterisation of the ophthalmic artery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1110,
          "offsetInEndSection": 1282,
          "text": "Whilst a number of observational series have shown that the recovery of vision can be quite dramatic, two recent randomised controlled trials have not demonstrated efficacy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23070637",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1284,
          "offsetInEndSection": 1539,
          "text": "On the contrary, intra-arterial delivery of thrombolytic may result in an increased risk of intracranial and systemic haemorrhage, while the intravenous use of tissue plasminogen activator (tPA) was not shown to be efficacious within 24 h of symptom onset"
        }
      ]
    },
    {
      "id": "67e2b80618b1e36f2e00008f",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21427575",
        "http://www.ncbi.nlm.nih.gov/pubmed/22658319",
        "http://www.ncbi.nlm.nih.gov/pubmed/18447956",
        "http://www.ncbi.nlm.nih.gov/pubmed/17967714",
        "http://www.ncbi.nlm.nih.gov/pubmed/26298794",
        "http://www.ncbi.nlm.nih.gov/pubmed/21057511",
        "http://www.ncbi.nlm.nih.gov/pubmed/23493652",
        "http://www.ncbi.nlm.nih.gov/pubmed/26912914",
        "http://www.ncbi.nlm.nih.gov/pubmed/18579285",
        "http://www.ncbi.nlm.nih.gov/pubmed/20435731"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21427575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 296,
          "text": "To review recent progress in the genetics of rheumatoid arthritis (RA) and discuss the implications for understanding the pathogenesis of the disease as well as clinical application.\nProtection against anticitrullinated protein antibody (ACPA) positive RA was shown to be associated wit DRB1*1301"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21427575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 532,
          "offsetInEndSection": 725,
          "text": "It is remarkable how few functional studies have been published.\nKnown genetic factors explain 50-60% of the genetic variance for susceptibility to ACPA-positive and 30-50% for ACPA-negative RA"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21427575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1084,
          "offsetInEndSection": 1260,
          "text": "I have a better suggestion, however: use the information that is already available to perform functional studies in order to understand the mechanism of the known associations!"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21427575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 877,
          "offsetInEndSection": 1082,
          "text": "Therefore, I conclude that if you want to find more genes you should have a lot of patience, time and money, stop with convential GWAS and invest in large-scale sequencing of selected patients and controls"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22658319",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1400,
          "offsetInEndSection": 1626,
          "text": "Here we will review the current scientific rationale for these agents and how combinations of these agents may yield additive or synergistic effects and lead to improved outcomes for patients with HER2-amplified breast cancer."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22658319",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 585,
          "offsetInEndSection": 765,
          "text": "Despite the improvement in overall survival with the addition of HER2-targeted agents to chemotherapy, many patients do not benefit from these agents because of inherent resistance"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22658319",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1051,
          "offsetInEndSection": 1398,
          "text": "There are several approaches under study to target these pathways of resistance, including blocking PI3 kinase and mammalian target of rapamycin signaling, blocking neoangiogenesis and the vascular endothelial growth factor axis, using monoclonal antibody targeting of the HER2 dimerization site, and using HER2 monoclonal antibody-drug conjugates"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22658319",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 767,
          "offsetInEndSection": 860,
          "text": "In addition, many patients who achieve an initial response eventually acquire drug resistance"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18447956",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1216,
          "offsetInEndSection": 1270,
          "text": "The avirulent strain dotO mutant showed no such effect"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18447956",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1299,
          "offsetInEndSection": 1454,
          "text": "pneumophila induced DNA fragmentation (shown by TUNEL staining) and activation of caspases 3, 8, 9, and 1 in A549 cells, while the avirulent strain did not"
        }
      ]
    },
    {
      "id": "680a21ff18b1e36f2e000151",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
        "http://www.ncbi.nlm.nih.gov/pubmed/1519448",
        "http://www.ncbi.nlm.nih.gov/pubmed/2309926",
        "http://www.ncbi.nlm.nih.gov/pubmed/11018246",
        "http://www.ncbi.nlm.nih.gov/pubmed/2249207",
        "http://www.ncbi.nlm.nih.gov/pubmed/9630636",
        "http://www.ncbi.nlm.nih.gov/pubmed/3736772",
        "http://www.ncbi.nlm.nih.gov/pubmed/25737004",
        "http://www.ncbi.nlm.nih.gov/pubmed/21398376",
        "http://www.ncbi.nlm.nih.gov/pubmed/12362891"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 66,
          "offsetInEndSection": 202,
          "text": "Thus, transfer of appropriate quantities of thyroid hormones from the blood into the brain at specific stages of development is critical"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 268,
          "offsetInEndSection": 419,
          "text": "In reptiles, birds and mammals, the main protein synthesized and secreted by the choroid plexus is a thyroid hormone distributor protein: transthyretin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 421,
          "offsetInEndSection": 551,
          "text": "This transthyretin is secreted into the cerebrospinal fluid and moves thyroid hormones from the blood into the cerebrospinal fluid"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 553,
          "offsetInEndSection": 845,
          "text": "Maximal transthyretin synthesis in the choroid plexus occurs just prior to the period of rapid brain growth, suggesting that choroid plexus-derived transthyretin moves thyroid hormones from blood into cerebrospinal fluid just prior to when thyroid hormones are required for rapid brain growth"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1322,
          "offsetInEndSection": 1497,
          "text": "Thyroid hormone transmembrane transporters are involved in moving thyroid hormones into and out of cells and have been identified in many tissues, including the choroid plexus"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1876,
          "offsetInEndSection": 1962,
          "text": "This is part of a review series on ontogeny and phylogeny of brain barrier mechanisms."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 64,
          "text": "Thyroid hormones are key players in regulating brain development"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 204,
          "offsetInEndSection": 266,
          "text": "The choroid plexus forms the blood-cerebrospinal fluid barrier"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 847,
          "offsetInEndSection": 965,
          "text": "The structure of transthyretin has been highly conserved, implying strong selection pressure and an important function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784853",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 967,
          "offsetInEndSection": 1099,
          "text": "In mammals, transthyretin binds T4 (precursor form of thyroid hormone) with higher affinity than T3 (active form of thyroid hormone)"
        }
      ]
    },
    {
      "id": "67fc546c18b1e36f2e000130",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
        "http://www.ncbi.nlm.nih.gov/pubmed/26189561",
        "http://www.ncbi.nlm.nih.gov/pubmed/29722936",
        "http://www.ncbi.nlm.nih.gov/pubmed/28991775",
        "http://www.ncbi.nlm.nih.gov/pubmed/37380142",
        "http://www.ncbi.nlm.nih.gov/pubmed/27573720",
        "http://www.ncbi.nlm.nih.gov/pubmed/27742734",
        "http://www.ncbi.nlm.nih.gov/pubmed/18389088",
        "http://www.ncbi.nlm.nih.gov/pubmed/27439523",
        "http://www.ncbi.nlm.nih.gov/pubmed/27358410"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "Limiting antibiotic use is one of the most important measures to prevent and control emergence of antibiotic resistance"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 121,
          "offsetInEndSection": 191,
          "text": "Therefore, antibiotics should usually only be prescribed for infection"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 193,
          "offsetInEndSection": 345,
          "text": "Yet recent well-designed studies have demonstrated that prophylactic antibiotic use is of significant benefit to patients prone to developing infections"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 474,
          "offsetInEndSection": 657,
          "text": "In the first 2 populations, use of antibiotics was associated with an increase in carriage of antibiotic-resistant bacteria, but in intensive care patients the opposite was documented"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 659,
          "offsetInEndSection": 731,
          "text": "These studies demonstrate that antibiotics do more than cause resistance"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 733,
          "offsetInEndSection": 821,
          "text": "The pros and cons of prophylactic antibiotic use must therefore be carefully considered."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26189561",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 105,
          "text": "Doxycycline is a commonly used tetracycline antibiotic showing the broad spectrum of antibacterial action"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26189561",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 107,
          "offsetInEndSection": 235,
          "text": "However, the use of this antibiotic is often connected with the risk of phototoxic reactions that lead to various skin disorders"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26189561",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 534,
          "offsetInEndSection": 687,
          "text": "The exposure of cells to doxycycline and UVA radiation resulted in concentration-dependent loss in melanocytes viability and induced melanin biosynthesis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29722936",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 247,
          "text": "Antibiotics have been used extensively by clinicians to treat patients with PANDAS or PANS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, respectively)"
        }
      ]
    },
    {
      "id": "680f4aa6353a4a2e6b000008",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
        "http://www.ncbi.nlm.nih.gov/pubmed/1067597",
        "http://www.ncbi.nlm.nih.gov/pubmed/17710455",
        "http://www.ncbi.nlm.nih.gov/pubmed/22005615",
        "http://www.ncbi.nlm.nih.gov/pubmed/24962887",
        "http://www.ncbi.nlm.nih.gov/pubmed/17068775",
        "http://www.ncbi.nlm.nih.gov/pubmed/15642960",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
        "http://www.ncbi.nlm.nih.gov/pubmed/27064462",
        "http://www.ncbi.nlm.nih.gov/pubmed/30448932"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1652,
          "offsetInEndSection": 1768,
          "text": "The area of resemblance does, however, have strong associations with the conformational behavior of the snake toxins"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "alpha-neurotoxins from elapid snake venoms and alpha-conotoxins from marine snails bind specifically and with high affinity to nicotinic cholinoceptors"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 308,
          "offsetInEndSection": 640,
          "text": "A systematic computer search of the three-dimensional structure of erabutoxin b (an alpha-neurotoxin from the false sea snake Laticauda semifasciata) was performed to identify the locality that most closely matched the amino acid compositions of the smaller alpha-conotoxins (from the marine snails Conus magus and Conus geographus)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 642,
          "offsetInEndSection": 809,
          "text": "The area of greatest similarity centered on residue position 25 of erabutoxin b, a locale that is conserved throughout the snake alpha-neurotoxins and their homologues"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1390,
          "offsetInEndSection": 1650,
          "text": "The alpha-conotoxin-like area of the snake alpha-neurotoxins is peripheral to the site previously considered important for binding to the cholinoceptor, even though it seems to represent the focus of evolutionary convergence between the two types of neurotoxin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2514275",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1770,
          "offsetInEndSection": 1957,
          "text": "Hence, the outcome of this study has important consequences for the current ideas on snake alpha-neurotoxin structure/activity relationships and the evolutionary origins of neurotoxicity."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1067597",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "The three-dimensional structure of erabutoxin b, a neurotoxin in the venom of the sea snake Laticauda semifasciata, has been determined from a 2.75 A resolution electron density map"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1067597",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 183,
          "offsetInEndSection": 345,
          "text": "Erabutoxin b is one of a family of snake venom neurotoxins, all low-molecular-weight proteins, which block neuromuscular transmission at the postsynaptic membrane"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1067597",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 799,
          "offsetInEndSection": 963,
          "text": "In 28 snake venom neurotoxins of established sequence which inhibit the acetylcholine receptor, the four disulfide bridges and seven other residues remain invariant"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17710455",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 156,
          "text": "Here we examine the actions of six snake neurotoxins (alpha-cobratoxin from Naja naja siamensis, erabutoxin-a and b from Laticauda semifasciata; CM12 from N"
        }
      ]
    },
    {
      "id": "680a078618b1e36f2e000146",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
        "http://www.ncbi.nlm.nih.gov/pubmed/25752517",
        "http://www.ncbi.nlm.nih.gov/pubmed/26156998",
        "http://www.ncbi.nlm.nih.gov/pubmed/11731238",
        "http://www.ncbi.nlm.nih.gov/pubmed/36515320",
        "http://www.ncbi.nlm.nih.gov/pubmed/15450085",
        "http://www.ncbi.nlm.nih.gov/pubmed/33786818",
        "http://www.ncbi.nlm.nih.gov/pubmed/16393992",
        "http://www.ncbi.nlm.nih.gov/pubmed/8834474",
        "http://www.ncbi.nlm.nih.gov/pubmed/20454996"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 242,
          "offsetInEndSection": 438,
          "text": "Yet, it is the signalling to surrounding glia and peripherally derived immune cells that initiates the noncell autonomous inflammatory process and promotes self-propagating motor neuron cell death"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 440,
          "offsetInEndSection": 961,
          "text": "The purpose of this review is to explore the systemic immune/inflammatory contributions to the pathogenesis of ALS: what are the peripheral pro-inflammatory signatures, what initiates their presence and do they represent potential therapeutic targets.\nIn ALS, motor neuron cell death is initiated by multiple cell autonomous pathways leading to misfolded proteins, oxidative stress, altered mitochondria, impaired autophagy and altered RNA metabolism, which collectively promote noncell autonomous inflammatory reactivity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 963,
          "offsetInEndSection": 1121,
          "text": "The resulting disease is characterized by activated microglia and astrocytes as well as peripherally derived pro-inflammatory innate and adaptive immune cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 112,
          "text": "Neuroinflammation is an important mediator of the pathogenesis of disease in amyotrophic lateral sclerosis (ALS)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 114,
          "offsetInEndSection": 240,
          "text": "Genetic mutations such as C9orf72 have begun to define the numerous cell autonomous pathways that initiate motor neuron injury"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1228,
          "offsetInEndSection": 1626,
          "text": "Furthermore, regulatory T lymphocytes are dysfunctional, and pro-inflammatory cytokines and acute phase proteins are elevated.\nThe collective dysregulation of cells and cytokines in patients with ALS accurately reflect increased disease burdens, more rapid progression rates and reduced survival times, reinforcing the concept of ALS as a disorder with extensive systemic pro-inflammatory responses"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1628,
          "offsetInEndSection": 1741,
          "text": "These increased systemic pro-inflammatory immune constituents provide potentially meaningful therapeutic targets."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1123,
          "offsetInEndSection": 1226,
          "text": "In this unrelenting disorder, circulating blood monocytes and natural killer cells are pro-inflammatory"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25752517",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 202,
          "offsetInEndSection": 440,
          "text": "These cells give rise to many different cell types of the body such as chondrocytes, smooth muscle cells, endocrine cells, melanocytes, and cells of the peripheral nervous system including different subtypes of neurons and peripheral glia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25752517",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 848,
          "offsetInEndSection": 1422,
          "text": "This review discusses transcriptional events and regulations occurring in neural crest cells and derived lineages, which control specification of peripheral glia, namely Schwann cell precursors that interact with peripheral axons and further differentiate into myelinating or nonmyelinating Schwann cells, satellite cells that remain tightly associated with neuronal cell bodies in sensory and autonomous ganglia, and olfactory ensheathing cells that wrap olfactory axons, both at the periphery in the olfactory mucosa and in the central nervous system in the olfactory bulb"
        }
      ]
    },
    {
      "id": "67e098cb18b1e36f2e00006d",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/1079649",
        "http://www.ncbi.nlm.nih.gov/pubmed/27354874",
        "http://www.ncbi.nlm.nih.gov/pubmed/18507035",
        "http://www.ncbi.nlm.nih.gov/pubmed/21372459",
        "http://www.ncbi.nlm.nih.gov/pubmed/12176667",
        "http://www.ncbi.nlm.nih.gov/pubmed/23582129",
        "http://www.ncbi.nlm.nih.gov/pubmed/24407542",
        "http://www.ncbi.nlm.nih.gov/pubmed/11964046",
        "http://www.ncbi.nlm.nih.gov/pubmed/12505612",
        "http://www.ncbi.nlm.nih.gov/pubmed/20139205"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1079649",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "We report upon a case of total retraction of an electrode (Twiddler syndrom) in an infected pacemaker battery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1079649",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 111,
          "offsetInEndSection": 273,
          "text": "The silk-thread fixation was still fastened at the right place on the electrode; the tissue owing to the inflammation was no longer sufficient as a fixation point"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1079649",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 275,
          "offsetInEndSection": 629,
          "text": "The casues of this total retraction of the electrode are the following factors: the battery hat sufficient freedom of movement for rotation following exudation into the pacemaker cavity, the electrode was elastic and above all the pacemaker system was infected which could no longer guarantee a sufficient fixation of the electrode in the infected tissue"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1079649",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 631,
          "offsetInEndSection": 706,
          "text": "Attention is drawn to the necessity to remove an infected pacemaker system."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27354874",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "text": "The twiddler syndrome results in retraction and coiling of the lead in the pacemaker pocket with subsequent pacemaker malfunction"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27354874",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 131,
          "offsetInEndSection": 229,
          "text": "If the lead׳s parameters are not affected, then the problem can be corrected by lead repositioning"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27354874",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 231,
          "offsetInEndSection": 380,
          "text": "We describe the first reported case of a dramatic pacemaker lead coiling with a double level of lead compromise, with one of them being intra-cardiac"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27354874",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 382,
          "offsetInEndSection": 478,
          "text": "This condition affected our treatment strategy, as the repositioning of the lead was unfeasible."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18507035",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 139,
          "text": "MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that have been shown to be aberrantly expressed in many human carcinomas"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18507035",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 141,
          "offsetInEndSection": 274,
          "text": "Of these miRNAs, miR-21 appears to be important in tumorigenesis given its up-regulation in almost all types of human cancer examined"
        }
      ]
    },
    {
      "id": "67d6be8a18b1e36f2e000022",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20976299",
        "http://www.ncbi.nlm.nih.gov/pubmed/23429543",
        "http://www.ncbi.nlm.nih.gov/pubmed/6518066",
        "http://www.ncbi.nlm.nih.gov/pubmed/31570786",
        "http://www.ncbi.nlm.nih.gov/pubmed/20132346",
        "http://www.ncbi.nlm.nih.gov/pubmed/2739769",
        "http://www.ncbi.nlm.nih.gov/pubmed/25793115",
        "http://www.ncbi.nlm.nih.gov/pubmed/23350610",
        "http://www.ncbi.nlm.nih.gov/pubmed/36281417",
        "http://www.ncbi.nlm.nih.gov/pubmed/15301044"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20976299",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "text": "Newborns and infants are often exposed to painful procedures during hospitalization"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20976299",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 85,
          "offsetInEndSection": 325,
          "text": "Several different scales have been validated to assess pain in specific populations of pediatric patients, but no single scale can easily and accurately assess pain in all newborns and infants regardless of gestational age and disease state"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20976299",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 449,
          "offsetInEndSection": 614,
          "text": "Newborns admitted to the Neonatal Intensive Care Unit or Well Baby Nursery were evaluated for pain/discomfort during two procedures, a heel prick and a diaper change"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20976299",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1060,
          "offsetInEndSection": 1273,
          "text": "The COVERS scale is a valid pain scale that can be used in the clinical setting to assess pain in newborns and infants and is universally applicable to all neonates, regardless of their age or physiological state."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23429543",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 191,
          "offsetInEndSection": 502,
          "text": "Neonatal testing for G6PD deficiency is not yet routine and the American Academy of Pediatrics recommends testing only in jaundiced newborns who are receiving phototherapy whose family history, ethnicity, or geographic origin suggest risk for the condition, or for infants whose response to phototherapy is poor"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23429543",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 504,
          "offsetInEndSection": 625,
          "text": "Screening tests for G6PD deficiency are available, are suitable for use in newborns and have been used in birth hospitals"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23429543",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 189,
          "text": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common X-linked enzymopathy can lead to severe hyperbilirubinemia, acute bilirubin encephalopathy and kernicterus in the United States"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6518066",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 310,
          "offsetInEndSection": 522,
          "text": "Cross-sectional echocardiographic screening of newborns exposed to lithium during gestation can provide highly accurate, noninvasive assessment of the presence or absence of lithium-induced cardiac malformations."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6518066",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 188,
          "offsetInEndSection": 308,
          "text": "In the other infant cross-sectional echocardiography provided reassurance that the infant did not have Ebstein's anomaly"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31570786",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 464,
          "offsetInEndSection": 672,
          "text": "Since newborns with cystinosis usually do not show symptoms within the first months of life and no biochemical markers are easily detectable, a DNA-based method seems to be an obvious tool for early diagnosis"
        }
      ]
    },
    {
      "id": "680bc74618b1e36f2e000155",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
        "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
        "http://www.ncbi.nlm.nih.gov/pubmed/33537496",
        "http://www.ncbi.nlm.nih.gov/pubmed/32092639",
        "http://www.ncbi.nlm.nih.gov/pubmed/29325625",
        "http://www.ncbi.nlm.nih.gov/pubmed/27064462",
        "http://www.ncbi.nlm.nih.gov/pubmed/29784744",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/19783418",
        "http://www.ncbi.nlm.nih.gov/pubmed/23900077"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1370,
          "offsetInEndSection": 1529,
          "text": "Herein we review some of the recent advances in immunotherapy as related to the treatment of prostate cancer and outline some of the challenges that lie ahead."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "Since the approval of sipuleucel-T for men with metastatic castrate resistant prostate cancer in 2010, great strides in the development of anti-cancer immunotherapies have been made"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 183,
          "offsetInEndSection": 267,
          "text": "Current drug development in this area has focused primarily on antigen-specific (i.e"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 269,
          "offsetInEndSection": 426,
          "text": "cancer vaccines and antibody based therapies) or checkpoint inhibitor therapies, with the checkpoint inhibitors perhaps gaining the most attention as of late"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 428,
          "offsetInEndSection": 664,
          "text": "Indeed, drugs blocking the inhibitory signal generated by the engagement of cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death-1 (PD-1) found on T-cells has emerged as potent means to combat the immunosuppressive milieu"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 666,
          "offsetInEndSection": 877,
          "text": "The anti-CTLA-4 monoclonal antibody ipilimumab has already been approved in advanced melanoma and two phase III trials evaluating ipilimumab in men with metastatic castrate-resistant prostate cancer are underway"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 879,
          "offsetInEndSection": 991,
          "text": "A phase III trial evaluating ProstVac-VF, a poxvirus-based therapeutic prostate cancer vaccine, is also underway"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 993,
          "offsetInEndSection": 1122,
          "text": "While there has been reason for encouragement over the past few years, many questions regarding the use of immunotherapies remain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24477411",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1124,
          "offsetInEndSection": 1368,
          "text": "Namely, it is unclear what stage of disease is most likely to benefit from these approaches, how best to incorporate said treatments with each other and into our current treatment regimens and which therapy is most appropriate for which disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22392219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 182,
          "offsetInEndSection": 423,
          "text": "Several technologies that harness next-generation sequencing have enabled recent advances in identifying promoters and their features, helping researchers who are investigating functional categories of promoters and their modes of regulation"
        }
      ]
    },
    {
      "id": "67f857eb18b1e36f2e000105",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
        "http://www.ncbi.nlm.nih.gov/pubmed/16351715",
        "http://www.ncbi.nlm.nih.gov/pubmed/19711147",
        "http://www.ncbi.nlm.nih.gov/pubmed/16732742",
        "http://www.ncbi.nlm.nih.gov/pubmed/27576903",
        "http://www.ncbi.nlm.nih.gov/pubmed/15077440",
        "http://www.ncbi.nlm.nih.gov/pubmed/19319925",
        "http://www.ncbi.nlm.nih.gov/pubmed/25337310",
        "http://www.ncbi.nlm.nih.gov/pubmed/21733178",
        "http://www.ncbi.nlm.nih.gov/pubmed/10701282"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "Delirium is a frequent form of psychopathology in elderly hospitalized patients; it is a symptom of acute somatic illness"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 375,
          "offsetInEndSection": 754,
          "text": "The aim of this study was to determine which of the two delirium observation screening scales, the NEECHAM Confusion Scale or the Delirium Observation Screening (DOS) scale, has the best discriminative capacity for diagnosing delirium and which is more practical for daily use by nurses.\nThe project was conducted on four wards of a university hospital; 87 patients were included"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 861,
          "offsetInEndSection": 930,
          "text": "A DSM-IV diagnosis of delirium was made or rejected by a geriatrician"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1552,
          "offsetInEndSection": 1721,
          "text": "In the final decision on the instrument we found that both scales were very acceptable in terms of sensitivity and specificity, so the opinion of the nurses was decisive"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1863,
          "offsetInEndSection": 2021,
          "text": "Our findings were obtained from a single site study with a small sample, so a large comparative trial to study the value of both scales further is recommended"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 2023,
          "offsetInEndSection": 2267,
          "text": "On the basis of our experience during this study and findings from the literature with regard to the implementation of delirium guidelines, we will monitor the further implementation of the DOS Scale in our hospital with intensive consultation."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 123,
          "offsetInEndSection": 242,
          "text": "The consequences of delirium include high morbidity and mortality, lengthened hospital stay, and nursing home placement"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 244,
          "offsetInEndSection": 373,
          "text": "Early recognition of delirium symptoms enables the underlying cause to be diagnosed and treated and can prevent negative outcomes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 756,
          "offsetInEndSection": 859,
          "text": "During 3 shifts, these patients were observed for symptoms of delirium, which were rated on both scales"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394635",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 932,
          "offsetInEndSection": 1135,
          "text": "Nurses were asked to rate the practical value of both scales using a structured questionnaire.\nThe sensitivity (0.89-1.00) and specificity (0.86-0.88) of the DOS and the NEECHAM were high for both scales"
        }
      ]
    },
    {
      "id": "67e291a718b1e36f2e000081",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10546306",
        "http://www.ncbi.nlm.nih.gov/pubmed/18450407",
        "http://www.ncbi.nlm.nih.gov/pubmed/15195716",
        "http://www.ncbi.nlm.nih.gov/pubmed/25297035",
        "http://www.ncbi.nlm.nih.gov/pubmed/19208107",
        "http://www.ncbi.nlm.nih.gov/pubmed/18673215",
        "http://www.ncbi.nlm.nih.gov/pubmed/25535102",
        "http://www.ncbi.nlm.nih.gov/pubmed/22930754",
        "http://www.ncbi.nlm.nih.gov/pubmed/24210986",
        "http://www.ncbi.nlm.nih.gov/pubmed/23776891"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10546306",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 229,
          "offsetInEndSection": 399,
          "text": "In addition, psychological disorders such as neuroses, depression, or phobias have been reported as playing a significant role in the initiation of burning mouth syndrome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18450407",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 241,
          "text": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans. It requires caution with the intake of oxidizing substances (e.g., medications and foods) because of the threat of hemolysis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18450407",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency affecting erythrocytes is the most common enzymopathy in humans"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15195716",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 527,
          "offsetInEndSection": 697,
          "text": "On the other hand psychological factors, such as anxiety, depression and phobias have been reported to play a significant role at the beginning of this nosological entity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25297035",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "text": "Corynebacterium pseudodiphtheriticum is a common commensal flora of the upper respiratory tract in humans. Though the pathogenicity of C"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25297035",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 386,
          "offsetInEndSection": 532,
          "text": "pseudodiphtheriticum causing diphtheria-like illness affecting the upper respiratory tract of a 6-year-old fully immunised otherwise healthy child"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19208107",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 106,
          "offsetInEndSection": 362,
          "text": "Recent studies have revealed that interactive effects between HERC2 and OCA2 may be responsible for blue eye colour determination in humans. Here we performed a population association study, examining important polymorphisms within the HERC2 and OCA2 genes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19208107",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 364,
          "offsetInEndSection": 583,
          "text": "Furthermore, pooling these results with genotyping data for MC1R, ASIP and SLC45A2 obtained for the same population sample we also analysed potential genetic interactions affecting variation in eye, hair and skin colour"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18673215",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 228,
          "offsetInEndSection": 541,
          "text": "EAE exhibits many similarities with MS, which is a chronic inflammatory disease affecting CNS white matter in humans. Various studies have indicated that EAE is a particularly useful animal model for understanding both the mechanisms of immune-mediated CNS pathology and also the progressive clinical course of MS"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18673215",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 228,
          "offsetInEndSection": 344,
          "text": "EAE exhibits many similarities with MS, which is a chronic inflammatory disease affecting CNS white matter in humans"
        }
      ]
    },
    {
      "id": "680b7f4818b1e36f2e000154",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
        "http://www.ncbi.nlm.nih.gov/pubmed/28026754",
        "http://www.ncbi.nlm.nih.gov/pubmed/31874597",
        "http://www.ncbi.nlm.nih.gov/pubmed/27197224",
        "http://www.ncbi.nlm.nih.gov/pubmed/28527813",
        "http://www.ncbi.nlm.nih.gov/pubmed/21909922",
        "http://www.ncbi.nlm.nih.gov/pubmed/19727257",
        "http://www.ncbi.nlm.nih.gov/pubmed/31388850",
        "http://www.ncbi.nlm.nih.gov/pubmed/25617436",
        "http://www.ncbi.nlm.nih.gov/pubmed/27546532"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 63,
          "offsetInEndSection": 190,
          "text": "Computer-aided diagnosis systems powered by convolutional neural networks (CNNs) can improve diagnostic accuracy and save lives"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 61,
          "text": "Melanoma is a fatal form of skin cancer when left undiagnosed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 913,
          "offsetInEndSection": 1165,
          "text": "Consequently, preprocessing methods which produce borders larger than the actual lesion can potentially improve classifier performance, more than both perfect segmentation, using dermatologist created ground truth masks, and no segmentation altogether."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 192,
          "offsetInEndSection": 276,
          "text": "CNNs have been successfully used in both skin lesion segmentation and classification"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 278,
          "offsetInEndSection": 438,
          "text": "For reasons heretofore unclear, previous works have found image segmentation to be, conflictingly, both detrimental and beneficial to skin lesion classification"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 440,
          "offsetInEndSection": 550,
          "text": "We investigate the effect of expanding the segmentation border to include pixels surrounding the target lesion"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 552,
          "offsetInEndSection": 688,
          "text": "Ostensibly, segmenting a target skin lesion will remove inessential information, non-lesion skin, and artifacts to aid in classification"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29047032",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 690,
          "offsetInEndSection": 911,
          "text": "Our results indicate that segmentation border enlargement produces, to a certain degree, better results across all metrics of interest when using a convolutional based classifier built using the transfer learning paradigm"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28026754",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 294,
          "offsetInEndSection": 440,
          "text": "In order to meet these challenges, we propose a novel method for melanoma recognition by leveraging very deep convolutional neural networks (CNNs)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28026754",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 442,
          "offsetInEndSection": 697,
          "text": "Compared with existing methods employing either low-level hand-crafted features or CNNs with shallower architectures, our substantially deeper networks (more than 50 layers) can acquire richer and more discriminative features for more accurate recognition"
        }
      ]
    },
    {
      "id": "67cde43c81b102733300001e",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21823231",
        "http://www.ncbi.nlm.nih.gov/pubmed/25276464",
        "http://www.ncbi.nlm.nih.gov/pubmed/23470070",
        "http://www.ncbi.nlm.nih.gov/pubmed/25314315",
        "http://www.ncbi.nlm.nih.gov/pubmed/22474732",
        "http://www.ncbi.nlm.nih.gov/pubmed/31122188",
        "http://www.ncbi.nlm.nih.gov/pubmed/15719322",
        "http://www.ncbi.nlm.nih.gov/pubmed/30215690",
        "http://www.ncbi.nlm.nih.gov/pubmed/33196758",
        "http://www.ncbi.nlm.nih.gov/pubmed/26912914"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21823231",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 965,
          "offsetInEndSection": 1089,
          "text": "WIREs RNA 2011 2 718-731 DOI: 10.1002/wrna.87 For further resources related to this article, please visit the WIREs website."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21823231",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 829,
          "offsetInEndSection": 963,
          "text": "We summarize the knowledge about the different steps with an emphasis on trans-acting factors of snRNP maturation of higher eukaryotes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25276464",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 78,
          "offsetInEndSection": 135,
          "text": "For additional information, please contact the publisher."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23470070",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 153,
          "offsetInEndSection": 217,
          "text": "Please visit the journal website for the most recent guidelines."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25314315",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 202,
          "offsetInEndSection": 259,
          "text": "Please see later in the article for the Editors' Summary."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22474732",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 516,
          "offsetInEndSection": 592,
          "text": "We describe a case of palmar telangiectases in a patient with Graves disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22474732",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 374,
          "offsetInEndSection": 514,
          "text": "Palmar telangiectases and palmar erythema both have primary cutaneous, systemic disease, neoplastic, infectious, and drug-induced etiologies"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31122188",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 364,
          "offsetInEndSection": 424,
          "text": "Please note that the final recommendations remain unchanged."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15719322",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 635,
          "offsetInEndSection": 962,
          "text": "These core diseases include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS), autoimmune thyroid disease (Hashimoto thyroiditis or Graves disease), juvenile RA, inflammatory bowel disease (Crohn disease or ulcerative colitis), psoriasis, and primary Sjogren syndrome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15719322",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 207,
          "offsetInEndSection": 399,
          "text": "Until very recently, no specific alleles--aside from a few common human leukocyte antigen class II genes--had been identified that clearly associate with multiple different autoimmune diseases"
        }
      ]
    },
    {
      "id": "67e2958018b1e36f2e000084",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
        "http://www.ncbi.nlm.nih.gov/pubmed/26085906",
        "http://www.ncbi.nlm.nih.gov/pubmed/19763518",
        "http://www.ncbi.nlm.nih.gov/pubmed/22522168",
        "http://www.ncbi.nlm.nih.gov/pubmed/28645128",
        "http://www.ncbi.nlm.nih.gov/pubmed/1600579",
        "http://www.ncbi.nlm.nih.gov/pubmed/24138046",
        "http://www.ncbi.nlm.nih.gov/pubmed/18971581",
        "http://www.ncbi.nlm.nih.gov/pubmed/15702702",
        "http://www.ncbi.nlm.nih.gov/pubmed/19348697"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1034,
          "offsetInEndSection": 1270,
          "text": "We can conclude that there are great opportunities for research on the genetics of human aging, particularly given the huge fund of information on human biology and pathobiology, and the rapidly developing knowledge of the human genome."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 620,
          "offsetInEndSection": 806,
          "text": "While linkage to a locus on Chromosome 4 has not been confirmed, association studies have revealed a number of significant polymorphisms that impact upon late-life diseases and life span"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 848,
          "offsetInEndSection": 1032,
          "text": "It would require longitudinal studies of large numbers of middle-aged sib-pairs who are extremely discordant or concordant for their rates of decline in various physiological functions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 526,
          "offsetInEndSection": 618,
          "text": "The second approach seeks to identify allelic contributions to exceptionally long life spans"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 291,
          "offsetInEndSection": 356,
          "text": "Collectively, they tell us much about the genetics of health span"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "We review three approaches to the genetic analysis of the biology and pathobiology of human aging"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 99,
          "offsetInEndSection": 243,
          "text": "The first and so far the best-developed is the search for the biochemical genetic basis of varying susceptibilities to major geriatric disorders"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 245,
          "offsetInEndSection": 289,
          "text": "These include a range of progeroid syndromes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 358,
          "offsetInEndSection": 524,
          "text": "Given that the major risk factor for virtually all geriatric disorders is biological aging, they may also serve as markers for the study of intrinsic biological aging"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17677003",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 808,
          "offsetInEndSection": 846,
          "text": "The third approach remains theoretical"
        }
      ]
    },
    {
      "id": "680c174d353a4a2e6b000001",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22122340",
        "http://www.ncbi.nlm.nih.gov/pubmed/20003072",
        "http://www.ncbi.nlm.nih.gov/pubmed/34645583",
        "http://www.ncbi.nlm.nih.gov/pubmed/22099844",
        "http://www.ncbi.nlm.nih.gov/pubmed/18926834",
        "http://www.ncbi.nlm.nih.gov/pubmed/19887490",
        "http://www.ncbi.nlm.nih.gov/pubmed/22812523",
        "http://www.ncbi.nlm.nih.gov/pubmed/24140722",
        "http://www.ncbi.nlm.nih.gov/pubmed/34472376",
        "http://www.ncbi.nlm.nih.gov/pubmed/23326524"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22122340",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 148,
          "offsetInEndSection": 382,
          "text": "Histone variant incorporation, histone post-translational modifications, and ATP-dependent chromatin remodeling are three major strategies for chromatin manipulation, and are relatively well characterized in transcriptional regulation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22122340",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 384,
          "offsetInEndSection": 722,
          "text": "Emerging lines of evidence indicate that histone variants (H2AX and H2A.Z), histone post-translational modifications (acetylation, phosphorylation, methylation and ubiquitination) and chromatin-remodeling complexes (INO80, SWR1, SWI/SNF, RSC and NuRD) are important and direct players in the DNA double-strand break (DSB) response as well"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22122340",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 724,
          "offsetInEndSection": 938,
          "text": "New studies also reveal that incorporation of histone variants into nucleosomes, histone modifications and ATP-dependent chromatin remodeling are specifically and intimately connected during the DSB damage response"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22122340",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 940,
          "offsetInEndSection": 1085,
          "text": "This article summarizes the recent advances in our understanding of the relationship between chromatin modifications and the DSB damage response."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22122340",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "Manipulation of chromatin, in which genomic DNA is packaged, is a fundamental requirement for all DNA-based metabolic processes in eukayotic cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20003072",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "*DNA methylation can cause heritable phenotypic modifications in the absence of changes in DNA sequence"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20003072",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1059,
          "offsetInEndSection": 1118,
          "text": "Many modifications were faithfully transmitted to offspring"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20003072",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1120,
          "offsetInEndSection": 1265,
          "text": "Stresses caused some epigenetic divergence between treatment and controls, but also increased epigenetic variation among plants within treatments"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20003072",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 507,
          "offsetInEndSection": 697,
          "text": "*Genetically identical apomictic dandelion (Taraxacum officinale) plants were exposed to different ecological stresses, and apomictic offspring were raised in a common unstressed environment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20003072",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1302,
          "offsetInEndSection": 1379,
          "text": "First, stress-induced methylation changes are common and are mostly heritable"
        }
      ]
    },
    {
      "id": "67e0053118b1e36f2e000067",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28494612",
        "http://www.ncbi.nlm.nih.gov/pubmed/20101443",
        "http://www.ncbi.nlm.nih.gov/pubmed/18570267",
        "http://www.ncbi.nlm.nih.gov/pubmed/22981836",
        "http://www.ncbi.nlm.nih.gov/pubmed/11805546",
        "http://www.ncbi.nlm.nih.gov/pubmed/17353151",
        "http://www.ncbi.nlm.nih.gov/pubmed/30463908",
        "http://www.ncbi.nlm.nih.gov/pubmed/21919012",
        "http://www.ncbi.nlm.nih.gov/pubmed/17089744",
        "http://www.ncbi.nlm.nih.gov/pubmed/15310345"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28494612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "The environment can elicit biological responses such as oxidative stress (OS) and inflammation as a consequence of chemical, physical, or psychological changes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28494612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 340,
          "offsetInEndSection": 512,
          "text": "Recent Advances: By using examples of stress induced by various mechanisms, we focus on the biomarkers that have been used to assess OS and inflammation in these conditions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28494612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 514,
          "offsetInEndSection": 1287,
          "text": "We discuss the difference between biomarkers that are the result of a chemical reaction (such as lipid peroxides or oxidized proteins that are a result of the reaction of molecules with reactive oxygen species) and those that represent the biological response to stress, such as the transcription factor NRF2 or inflammation and inflammatory cytokines.\nThe high-throughput and holistic approaches to biomarker discovery used extensively in large-scale molecular epidemiological exposome are also discussed in the context of human exposure to environmental stressors.\nWe propose to consider the role of biomarkers as signs and to distinguish between signs that are just indicators of biological processes and proxies that one can interact with and modify the disease process"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28494612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 161,
          "offsetInEndSection": 338,
          "text": "As population studies are essential for establishing these environment-organism interactions, biomarkers of OS or inflammation are critical in formulating mechanistic hypotheses"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28494612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1299,
          "offsetInEndSection": 1311,
          "text": "Redox Signal"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20101443",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 126,
          "text": "This paper presents results of an investigation and listing of tick species found in China during a survey in all 28 provinces"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20101443",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 128,
          "offsetInEndSection": 212,
          "text": "This will be a step towards a definitive list of tick species and their distribution"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20101443",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 214,
          "offsetInEndSection": 566,
          "text": "To date, the tick fauna of this area consists of 117 species in the following families: Argasidae-Argas (7 species), Carios (4 species) and Ornithodoros (2 species); Ixodidae-Amblyomma (8 species), Anomalohimalaya (2 species), Dermacentor (12 species), Haemaphysalis (44 species), Hyalomma (6 species), Ixodes (24 species) and Rhipicephalus (8 species)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20101443",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 568,
          "offsetInEndSection": 690,
          "text": "Some well known ticks carrying and transmitting many infectious agents to man and domestic animals are also found in China"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20101443",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 782,
          "offsetInEndSection": 826,
          "text": "(Boophilus) microplus and Hyalomma asiaticum"
        }
      ]
    },
    {
      "id": "67e2a8d618b1e36f2e000088",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
        "http://www.ncbi.nlm.nih.gov/pubmed/28196318",
        "http://www.ncbi.nlm.nih.gov/pubmed/37104530",
        "http://www.ncbi.nlm.nih.gov/pubmed/12602722",
        "http://www.ncbi.nlm.nih.gov/pubmed/25635706",
        "http://www.ncbi.nlm.nih.gov/pubmed/21993656",
        "http://www.ncbi.nlm.nih.gov/pubmed/35145797",
        "http://www.ncbi.nlm.nih.gov/pubmed/25975649",
        "http://www.ncbi.nlm.nih.gov/pubmed/18250491",
        "http://www.ncbi.nlm.nih.gov/pubmed/12195563"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 148,
          "text": "Zoonotic infections are increasingly becoming public health menaces and are usually transmitted to humans due to unsuitable environmental conditions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1141,
          "offsetInEndSection": 1523,
          "text": "The study emphasizes the need for hepatic capillariasis to be considered as a differential diagnosis in cases of suspected hepatitis, leptospirosis, abdominal lymphadenopathy or other hepatic or parasitic infections prevalent in the region concerned; and meticulously assess the cases to facilitate early diagnosis and prompt treatment, thus reducing the distress faced by patients."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 303,
          "offsetInEndSection": 433,
          "text": "Although its prevalence is very low, it can cause significant morbidity and mortality, with cases reported from all over the world"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 886,
          "offsetInEndSection": 995,
          "text": "Diagnostic modalities include liver biopsy, ultrasonography, CT scan, immunological tests like ELISA and IIFT"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 997,
          "offsetInEndSection": 1139,
          "text": "The infection can be treated mainly with a combination of benzimidazoles like thiabendazole, mebendazole and albendazole; with corticosteroids"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 150,
          "offsetInEndSection": 301,
          "text": "One of them is hepatic capillariasis, caused by the parasite Capillaria hepatica, primarily a disease of rodents, with hepatic manifestations in humans"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 576,
          "offsetInEndSection": 713,
          "text": "The larvae mature and reproduce, and eventually form embryonated eggs, which cause chronic focal inflammation and septal hepatic fibrosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 810,
          "offsetInEndSection": 884,
          "text": "Spurious infection with unembryonated eggs cause gastrointestinal symptoms"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28460612",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 435,
          "offsetInEndSection": 574,
          "text": "The main infective form for humans is the embryonated egg of the parasite, which hatches in the intestine and ultimately colonize the liver"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28196318",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "text": "Skin infections account for a significant subset of dermatologic conditions of childhood"
        }
      ]
    },
    {
      "id": "680a07ed18b1e36f2e000149",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
        "http://www.ncbi.nlm.nih.gov/pubmed/20173718",
        "http://www.ncbi.nlm.nih.gov/pubmed/17854832",
        "http://www.ncbi.nlm.nih.gov/pubmed/36012442",
        "http://www.ncbi.nlm.nih.gov/pubmed/17241784",
        "http://www.ncbi.nlm.nih.gov/pubmed/2782563",
        "http://www.ncbi.nlm.nih.gov/pubmed/21133188",
        "http://www.ncbi.nlm.nih.gov/pubmed/36401050",
        "http://www.ncbi.nlm.nih.gov/pubmed/8387255",
        "http://www.ncbi.nlm.nih.gov/pubmed/21488203"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 156,
          "text": "The neurotoxins produced by Clostridium botulinum are the most potent acute toxins known and are the causative agents of the neuroparalytic disease botulism"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 288,
          "offsetInEndSection": 331,
          "text": "There are seven distinct serotypes of toxin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 430,
          "offsetInEndSection": 574,
          "text": "In their most active forms the toxins exist as dichain molecules in which a heavy (H) chain is linked by disulphide bonding to a light (L) chain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 576,
          "offsetInEndSection": 755,
          "text": "The H chain is believed to be associated with the highly specific and avid binding of toxin to the motor nerve end plates and also with the process of internalisation of the toxin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 757,
          "offsetInEndSection": 1019,
          "text": "The toxic activity appears to be associated with the L chain which blockades the calcium-mediated release of acetylcholine, probably by interfering at the molecular level with the mechanisms whereby neurotransmitter-containing vesicles merge with the plasmalemma"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1021,
          "offsetInEndSection": 1133,
          "text": "The type A toxin is now used therapeutically to treat a variety of conditions involving involuntary muscle spasm"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1135,
          "offsetInEndSection": 1223,
          "text": "The therapeutic toxin is a neurotoxin-haemagglutinin complex isolated from cultures of C"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1236,
          "offsetInEndSection": 1399,
          "text": "A controlled manufacturing process has been developed for the therapeutic toxin which is specially formulated to give a freeze-dried product having good stability."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1311751",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 158,
          "offsetInEndSection": 286,
          "text": "The toxins act primarily at peripheral cholinergic synapses by blocking the evoked release of the neurotransmitter acetylcholine"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20173718",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "Masseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek"
        }
      ]
    },
    {
      "id": "67e93f2d18b1e36f2e0000db",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2199873",
        "http://www.ncbi.nlm.nih.gov/pubmed/33433580",
        "http://www.ncbi.nlm.nih.gov/pubmed/18970928",
        "http://www.ncbi.nlm.nih.gov/pubmed/12114921",
        "http://www.ncbi.nlm.nih.gov/pubmed/22645702",
        "http://www.ncbi.nlm.nih.gov/pubmed/20415926",
        "http://www.ncbi.nlm.nih.gov/pubmed/15056065",
        "http://www.ncbi.nlm.nih.gov/pubmed/34402459",
        "http://www.ncbi.nlm.nih.gov/pubmed/34745484",
        "http://www.ncbi.nlm.nih.gov/pubmed/11475927"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2199873",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 159,
          "offsetInEndSection": 270,
          "text": "The most common side effect in the patient taking lithium is polyuria, a form of nephrogenic diabetes insipidus"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33433580",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 145,
          "offsetInEndSection": 393,
          "text": "Primary care clinicians should know which patients to refer to an eye care professional for a complete eye examination to check for signs of glaucoma and to determine what systemic conditions or medications can increase a patient's risk of glaucoma"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33433580",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 922,
          "offsetInEndSection": 1094,
          "text": "Several systemic medical conditions and medications including corticosteroids, anticholinergics, certain antidepressants, and topiramate may predispose patients to glaucoma"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33433580",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1411,
          "offsetInEndSection": 1741,
          "text": "This can be achieved with various classes of glaucoma medications as well as laser and incisional surgical procedures.\nVision loss from glaucoma can be minimized by recognizing systemic conditions and medications that increase a patient's risk of glaucoma and referring high-risk patients for a complete ophthalmologic examination"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33433580",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1743,
          "offsetInEndSection": 1931,
          "text": "Clinicians should ensure that patients remain adherent with taking glaucoma medications and should monitor for adverse events from medical or surgical interventions used to treat glaucoma."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18970928",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1187,
          "offsetInEndSection": 1346,
          "text": "One lesion (4 cm) showed an intralobar nephrogenic rest, another lesion of unknown size was read as favorable histologic findings vs perilobar nephrogenic rest"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18970928",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 2497,
          "offsetInEndSection": 2760,
          "text": "All patients were alive at a median follow-up of 9 years (range, 9 months to 15 years).\nChildren with synchronous BWT or Wilm's tumor and contralateral nephrogenic rests that have radiographic resolution, after initial treatment, have a low risk for local relapse"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12114921",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 383,
          "offsetInEndSection": 674,
          "text": "Reported neonatal problems with maternal lithium therapy include Ebstein's anomaly, poor respiratory effort and cyanosis, rhythm disturbances, nephrogenic diabetes insipidus, thyroid dysfunction, hypoglycemia, hypotonia and lethargy, hyperbilirubinemia, and large-for-gestational-age infants"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22645702",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 530,
          "offsetInEndSection": 633,
          "text": "Advances in medical therapy have also enabled further risk reduction in the overall incidence of stroke"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22645702",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 787,
          "offsetInEndSection": 986,
          "text": "We will attempt to highlight some of the pivotal trials already completed, discuss the current controversies and complexities in the treatment decision-making, and postulate on what likely lies ahead"
        }
      ]
    },
    {
      "id": "67e2bde318b1e36f2e000093",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
        "http://www.ncbi.nlm.nih.gov/pubmed/23914326",
        "http://www.ncbi.nlm.nih.gov/pubmed/36672434",
        "http://www.ncbi.nlm.nih.gov/pubmed/24917451",
        "http://www.ncbi.nlm.nih.gov/pubmed/17324369",
        "http://www.ncbi.nlm.nih.gov/pubmed/9335502",
        "http://www.ncbi.nlm.nih.gov/pubmed/37947489",
        "http://www.ncbi.nlm.nih.gov/pubmed/29060173",
        "http://www.ncbi.nlm.nih.gov/pubmed/20098695",
        "http://www.ncbi.nlm.nih.gov/pubmed/25612864"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 53,
          "offsetInEndSection": 155,
          "text": "First, both are prevalent and disabling disorders influenced by genetic and environmental risk factors"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 157,
          "offsetInEndSection": 248,
          "text": "Second, migraine with aura, as obesity, seems to be a risk factor for cardiovascular events"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 250,
          "offsetInEndSection": 382,
          "text": "Finally, large population-based studies suggest that obesity is a risk factor for chronic migraine after adjusting for comorbidities"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 384,
          "offsetInEndSection": 470,
          "text": "In this article, we discuss plausible mechanisms that may account for this association"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 953,
          "offsetInEndSection": 1058,
          "text": "Obesity is also a state of sympathetic activation, which may contribute to increase in headache frequency"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1125,
          "offsetInEndSection": 1181,
          "text": "At low but not normal levels, adiponectin is nociceptive"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1183,
          "offsetInEndSection": 1240,
          "text": "Shared biologic predisposition may also play a major role"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1242,
          "offsetInEndSection": 1283,
          "text": "Orexins modulate both pain and metabolism"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1285,
          "offsetInEndSection": 1366,
          "text": "Dysfunction in the orexins pathways seems to be a risk factor for both conditions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17515549",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1368,
          "offsetInEndSection": 1519,
          "text": "Finally, conditions that are comorbid to both states (e.g., depression, sleep apnea) may also make the relationship between both diseases more complex."
        }
      ]
    },
    {
      "id": "680c137818b1e36f2e000158",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
        "http://www.ncbi.nlm.nih.gov/pubmed/31147872",
        "http://www.ncbi.nlm.nih.gov/pubmed/36797245",
        "http://www.ncbi.nlm.nih.gov/pubmed/35269652",
        "http://www.ncbi.nlm.nih.gov/pubmed/21151591",
        "http://www.ncbi.nlm.nih.gov/pubmed/23509776",
        "http://www.ncbi.nlm.nih.gov/pubmed/19698742",
        "http://www.ncbi.nlm.nih.gov/pubmed/32942567",
        "http://www.ncbi.nlm.nih.gov/pubmed/24818721",
        "http://www.ncbi.nlm.nih.gov/pubmed/31119147"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 721,
          "offsetInEndSection": 906,
          "text": "Inflammation is driven by soluble factors, cytokines and chemokines, which can be produced by tumor cells themselves or, more often, by the cells recruited to the tumor microenvironment"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1050,
          "offsetInEndSection": 1218,
          "text": "Tumor cells become addicted to inflammatory stroma, suggesting that the tumor microenvironment represents an attractive target for preventive and therapeutic strategies"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1703,
          "offsetInEndSection": 1906,
          "text": "Therefore, development of drugs that normalize the tumor microenvironment or interrupt the crosstalk between the tumor and the tumor microenvironment is an important approach to the management of cancer."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 214,
          "text": "Patients with inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, are at increased risk of developing colon cancer, confirming that chronic inflammation predisposes to development of tumors"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 216,
          "offsetInEndSection": 623,
          "text": "Moreover, it appears that colon cancers that do not develop as a complication of inflammatory bowel disease are also driven by inflammation, because it has been shown that regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) lowers the mortality from sporadic colon cancer and results in regression of adenomas in familial adenomatous polyposis (FAP) patients, who inherit a mutation in the Apc gene"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 625,
          "offsetInEndSection": 719,
          "text": "Colorectal cancer therefore represents a paradigm for the link between inflammation and cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 908,
          "offsetInEndSection": 1048,
          "text": "Inflammatory cytokines and chemokines promote growth of tumor cells, perturb their differentiation, and support the survival of cancer cells"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1220,
          "offsetInEndSection": 1444,
          "text": "Proinflammatory cytokines, such as TNFα, IL-6 and IL-1β, or transcription factors that are required for signaling by these cytokines, including NF-κB and STATs, are indeed emerging as potential targets for anticancer therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247378",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1446,
          "offsetInEndSection": 1701,
          "text": "TNFα antagonists are in phase I/II clinical trials and have been shown to be well tolerated in patients with solid tumors, and IL-1β antagonists that ameliorate several inflammatory disorders characterized by excessive IL-1β production, will likely follow"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31147872",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1859,
          "offsetInEndSection": 1999,
          "text": "This chapter will introduce hallmarks of GBM and elaborate on the contributions of pericytes to these hallmarks by examining recent findings"
        }
      ]
    },
    {
      "id": "67ca061181b102733300000a",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25747039",
        "http://www.ncbi.nlm.nih.gov/pubmed/26282267",
        "http://www.ncbi.nlm.nih.gov/pubmed/29237010",
        "http://www.ncbi.nlm.nih.gov/pubmed/23166390",
        "http://www.ncbi.nlm.nih.gov/pubmed/24099087",
        "http://www.ncbi.nlm.nih.gov/pubmed/27492478",
        "http://www.ncbi.nlm.nih.gov/pubmed/32535328",
        "http://www.ncbi.nlm.nih.gov/pubmed/15015744",
        "http://www.ncbi.nlm.nih.gov/pubmed/21604127",
        "http://www.ncbi.nlm.nih.gov/pubmed/21029754"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25747039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 224,
          "offsetInEndSection": 423,
          "text": "Xist RNA is thought to play a role as a platform in recruiting proteins involved in gene silencing and heterochromatinization, which mediate serial changes in epigenetic modification of the chromatin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25747039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 425,
          "offsetInEndSection": 549,
          "text": "During the last two decades, many proteins have been shown to be enriched on the inactivated X chromosome in mouse and human"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25747039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 551,
          "offsetInEndSection": 807,
          "text": "Although the biological significance of most of them for X-inactivation has not been fully established, extensive studies of these proteins should provide a better understanding of the molecular basis of how X-inactivation mediated by Xist RNA is regulated"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25747039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 809,
          "offsetInEndSection": 937,
          "text": "Here, we review the potential roles of some of these proteins in the stepwise process of Xist RNA-mediated chromosome silencing."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25747039",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 222,
          "text": "X chromosome inactivation (X-inactivation) is triggered by X-linked noncoding Xist RNA, which is expressed asymmetrically from one of the two X chromosomes in females and coats it in cis to induce chromosome-wide silencing"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26282267",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 692,
          "offsetInEndSection": 853,
          "text": "Recent studies have improved our understanding of Xist localization and the proteins with which it interacts, allowing a reappraisal of ideas about Xist function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26282267",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 198,
          "offsetInEndSection": 266,
          "text": "The master regulator of this process is the long non-coding RNA Xist"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26282267",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 268,
          "offsetInEndSection": 485,
          "text": "During X-inactivation, Xist accumulates in cis on the future inactive X chromosome, triggering a cascade of events that provoke the stable silencing of the entire chromosome, with relatively few genes remaining active"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26282267",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 487,
          "offsetInEndSection": 690,
          "text": "How Xist spreads, what are its binding sites, how it recruits silencing factors and how it induces a specific topological and nuclear organization of the chromatin all remain largely unanswered questions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26282267",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 855,
          "offsetInEndSection": 1125,
          "text": "We discuss recent advances in our knowledge of Xist-mediated silencing, focusing on Xist spreading, the nuclear organization of the inactive X chromosome, recruitment of the polycomb complex and the role of the nuclear matrix in the process of X chromosome inactivation."
        }
      ]
    },
    {
      "id": "67e26d6218b1e36f2e000074",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
        "http://www.ncbi.nlm.nih.gov/pubmed/23597147",
        "http://www.ncbi.nlm.nih.gov/pubmed/17375009",
        "http://www.ncbi.nlm.nih.gov/pubmed/23830395",
        "http://www.ncbi.nlm.nih.gov/pubmed/24665294",
        "http://www.ncbi.nlm.nih.gov/pubmed/11545478",
        "http://www.ncbi.nlm.nih.gov/pubmed/1449769",
        "http://www.ncbi.nlm.nih.gov/pubmed/18694539",
        "http://www.ncbi.nlm.nih.gov/pubmed/8677022",
        "http://www.ncbi.nlm.nih.gov/pubmed/16735000"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "text": "Juvenile systemic lupus erythematosus is more incident in female affecting different systems including the central nervous system"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 131,
          "offsetInEndSection": 406,
          "text": "The aim of this study was to check the incidence of seizures and electroencephalographic features in these patients.\nIt was analyzed all patients with juvenile systemic lupus erythematosus referred to the Pequeno Príncipe Hospital in Curitiba, PR, Brazil, in the year of 2007"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1223,
          "offsetInEndSection": 1526,
          "text": "The statistic analysis showed no significantly difference between age of onset of symptoms and the risk of seizures (p 0.675) as well as between time of the disease and the risk of seizures (p 0.436).\nNeurologic manifestations, in special epileptic seizures, are frequent in systemic lupus erythematosus"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 534,
          "offsetInEndSection": 700,
          "text": "Mann-Whitney statistical test was used.\nForty-nine cases were included, there were 73.45% female, with an age between 3 and 28 years (micro=17.00 years; s=5.01 years)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 825,
          "offsetInEndSection": 892,
          "text": "Cerebral vasculites were the most frequent alteration in neuroimage"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1528,
          "offsetInEndSection": 1641,
          "text": "Age of onset of symptoms and the time of disease did not increase the risk of epileptic seizures in this disease."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 408,
          "offsetInEndSection": 532,
          "text": "The patients were submitted to EEG and subdivided into two groups according to the presence or absence of epileptic seizures"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18813701",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 894,
          "offsetInEndSection": 1221,
          "text": "The abnormalities of EEG were characterized by asymmetry of the electric cerebral activity, diffuse disorganized background activity, focal epileptiform discharges in the right central-temporal region, generalized paroxysmal of 3 Hz spike-waves, and bursts of theta-delta slowness activity in the right parietal-occiptal region"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597147",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 166,
          "offsetInEndSection": 302,
          "text": "The availability of a formulation permitting convenient systemic delivery might have applicability to scleroderma vascular complications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597147",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1737,
          "offsetInEndSection": 2009,
          "text": "The most frequent adverse events were similar to those seen with prostacyclin analogues.\nOral treprostinil diethanolamine was effectively absorbed in patients with scleroderma. Drug administration was temporally associated with improved cutaneous perfusion and temperature"
        }
      ]
    },
    {
      "id": "680a21eb18b1e36f2e000150",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
        "http://www.ncbi.nlm.nih.gov/pubmed/23749404",
        "http://www.ncbi.nlm.nih.gov/pubmed/27821050",
        "http://www.ncbi.nlm.nih.gov/pubmed/26480925",
        "http://www.ncbi.nlm.nih.gov/pubmed/14730707",
        "http://www.ncbi.nlm.nih.gov/pubmed/15136145",
        "http://www.ncbi.nlm.nih.gov/pubmed/25614629",
        "http://www.ncbi.nlm.nih.gov/pubmed/3359982",
        "http://www.ncbi.nlm.nih.gov/pubmed/35311140",
        "http://www.ncbi.nlm.nih.gov/pubmed/22302795"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 71,
          "offsetInEndSection": 187,
          "text": "Astrocytes are the most abundant glial cells in the brain and are the only cells in close contact with blood vessels"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 69,
          "text": "How iron is delivered to the CNS for myelination is poorly understood"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 189,
          "offsetInEndSection": 288,
          "text": "Therefore, they are strategically located to obtain nutrients, such as iron, from circulating blood"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 290,
          "offsetInEndSection": 579,
          "text": "To determine the importance of astrocyte iron uptake and storage in myelination and remyelination, we conditionally knocked-out the expression of the divalent metal transporter 1 (DMT1), the transferrin receptor 1 (Tfr1), and the ferritin heavy subunit (Fth) in Glast-1-positive astrocytes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 581,
          "offsetInEndSection": 728,
          "text": "DMT1 or Tfr1 ablation in astrocytes throughout early brain development did not significantly affects oligodendrocyte maturation or iron homeostasis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 730,
          "offsetInEndSection": 877,
          "text": "However, blocking Fth production in astrocytes during the first postnatal week drastically delayed oligodendrocyte development and myelin synthesis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 879,
          "offsetInEndSection": 1043,
          "text": "Fth knockout animals presented an important decrease in the number of myelinating oligodendrocytes and a substantial reduction in the percentage of myelinated axons"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1045,
          "offsetInEndSection": 1182,
          "text": "This postnatal hypomyelination was accompanied by a decline in oligodendrocyte iron uptake and with an increase in brain oxidative stress"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1184,
          "offsetInEndSection": 1292,
          "text": "We also tested the relevance of astrocytic Fth expression in the cuprizone model of myelin damage and repair"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1294,
          "offsetInEndSection": 1477,
          "text": "Fth deletion in Glast1-positive astrocytes significantly reduced myelin production and the density of mature myelinating oligodendrocytes throughout the complete remyelination process"
        }
      ]
    },
    {
      "id": "67fa3c5818b1e36f2e000109",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
        "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
        "http://www.ncbi.nlm.nih.gov/pubmed/20071548",
        "http://www.ncbi.nlm.nih.gov/pubmed/29295136",
        "http://www.ncbi.nlm.nih.gov/pubmed/25130173",
        "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
        "http://www.ncbi.nlm.nih.gov/pubmed/23145817",
        "http://www.ncbi.nlm.nih.gov/pubmed/36572998"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 153,
          "text": "canSAR (http://cansar.icr.ac.uk) is a public integrative cancer-focused knowledgebase for the support of cancer translational research and drug discovery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 155,
          "offsetInEndSection": 884,
          "text": "Through the integration of biological, pharmacological, chemical, structural biology and protein network data, it provides a single information portal to answer complex multidisciplinary questions including--among many others--what is known about a protein, in which cancers is it expressed or mutated, and what chemical tools and cell line models can be used to experimentally probe its activity? What is known about a drug, its cellular sensitivity profile and what proteins is it known to bind that may explain unusual bioactivity? Here we describe major enhancements to canSAR including new data, improved search and browsing capabilities and new target, cancer cell line, protein family and 3D structure summaries and tools."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "This article explains what methicillin-resistant Staphylococcus aureus (MRSA) is, how it is spread and what the real challenges are in healthcare settings in the UK"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 262,
          "offsetInEndSection": 317,
          "text": "It is intended to be a reference source for all nurses."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 193,
          "text": "One of the most important protein complexes involved in maintaining correct RNA levels in eukaryotic cells is the exosome, a complex consisting almost exclusively of exoribonucleolytic proteins"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 195,
          "offsetInEndSection": 381,
          "text": "Since the identification of the exosome complex, seven years ago, much progress has been made in the characterization of its composition, structure and function in a variety of organisms"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 383,
          "offsetInEndSection": 528,
          "text": "Although the exosome seems to accumulate in the nucleolus, it has been clearly established that it is also localized in cytoplasm and nucleoplasm"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 530,
          "offsetInEndSection": 680,
          "text": "In accordance with its widespread intracellular distribution, the exosome has been implicated in a variety of RNA processing and degradation processes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 736,
          "offsetInEndSection": 1394,
          "text": "What are the factors that regulate the activity of the exosome? How and where is the complex assembled? What are the differences in the composition of the nuclear and cytoplasmic exosome? What is the detailed structure of exosome subunits? What are the mechanisms by which the exosome is recruited to substrate RNAs? Here, we summarize the current knowledge on the composition and architecture of this complex, explain its role in both the production and degradation of various types of RNA molecules and discuss the implications of recent research developments that shed some light on the questions above and the mechanisms that are controlling the exosome."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "What is the function of the Hox genes? At first glance, it is a curious question"
        }
      ]
    },
    {
      "id": "6810c54b353a4a2e6b000011",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
        "http://www.ncbi.nlm.nih.gov/pubmed/20184241",
        "http://www.ncbi.nlm.nih.gov/pubmed/23700188",
        "http://www.ncbi.nlm.nih.gov/pubmed/35358718",
        "http://www.ncbi.nlm.nih.gov/pubmed/11154213",
        "http://www.ncbi.nlm.nih.gov/pubmed/16444286",
        "http://www.ncbi.nlm.nih.gov/pubmed/37138935",
        "http://www.ncbi.nlm.nih.gov/pubmed/21955200",
        "http://www.ncbi.nlm.nih.gov/pubmed/20676553",
        "http://www.ncbi.nlm.nih.gov/pubmed/12171680"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1097,
          "offsetInEndSection": 1560,
          "text": "Radiosurgical ventrolateral thalamotomy for the treatment of tremor in patients with Parkinson disease or multiple sclerosis, as well as in the treatment of essential tremor, may be indicated for a select group of patients with advanced age, significant medical conditions that preclude treatment with open surgery, or patients who must receive anticoagulation therapy. A promising new application of SRS is high-dose radiosurgery delivered to the pituitary stalk"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 132,
          "offsetInEndSection": 238,
          "text": "The most common indications for radiosurgery today are tumors and arteriovenous malformations of the brain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 240,
          "offsetInEndSection": 377,
          "text": "Functional indications such as treatment of movement disorders or intractable pain only contribute a small percentage of treated patients"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 379,
          "offsetInEndSection": 626,
          "text": "Although SRS is the only noninvasive form of treatment for functional disorders, it also has some limitations: neurophysiological confirmation of the target structure is not possible, and one therefore must rely exclusively on anatomical targeting"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 752,
          "offsetInEndSection": 838,
          "text": "The most common indication for functional SRS is the treatment of trigeminal neuralgia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 840,
          "offsetInEndSection": 1095,
          "text": "Radiosurgical treatment for epilepsy and certain psychiatric illnesses is performed in several centers as part of strict research protocols, and radiosurgical pallidotomy or medial thalamotomy is no longer recommended due to the high risk of complications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1097,
          "offsetInEndSection": 1465,
          "text": "Radiosurgical ventrolateral thalamotomy for the treatment of tremor in patients with Parkinson disease or multiple sclerosis, as well as in the treatment of essential tremor, may be indicated for a select group of patients with advanced age, significant medical conditions that preclude treatment with open surgery, or patients who must receive anticoagulation therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18081480",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1562,
          "offsetInEndSection": 1708,
          "text": "This treatment has already been successfully performed in several centers around the world to treat severe pain in patients with end-stage cancer."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20184241",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 804,
          "offsetInEndSection": 1079,
          "text": "Our patient had a favorable response to oral corticosteroid therapy (PSL 30 mg/day), gradually tapered 2.5-5 mg every 4 weeks, then stopped at the eighth month after commencing therapy. However, pulmonary lesions have relapsed 3 years after the discontinuation of the therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20184241",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 990,
          "offsetInEndSection": 1263,
          "text": "However, pulmonary lesions have relapsed 3 years after the discontinuation of the therapy. It is well known that relapses can happen when corticosteroids are used, and we should consider the progression of this disease and the indications of further treatment in this case."
        }
      ]
    },
    {
      "id": "67fd5d6518b1e36f2e000138",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
        "http://www.ncbi.nlm.nih.gov/pubmed/22192390",
        "http://www.ncbi.nlm.nih.gov/pubmed/17113236",
        "http://www.ncbi.nlm.nih.gov/pubmed/10440458",
        "http://www.ncbi.nlm.nih.gov/pubmed/8545913",
        "http://www.ncbi.nlm.nih.gov/pubmed/23445489",
        "http://www.ncbi.nlm.nih.gov/pubmed/25994244",
        "http://www.ncbi.nlm.nih.gov/pubmed/11723754",
        "http://www.ncbi.nlm.nih.gov/pubmed/11706120",
        "http://www.ncbi.nlm.nih.gov/pubmed/8800628"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Weight gain has been reported with nearly every antipsychotic drug on the market (molindone is an exception)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 110,
          "offsetInEndSection": 230,
          "text": "Weight gain occurs no matter what the patient's age, sex, or race and is seen with both oral and depot drug formulations"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 389,
          "offsetInEndSection": 586,
          "text": "The newer, novel antipsychotics offer advantages over conventional antipsychotics, especially a relative lack of extrapyramidal symptoms, but some still have the disadvantage of causing weight gain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 588,
          "offsetInEndSection": 756,
          "text": "Clozapine and olanzapine in particular appear to cause substantial weight gain, much more so than do most conventional neuroleptics and novel agents such as risperidone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 758,
          "offsetInEndSection": 988,
          "text": "Given the risks to health and treatment compliance associated with weight gain and obesity, clinicians should monitor weight during the course of antipsychotic therapy and consider switching agents if excessive weight gain occurs."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 232,
          "offsetInEndSection": 387,
          "text": "Numerous studies have found that patients gain weight when treated with a conventional antipsychotic, such as chlorpromazine, fluphenazine, and haloperidol"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22192390",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 416,
          "offsetInEndSection": 710,
          "text": "In this study, CGH was applied to high-quality metaphase spreads of pangolin (Pholidota), using probes of sloth and canine (Xenarthra and Carnivora, respectively) genomic DNA labeled with different fluorophores, thereby facilitating analysis of the visible color spectrum on pangolin karyotypes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22192390",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 973,
          "offsetInEndSection": 1164,
          "text": "Since the modified CGH technique used is genome-wide, has chromosome-level resolution, and does not need full genome sequencing, it has considerable potential in systematics and other fields."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22192390",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 414,
          "text": "The objective was to apply a novel modification of a genome-wide, comparative cytogenetic technique (comparative genomic hybridization, comparative genomic hybridization (CGH)), to study species belonging to the myrmecophagous (ant/termite eating) mammalian orders/superorders (Pholidota, Tubulidentata, Carnivora, and Xenarthra), as a model for other applications in mammalian systematics and conservation biology"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22192390",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 712,
          "offsetInEndSection": 971,
          "text": "Our results posited that pholidotes are closer to carnivores than to xenarthrans, which confirmed the current consensus that myrmecophagy in these mammalian lineages was more likely because of homoplasy (convergent evolution) than being an ancestral character"
        }
      ]
    },
    {
      "id": "67fb046e18b1e36f2e00010c",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
        "http://www.ncbi.nlm.nih.gov/pubmed/18801164",
        "http://www.ncbi.nlm.nih.gov/pubmed/21854862",
        "http://www.ncbi.nlm.nih.gov/pubmed/26140505",
        "http://www.ncbi.nlm.nih.gov/pubmed/31314901",
        "http://www.ncbi.nlm.nih.gov/pubmed/16939780",
        "http://www.ncbi.nlm.nih.gov/pubmed/28583723",
        "http://www.ncbi.nlm.nih.gov/pubmed/28991104",
        "http://www.ncbi.nlm.nih.gov/pubmed/28303677",
        "http://www.ncbi.nlm.nih.gov/pubmed/15884297"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 257,
          "offsetInEndSection": 368,
          "text": "It is still unclear what factors determine whether a target transcript is degraded or translationally repressed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 370,
          "offsetInEndSection": 612,
          "text": "In this study, we collected two classes of genes that are targeted by miR-1, miR-155, miR-16, miR-30a, and let-7b and built new computational models with machine-learning methods to predict the fates of target genes based on sequence features"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 820,
          "offsetInEndSection": 951,
          "text": "Further analysis shows that four out of the five studied miRNAs probably share similar regulatory mechanisms on their target genes."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "MicroRNAs (miRNAs) are important post-transcriptional regulators that repress gene expression by binding to the 3'UTRs of their target mRNAs"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 614,
          "offsetInEndSection": 818,
          "text": "The prediction results indicate that the sequence context of the miRNA binding site at the 3'UTR of a target gene plays an important role in determining how an miRNA regulates the expression of its target"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643113",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 142,
          "offsetInEndSection": 255,
          "text": "There are two main outcomes for the transcripts targeted by miRNAs: mRNA degradation and translational repression"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18801164",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 100,
          "text": "Obtaining the gene structure for a given protein encoding gene is an important step in many analyses"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18801164",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 102,
          "offsetInEndSection": 283,
          "text": "A software suited for this task should be readily accessible, accurate, easy to handle and should provide the user with a coherent representation of the most probable gene structure"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18801164",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 285,
          "offsetInEndSection": 652,
          "text": "It should be rigorous enough to optimise features on the level of single bases and at the same time flexible enough to allow for cross-species searches.\nWebScipio, a web interface to the Scipio software, allows a user to obtain the corresponding coding sequence structure of a here given a query protein sequence that belongs to an already assembled eukaryotic genome"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18801164",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 654,
          "offsetInEndSection": 855,
          "text": "The resulting gene structure is presented in various human readable formats like a schematic representation, and a detailed alignment of the query and the target sequence highlighting any discrepancies"
        }
      ]
    },
    {
      "id": "67d6bbfa18b1e36f2e000020",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24789219",
        "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
        "http://www.ncbi.nlm.nih.gov/pubmed/24133558",
        "http://www.ncbi.nlm.nih.gov/pubmed/21427575",
        "http://www.ncbi.nlm.nih.gov/pubmed/24849622",
        "http://www.ncbi.nlm.nih.gov/pubmed/32593355",
        "http://www.ncbi.nlm.nih.gov/pubmed/31316514",
        "http://www.ncbi.nlm.nih.gov/pubmed/24171696",
        "http://www.ncbi.nlm.nih.gov/pubmed/34082434",
        "http://www.ncbi.nlm.nih.gov/pubmed/36589732"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 922,
          "offsetInEndSection": 1274,
          "text": "This article reviews recent literature concerning HIV/AIDS in older adults, as regard the related epidemiological, clinical and public health issues, with a view to suggesting how the rising rate of HIV transmission in this age group might be mitigated, and shows the main points that HCP should tackle to identify older people at risk of HIV infection"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "text": "HIV is often assumed to only affect younger people, and many older people do not realize that they might risk acquiring the virus"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 131,
          "offsetInEndSection": 446,
          "text": "Given that sexual transmission is by far the most common way to contract HIV around the world, health care professionals do not usually pay enough attention to the possibility of HIV/AIDS in older adults, based on the common conviction that they no longer have any sexual desires and that they are sexually inactive"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 688,
          "offsetInEndSection": 788,
          "text": "Hence the urgent need to awareness is that HIV remains as a major health threat even in advanced age"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789219",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1276,
          "offsetInEndSection": 1452,
          "text": "In summary, there is a pressing need to develop effective prevention schemes and to adapt clinical and programmatic approaches to improve the survival of older people with HIV."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 111,
          "offsetInEndSection": 218,
          "text": "The first HIV antibody test, developed in 1985, was designed to screen blood products, not to diagnose AIDS"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 470,
          "offsetInEndSection": 660,
          "text": "The second-generation HIV test added recombinant antigens, and the third-generation HIV tests included IgM detection, reducing the test-negative window to approximately 3 weeks postinfection"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 662,
          "offsetInEndSection": 804,
          "text": "Fourth- and fifth-generation HIV assays added p24 antigen detection to the screening assay, reducing the test-negative window to 11 to 14 days"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 946,
          "offsetInEndSection": 1062,
          "text": "The fifth-generation HIV assay provides separate antigen and antibody results and will require yet another algorithm"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1064,
          "offsetInEndSection": 1182,
          "text": "HIV infection may now be detected approximately 2 weeks postexposure, with a reduced number of false-positive results."
        }
      ]
    },
    {
      "id": "680fe1e3353a4a2e6b00000f",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21461655",
        "http://www.ncbi.nlm.nih.gov/pubmed/33526437",
        "http://www.ncbi.nlm.nih.gov/pubmed/20574445",
        "http://www.ncbi.nlm.nih.gov/pubmed/21747952",
        "http://www.ncbi.nlm.nih.gov/pubmed/22749034",
        "http://www.ncbi.nlm.nih.gov/pubmed/16607562",
        "http://www.ncbi.nlm.nih.gov/pubmed/24781087",
        "http://www.ncbi.nlm.nih.gov/pubmed/25522693",
        "http://www.ncbi.nlm.nih.gov/pubmed/17341507",
        "http://www.ncbi.nlm.nih.gov/pubmed/22427951"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21461655",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 156,
          "text": "The common p53 codon 72 polymorphism has been investigated as a risk factor for cancer in different populations; however, the results have been inconsistent"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21461655",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 158,
          "offsetInEndSection": 455,
          "text": "This study investigated the risk of developing gastric or colorectal cancer associated with the p53 codon 72 polymorphism in a Korean population.\nWe conducted a large-scale case-control study that included 2,213 gastric cancer patients; 1,829 colorectal cancer patients; and 1,700 healthy controls"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21461655",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 457,
          "offsetInEndSection": 863,
          "text": "Genotyping was performed with real-time polymerase chain reaction (PCR), using a TaqMan single-nucleotide polymorphism (SNP) genotyping assay.\nThe frequencies of Arg/Arg, Arg/Pro, and Pro/Pro genotypes of the p53 codon 72 polymorphism were 43.3, 42.0, and 13.0% in the gastric cancer patients; 40.5, 45.0, and 14.0% in the colorectal cancer patients; and 43.2, 45.6, and 11.2% in the controls, respectively"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21461655",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 865,
          "offsetInEndSection": 1097,
          "text": "The Pro/Pro genotype was associated with an increased risk of gastric [age- and sex-adjusted odds ratio (OR) = 1.25, 95% confidence interval (CI) = 1.01-1.56, P = 0.04] and colorectal cancer (OR = 1.36, 95% CI = 1.07-1.72, P = 0.01)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21461655",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1099,
          "offsetInEndSection": 1359,
          "text": "There were no significant interactions between the p53 codon 72 polymorphism and smoking or drinking.\nOur results suggest that the Pro/Pro genotype is associated with modest increases in the risks of gastric cancer and colorectal cancer in a Korean population."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33526437",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 106,
          "text": "Coeliac disease (CD) is a complex autoimmune disorder that develops in genetically susceptible individuals"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33526437",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 108,
          "offsetInEndSection": 235,
          "text": "Dietary gluten triggers an immune response for which the only available treatment so far is a strict, lifelong gluten free diet"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33526437",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 237,
          "offsetInEndSection": 508,
          "text": "Human leucocyte antigen (HLA) genes and several non-HLA regions have been associated with the genetic susceptibility to CD, but their role in the pathogenesis of the disease is still essentially unknown, making it complicated to develop much needed non-dietary treatments"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33526437",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 510,
          "offsetInEndSection": 842,
          "text": "Here, we describe the functional involvement of a CD-associated single-nucleotide polymorphism (SNP) located in the 5'UTR of \nThe function of the CD-associated SNP was investigated using an intestinal cell line heterozygous for the SNP, N6-methyladenosine (m\nIndividuals harbouring the risk allele had higher m\nWe identify a novel m"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20574445",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 131,
          "text": "Several single-nucleotide polymorphism (SNP) genome-wide association studies (GWASs) have been completed in multiple sclerosis (MS)"
        }
      ]
    },
    {
      "id": "680d5dd8353a4a2e6b000004",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
        "http://www.ncbi.nlm.nih.gov/pubmed/30476721",
        "http://www.ncbi.nlm.nih.gov/pubmed/24610704",
        "http://www.ncbi.nlm.nih.gov/pubmed/28566124",
        "http://www.ncbi.nlm.nih.gov/pubmed/20733416",
        "http://www.ncbi.nlm.nih.gov/pubmed/12111545",
        "http://www.ncbi.nlm.nih.gov/pubmed/12614473",
        "http://www.ncbi.nlm.nih.gov/pubmed/15303021",
        "http://www.ncbi.nlm.nih.gov/pubmed/35219702",
        "http://www.ncbi.nlm.nih.gov/pubmed/37600520"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 368,
          "text": "A genetic study of patients with familial adolescent idiopathic scoliosis.\nThe purpose of this study was to evaluate the evidence for linkage on chromosome 4q and determine whether mutations in the gene coding for melatonin receptor are present.\nAdolescent idiopathic scoliosis is the most common spine deformity arising during childhood, but its cause remains unknown"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 370,
          "offsetInEndSection": 502,
          "text": "The fact that adolescent idiopathic scoliosis is often seen in several members of the same family strongly suggests a genetic factor"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 504,
          "offsetInEndSection": 646,
          "text": "Recent work by Wise et al provides evidence for linkage of adolescent idiopathic scoliosis at several different chromosome sites, including 4q"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 648,
          "offsetInEndSection": 972,
          "text": "In addition, there is some evidence that adolescent idiopathic scoliosis may be related to a disturbance in melatonin metabolism, and the human melatonin-1A receptor is known to be located on chromosome 4q.\nProbands having clinically relevant idiopathic scoliosis (Cobb angle >30 degrees) and their relatives were identified"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 974,
          "offsetInEndSection": 1037,
          "text": "Radiographic confirmation was required for a positive diagnosis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1039,
          "offsetInEndSection": 1237,
          "text": "Linkage analysis was performed with 15 microsatellite markers of chromosome 4q spaced at approximately 10-cM resolution and 5 microsatellite markers surrounding the site for human melatonin receptor"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1239,
          "offsetInEndSection": 1404,
          "text": "The gene for human melatonin receptor was screened for mutations in the coding region using genomic DNA samples by single-strand conformational polymorphism analysis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1406,
          "offsetInEndSection": 1560,
          "text": "Amplimers showing a band shift were reamplified and sequenced bidirectionally.\nThere was no evidence for linkage at chromosome 4q in this study population"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1562,
          "offsetInEndSection": 1767,
          "text": "Twenty-nine individuals demonstrated aberrant single-strand conformation polymorphism band patterns, and sequence evaluation demonstrated six genetic polymorphisms for the gene for human melatonin receptor"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12973153",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1769,
          "offsetInEndSection": 2114,
          "text": "These genetic variations were found in both affected and nonaffected individuals, and there was no correlation between gene variants and the phenotype for adolescent idiopathic scoliosis.\nThe results of this study demonstrated no evidence of linkage to chromosome 4q and no mutations in the coding region of the gene for human melatonin receptor"
        }
      ]
    },
    {
      "id": "67d7208218b1e36f2e00002e",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19231646",
        "http://www.ncbi.nlm.nih.gov/pubmed/1554931",
        "http://www.ncbi.nlm.nih.gov/pubmed/11022098",
        "http://www.ncbi.nlm.nih.gov/pubmed/21302639",
        "http://www.ncbi.nlm.nih.gov/pubmed/20300365",
        "http://www.ncbi.nlm.nih.gov/pubmed/21949534",
        "http://www.ncbi.nlm.nih.gov/pubmed/23588149",
        "http://www.ncbi.nlm.nih.gov/pubmed/2087835",
        "http://www.ncbi.nlm.nih.gov/pubmed/11807448",
        "http://www.ncbi.nlm.nih.gov/pubmed/35999833"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19231646",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 192,
          "offsetInEndSection": 395,
          "text": "Both chronic and acute inflammatory infections may damage the hair follicle leading to secondary cicatricial alopecia. In rare instances, the initial presentation can mimic a primary cicatricial alopecia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19231646",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 311,
          "offsetInEndSection": 622,
          "text": "In rare instances, the initial presentation can mimic a primary cicatricial alopecia. We present three cases of tinea capitis in children masquerading as cicatricial alopecia and discuss the possible host immune and fungal antigenic factors that may influence the course of disease and its clinical presentation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19231646",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 397,
          "offsetInEndSection": 622,
          "text": "We present three cases of tinea capitis in children masquerading as cicatricial alopecia and discuss the possible host immune and fungal antigenic factors that may influence the course of disease and its clinical presentation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19231646",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 624,
          "offsetInEndSection": 804,
          "text": "An understanding of the clinical morphology of tinea capitis in the context of both host and fungal factors may improve treatment strategies and direct future paradigms of therapy."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1554931",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 174,
          "offsetInEndSection": 366,
          "text": "Topical minoxidil was approved as a treatment for androgenital alopecia. Only few side effects have been reported during treatment with topical minoxidil, most of them localized skin reactions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1554931",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 368,
          "offsetInEndSection": 791,
          "text": "Two of our patients developed smoking intolerance during treatment with topical minoxidil for androgenital alopecia. The relation between treatment with minoxidil and smoking intolerance was emphasized by stopping treatment and the disappearance of the smoking intolerance, and then by rechallenge in both patients.\nTopical minoxidil may cause smoking intolerance; further studies are needed to evaluation this side effect."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1554931",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 247,
          "offsetInEndSection": 366,
          "text": "Only few side effects have been reported during treatment with topical minoxidil, most of them localized skin reactions"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1554931",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 368,
          "offsetInEndSection": 483,
          "text": "Two of our patients developed smoking intolerance during treatment with topical minoxidil for androgenital alopecia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1554931",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 485,
          "offsetInEndSection": 791,
          "text": "The relation between treatment with minoxidil and smoking intolerance was emphasized by stopping treatment and the disappearance of the smoking intolerance, and then by rechallenge in both patients.\nTopical minoxidil may cause smoking intolerance; further studies are needed to evaluation this side effect."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11022098",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 59,
          "text": "Dendritic cells are critical initiators of immune responses"
        }
      ]
    },
    {
      "id": "67fc381f18b1e36f2e00012f",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
        "http://www.ncbi.nlm.nih.gov/pubmed/18484624",
        "http://www.ncbi.nlm.nih.gov/pubmed/30448867",
        "http://www.ncbi.nlm.nih.gov/pubmed/25994244",
        "http://www.ncbi.nlm.nih.gov/pubmed/27328325",
        "http://www.ncbi.nlm.nih.gov/pubmed/10548138",
        "http://www.ncbi.nlm.nih.gov/pubmed/16140943",
        "http://www.ncbi.nlm.nih.gov/pubmed/10408447",
        "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
        "http://www.ncbi.nlm.nih.gov/pubmed/24196393"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 183,
          "offsetInEndSection": 346,
          "text": "However, the hiPS-CM phenotype is dependent on their derivation, age, and culture conditions, and there is disagreement as to what constitutes a functional hiPS-CM"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 348,
          "offsetInEndSection": 621,
          "text": "The aim of the present study is to characterize the temporal changes in hiPS-CM phenotype by examining five determinants of cardiomyocyte function: gene expression, ion channel functionality, calcium cycling, metabolic activity, and responsiveness to cardioactive compounds"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 858,
          "offsetInEndSection": 1091,
          "text": "This phenotype is characterized by adult-like gene expression patterns, action potentials exhibiting ventricular atrial and nodal properties, coordinated calcium cycling and beating, suggesting the formation of a functional syncytium"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1093,
          "offsetInEndSection": 1311,
          "text": "Pharmacological responses to pathological (endothelin-1), physiological (IGF-1), and autonomic (isoproterenol) stimuli similar to those characteristic of isolated adult cardiac myocytes are present in maturing hiPS-CMs"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1553,
          "offsetInEndSection": 1675,
          "text": "The description of this evolving phenotype helps to identify optimal use of hiPS-CMs for a range of research applications."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 623,
          "offsetInEndSection": 856,
          "text": "Based on both gene expression and electrophysiological properties, at day 30 of differentiation, hiPS-CMs are immature cells that, with time in culture, progressively develop a more mature phenotype without signs of dedifferentiation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "Human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) have been recently derived and are used for basic research, cardiotoxicity assessment, and phenotypic screening"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1313,
          "offsetInEndSection": 1438,
          "text": "In addition, thyroid hormone treatment of hiPS-CMs attenuated the fetal gene expression in favor of a more adult-like pattern"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23832699",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1440,
          "offsetInEndSection": 1551,
          "text": "Overall, hiPS-CMs progressively acquire functionality when maintained in culture for a prolonged period of time"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18484624",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 160,
          "text": "The Melanocortin-1 Receptor (MC1R) is a G-protein coupled receptor, which is responsible for production of the darker eumelanin pigment and the tanning response"
        }
      ]
    },
    {
      "id": "67c9e46881b1027333000004",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
        "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
        "http://www.ncbi.nlm.nih.gov/pubmed/15346807",
        "http://www.ncbi.nlm.nih.gov/pubmed/15884297",
        "http://www.ncbi.nlm.nih.gov/pubmed/29295136",
        "http://www.ncbi.nlm.nih.gov/pubmed/16536004",
        "http://www.ncbi.nlm.nih.gov/pubmed/31305235",
        "http://www.ncbi.nlm.nih.gov/pubmed/23700068",
        "http://www.ncbi.nlm.nih.gov/pubmed/25079039",
        "http://www.ncbi.nlm.nih.gov/pubmed/6270614"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 153,
          "text": "canSAR (http://cansar.icr.ac.uk) is a public integrative cancer-focused knowledgebase for the support of cancer translational research and drug discovery"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24304894",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 155,
          "offsetInEndSection": 884,
          "text": "Through the integration of biological, pharmacological, chemical, structural biology and protein network data, it provides a single information portal to answer complex multidisciplinary questions including--among many others--what is known about a protein, in which cancers is it expressed or mutated, and what chemical tools and cell line models can be used to experimentally probe its activity? What is known about a drug, its cellular sensitivity profile and what proteins is it known to bind that may explain unusual bioactivity? Here we describe major enhancements to canSAR including new data, improved search and browsing capabilities and new target, cancer cell line, protein family and 3D structure summaries and tools."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "What is the function of the Hox genes? At first glance, it is a curious question"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 82,
          "offsetInEndSection": 291,
          "text": "Indeed, the answer seems so obvious that several authors have spoken of 'the Hox function' about some of the Hox genes, namely Hox3/zen and Hox6/ftz that seem to have lost it during the evolution of Arthropods"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 293,
          "offsetInEndSection": 373,
          "text": "What these authors meant is that these genes have lost their 'homeotic' function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 375,
          "offsetInEndSection": 472,
          "text": "Indeed, 'homeotic' refers to a functional property that is so often associated with the Hox genes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 474,
          "offsetInEndSection": 564,
          "text": "However, the word 'Hox' should not be used to refer to a function, but to a group of genes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 566,
          "offsetInEndSection": 726,
          "text": "The above examples of Hox3/zen (see Schmitt-Ott's chapter, this book) and Hox6/ftz show that the homeotic function may be not so tightly linked to the Hox genes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 728,
          "offsetInEndSection": 813,
          "text": "Reversely, many genes, not belonging to the Hox group, do present a homeotic function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20795330",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 815,
          "offsetInEndSection": 886,
          "text": "In the present chapter, I will first give a definition of the Hox genes"
        }
      ]
    },
    {
      "id": "67fbe2ab18b1e36f2e000116",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30485523",
        "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
        "http://www.ncbi.nlm.nih.gov/pubmed/33114764",
        "http://www.ncbi.nlm.nih.gov/pubmed/23037146",
        "http://www.ncbi.nlm.nih.gov/pubmed/12414442",
        "http://www.ncbi.nlm.nih.gov/pubmed/30726693",
        "http://www.ncbi.nlm.nih.gov/pubmed/33178308",
        "http://www.ncbi.nlm.nih.gov/pubmed/29214616",
        "http://www.ncbi.nlm.nih.gov/pubmed/3736130",
        "http://www.ncbi.nlm.nih.gov/pubmed/24409030"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30485523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1255,
          "offsetInEndSection": 1698,
          "text": "The effects of sulfated hyaluronic acid were predominantly linked to an alteration in the composition of the extracellular matrix, affecting the synthesis, secretion, and/or activity of fibrillary (fibronectin and thrombospondin-2) and nonfibrillary (transglutaminase-2, periostin, and lysyloxidase) extracellular matrix components, including proteases and their inhibitors (matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-3)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30485523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 109,
          "offsetInEndSection": 335,
          "text": "Both sulfated hyaluronic acid and dexamethasone are candidates for the functionalization of bone grafts, as they have been shown to enhance the differentiation of osteoblasts from bone marrow stromal cells in vitro and in vivo"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30485523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 493,
          "offsetInEndSection": 844,
          "text": "In this study, we aim to gain insights into the mode of action of both sulfated hyaluronic acid and dexamethasone by a comprehensive analysis of the cellular fraction, released matrix vesicles, and the extracellular matrix, combining classical biochemical assays with mass spectrometry-based proteomics, supported by novel bioinformatical computations"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30485523",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 846,
          "offsetInEndSection": 998,
          "text": "We found elevated differentiation levels for both treatments, which were further enhanced by a combination of sulfated hyaluronic acid and dexamethasone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 576,
          "offsetInEndSection": 813,
          "text": "Various orthopaedic biologics (orthobiologics) have been investigated for the treatment of pathology involving the shoulder including the rotator cuff tendons, glenohumeral articular cartilage, glenoid labrum, the joint capsule, and bone"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 815,
          "offsetInEndSection": 1799,
          "text": "Promising and established treatment modalities include hyaluronic acid (HA); platelet-rich plasma (PRP) and platelet rich concentrates (PRC); bone marrow aspirate (BMA) comprising mesenchymal stromal cells (MSCs alternatively termed medicinal signaling cells and frequently, misleadingly labelled \"mesenchymal stem cells\"); MSC harvested from adipose, umbilical, or placental sources; factors including vascular endothelial growth factors (VEGF), basic fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), transforming growth factor-beta (TGFβ), bone morphogenic protein (BMP), and matrix metalloproteinases (MMPs); prolotherapy; pulsed electromagnetic field therapy; microfracture and other marrow-stimulation techniques; biologic resurfacing using acellular dermal allografts, allograft Achilles tendons, allograft lateral menisci, fascia lata autografts, and porcine xenografts; osteochondral autograft or allograft); and autologous chondrocyte implantation (ACI)"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1801,
          "offsetInEndSection": 1994,
          "text": "Studies involving hyaluronic acid, platelet rich plasma, and medicinal signaling cells of various origin tissues have shown mixed results to-date as isolated treatments and as surgical adjuncts"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 221,
          "text": "Orthoregeneration is defined as a solution for orthopaedic conditions that harnesses the benefits of biology to improve healing, reduce pain, improve function, and optimally, provide an environment for tissue regeneration"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 356,
          "offsetInEndSection": 574,
          "text": "The goal of regenerative medicine is to enhance the healing of tissue after musculoskeletal injuries as both isolated treatment and adjunct to surgical management, using novel therapies to improve recovery and outcomes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34293441",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1996,
          "offsetInEndSection": 2160,
          "text": "Despite varied results thus far, there is great potential for improved efficacy with refinement of current techniques and translation of burgeoning preclinical work"
        }
      ]
    },
    {
      "id": "67eaf14c18b1e36f2e0000de",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
        "http://www.ncbi.nlm.nih.gov/pubmed/26277449",
        "http://www.ncbi.nlm.nih.gov/pubmed/26067407",
        "http://www.ncbi.nlm.nih.gov/pubmed/23582322",
        "http://www.ncbi.nlm.nih.gov/pubmed/9291094",
        "http://www.ncbi.nlm.nih.gov/pubmed/25936917",
        "http://www.ncbi.nlm.nih.gov/pubmed/31605096",
        "http://www.ncbi.nlm.nih.gov/pubmed/24119843",
        "http://www.ncbi.nlm.nih.gov/pubmed/32396464",
        "http://www.ncbi.nlm.nih.gov/pubmed/20226168"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 647,
          "offsetInEndSection": 856,
          "text": "By searching for transcription factors that function at these elements, we identified NFIA and ATF3 as drivers of astrocyte differentiation from neural precursor cells while RUNX2 promotes astrocyte maturation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 858,
          "offsetInEndSection": 1027,
          "text": "These transcription factors facilitate stage-specific gene expression programs by switching the chromatin state of their target regulatory elements from primed to active"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 132,
          "text": "A broad molecular framework of how neural stem cells are specified toward astrocyte fate during brain development has proven elusive"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 134,
          "offsetInEndSection": 341,
          "text": "Here we perform comprehensive and integrated transcriptomic and epigenomic analyses to delineate gene regulatory programs that drive the developmental trajectory from mouse embryonic stem cells to astrocytes"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 343,
          "offsetInEndSection": 645,
          "text": "We report molecularly distinct phases of astrogliogenesis that exhibit stage- and lineage-specific transcriptomic and epigenetic signatures with unique primed and active chromatin regions, thereby revealing regulatory elements and transcriptional programs underlying astrocyte generation and maturation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30290178",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1029,
          "offsetInEndSection": 1171,
          "text": "Altogether, these findings provide integrated insights into the genetic and epigenetic mechanisms steering the trajectory of astrogliogenesis."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26277449",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 524,
          "offsetInEndSection": 692,
          "text": "Here we review the features that define SEs, and discuss their function within the broader understanding of the mechanisms that define immune cell identity and function"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26277449",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 694,
          "offsetInEndSection": 946,
          "text": "We propose that SEs present crucial regulatory hubs, coordinating intrinsic and extrinsic differentiation signals, and argue that delineating these regions will provide important insight into the factors and mechanisms that define immune cell identity."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26277449",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 251,
          "text": "Super-enhancers (SEs) are regions of the genome consisting of clusters of regulatory elements bound with very high amounts of transcription factors, and this architecture appears to be the hallmark of genes and noncoding RNAs linked with cell identity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26277449",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 253,
          "offsetInEndSection": 522,
          "text": "Recent studies have identified SEs in CD4(+) T cells and have further linked these regions to single nucleotide polymorphisms (SNPs) associated with immune-mediated disorders, pointing to an important role for these structures in the T cell differentiation and function"
        }
      ]
    },
    {
      "id": "67c9e7ee81b1027333000007",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
        "http://www.ncbi.nlm.nih.gov/pubmed/6823106",
        "http://www.ncbi.nlm.nih.gov/pubmed/20925138",
        "http://www.ncbi.nlm.nih.gov/pubmed/3117031",
        "http://www.ncbi.nlm.nih.gov/pubmed/24289081",
        "http://www.ncbi.nlm.nih.gov/pubmed/23732207",
        "http://www.ncbi.nlm.nih.gov/pubmed/16532398",
        "http://www.ncbi.nlm.nih.gov/pubmed/26836985",
        "http://www.ncbi.nlm.nih.gov/pubmed/2720439",
        "http://www.ncbi.nlm.nih.gov/pubmed/21778740"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 153,
          "offsetInEndSection": 245,
          "text": "This phenomenon, first described by Zimmerman and Hulsmann, was termed the \"calcium paradox\""
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 364,
          "offsetInEndSection": 509,
          "text": "The taurine (2-aminoethanesulfonic acid) content of hearts in the newborn animal is high, and decreases rapidly during the first few days of life"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1134,
          "offsetInEndSection": 1244,
          "text": "It is proposed that myocardial taurine is one factor in the protection against the calcium paradox phenomenon."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "When hearts were reperfused with Ca++ after a short period of Ca++-free perfusion, irreversible loss of electrical and mechanical activity was observed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 967,
          "offsetInEndSection": 1132,
          "text": "The age-related response to the calcium paradox was partially protected by oral pretreatment with taurine, and there was a small increase in myocardial taurine level"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 247,
          "offsetInEndSection": 362,
          "text": "Chizzonite and Zak recently reported that rat hearts exhibited an age-dependent response in a calcium paradox model"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 511,
          "offsetInEndSection": 700,
          "text": "The present experiments were performed to test whether the myocardial taurine content was closely linked to an age-dependent response in the calcium paradox model, using post-hatched chicks"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4058248",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 702,
          "offsetInEndSection": 874,
          "text": "The mechanical dysfunction of the heart was much more severe in 9-day-old post-hatched chicks than in 2-day-old chicks when the hearts were subjected to the calcium paradox"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6823106",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 218,
          "text": "Isolated perfusion of the heart with a Ca2+-free perfusate followed by a Ca2+-containing perfusate causes dramatic alterations in the physiology and biochemistry of the tissue, a phenomenon known as the calcium paradox"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6823106",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 304,
          "offsetInEndSection": 446,
          "text": "In this study an attempt was made to reproduce the calcium paradox in canine kidneys and to characterize more fully its metabolic consequences"
        }
      ]
    },
    {
      "id": "67d71d8f18b1e36f2e00002b",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
        "http://www.ncbi.nlm.nih.gov/pubmed/35789381",
        "http://www.ncbi.nlm.nih.gov/pubmed/28366569",
        "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
        "http://www.ncbi.nlm.nih.gov/pubmed/25547793",
        "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
        "http://www.ncbi.nlm.nih.gov/pubmed/27905086",
        "http://www.ncbi.nlm.nih.gov/pubmed/29076071",
        "http://www.ncbi.nlm.nih.gov/pubmed/28480750",
        "http://www.ncbi.nlm.nih.gov/pubmed/28107612"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "Clostridium difficile is a spore-forming obligate anaerobe that is a leading cause of healthcare-associated infections"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 237,
          "offsetInEndSection": 420,
          "text": "Binding of bile salt germinants to the Csp family pseudoprotease CspC triggers a proteolytic signaling cascade consisting of the Csp family protease CspB and the cortex hydrolase SleC"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 422,
          "offsetInEndSection": 579,
          "text": "Conserved across many of the Clostridia, Csp proteases are subtilisin-like serine proteases that activate pro-SleC by cleaving off its inhibitory pro-peptide"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 581,
          "offsetInEndSection": 678,
          "text": "Active SleC degrades the protective cortex layer, allowing spores to resume metabolism and growth"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 680,
          "offsetInEndSection": 838,
          "text": "This signaling pathway, however, is differentially regulated in C. difficile, since CspC functions both as a germinant receptor and regulator of CspB activity"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 840,
          "offsetInEndSection": 987,
          "text": "CspB is also produced as a fusion to a catalytically inactive CspA domain that subsequently undergoes interdomain processing during spore formation"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 989,
          "offsetInEndSection": 1107,
          "text": "In this study, we investigated the role of the CspA pseudoprotease domain in regulating C. difficile spore germination"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1109,
          "offsetInEndSection": 1315,
          "text": "Mutational analyses revealed that the CspA domain controls CspC germinant receptor levels in mature spores and is required for optimal spore germination, particularly when CspA is fused to the CspB protease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1317,
          "offsetInEndSection": 1435,
          "text": "During spore formation, the YabG protease separates these domains, although YabG itself is dispensable for germination"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1437,
          "offsetInEndSection": 1671,
          "text": "Bioinformatic analyses of Csp family members suggest that the CspC-regulated signaling pathway characterized in C. difficile is conserved in related Peptostreptococcaceae family members but not in the Clostridiaceae or Lachnospiraceae"
        }
      ]
    },
    {
      "id": "67cdb26a81b1027333000017",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25688893",
        "http://www.ncbi.nlm.nih.gov/pubmed/28090050",
        "http://www.ncbi.nlm.nih.gov/pubmed/22433611",
        "http://www.ncbi.nlm.nih.gov/pubmed/29916741",
        "http://www.ncbi.nlm.nih.gov/pubmed/25648671",
        "http://www.ncbi.nlm.nih.gov/pubmed/22977310",
        "http://www.ncbi.nlm.nih.gov/pubmed/28634592",
        "http://www.ncbi.nlm.nih.gov/pubmed/24998153",
        "http://www.ncbi.nlm.nih.gov/pubmed/29937430",
        "http://www.ncbi.nlm.nih.gov/pubmed/24025022"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25688893",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "Sodium-glucose cotransporter type 2 (SGLT2) inhibitors such as canagliflozin and dapagliflozin have been approved for the treatment of type 2 diabetes mellitus"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25688893",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 161,
          "offsetInEndSection": 297,
          "text": "A PubMed search was conducted of the literature from April 1996 to August 2014 to identify all human studies related to SGLT2 inhibitors"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25688893",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 413,
          "offsetInEndSection": 594,
          "text": "SGLT2 inhibitors may be used as an add-on therapy in select and relatively healthy older patients with type 2 diabetes mellitus who are overweight and have uncontrolled hypertension"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25688893",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 299,
          "offsetInEndSection": 411,
          "text": "Pertinent guidelines of experts and the prescribing information for canagliflozin and dapagliflozin are reviewed"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25688893",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 596,
          "offsetInEndSection": 741,
          "text": "These medications should be avoided in patients who are frail, who have chronic kidney disease, and in conjunction with insulin or sulfonylureas."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28090050",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 443,
          "offsetInEndSection": 575,
          "text": "Physicians should consider euglycemic diabetic ketoacidosis in the differential diagnosis of patients treated with SGLT2 inhibitors."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28090050",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 175,
          "offsetInEndSection": 441,
          "text": "We herein report the case of a 27-year-old Asian woman with type 2 diabetes who was treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor (canagliflozin) who developed euglycemic diabetic ketoacidosis and persistent diuresis in the absence of hyperglycemia"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28090050",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 107,
          "offsetInEndSection": 173,
          "text": "After the resolution of hyperglycemia, persistent diuresis is rare"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22433611",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 435,
          "text": "To review the literature and describe the pharmacologic, pharmacokinetic, and pharmacodynamic properties; clinical safety; and efficacy of dapagliflozin, a new drug currently under review by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes.\nA MEDLINE (1995-November 2011) and ClinicalTrials.gov search was conducted using the terms dapagliflozin, sodium-glucose cotransporter 2 inhibitor, and SGLT2 inhibitor"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22433611",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 437,
          "offsetInEndSection": 812,
          "text": "Reference citations from publications identified were also reviewed.\nAll English-language studies, including abstracts, evaluating dapagliflozin use in humans were included in this review.\nDapagliflozin is the first-in-class oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that represents a new potential therapeutic option for the treatment of type 2 diabetes mellitus"
        }
      ]
    },
    {
      "id": "67e2b0a018b1e36f2e00008b",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
        "http://www.ncbi.nlm.nih.gov/pubmed/8771575",
        "http://www.ncbi.nlm.nih.gov/pubmed/19636526",
        "http://www.ncbi.nlm.nih.gov/pubmed/29351538",
        "http://www.ncbi.nlm.nih.gov/pubmed/22473602",
        "http://www.ncbi.nlm.nih.gov/pubmed/23568066",
        "http://www.ncbi.nlm.nih.gov/pubmed/18495029",
        "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
        "http://www.ncbi.nlm.nih.gov/pubmed/24669633",
        "http://www.ncbi.nlm.nih.gov/pubmed/33243181"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 467,
          "offsetInEndSection": 599,
          "text": "CASE REPORT A 88-year-old man with recurrent urinary tract infections was treated with long-term nitrofurantoin prophylactic therapy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 601,
          "offsetInEndSection": 817,
          "text": "He took 100 mg of nitrofurantoin on a daily basis for over 10 years as prophylactic therapy for recurrent urinary tract infections, and subsequently developed chronic respiratory failure requiring supplemental oxygen"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 975,
          "offsetInEndSection": 1226,
          "text": "CONCLUSIONS Although nitrofurantoin is one of the most commonly used antibiotics in the treatment of urinary tract infections and is often considered a relatively safe medication, long-term use can lead to the development of interstitial lung disease."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 203,
          "offsetInEndSection": 382,
          "text": "The potential causes of interstitial lung disease are broad and includes infection, malignancy, autoimmune/connective tissues diseases, inhaled substances, and certain medications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 201,
          "text": "BACKGROUND Interstitial lung disease, also known as diffuse parenchymal lung disease, is a group of diseases that affects the interstitium of the lungs and can lead to progressive fibrosis of the lungs"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32238797",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 384,
          "offsetInEndSection": 465,
          "text": "One of the medications that can cause interstitial lung disease is nitrofurantoin"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8771575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 882,
          "offsetInEndSection": 964,
          "text": "Nitrofurantoin is commonly used to treat urinary tract infections during pregnancy"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8771575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1094,
          "offsetInEndSection": 1251,
          "text": "We present a case of respiratory failure occurring in a woman at 16 weeks' gestation who was being treated with nitrofurantoin for a urinary tract infection."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8771575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 280,
          "offsetInEndSection": 375,
          "text": "Diagnosis is made by clinical suspicion and exclusion of other causes of respiratory compromise"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8771575",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 740,
          "offsetInEndSection": 880,
          "text": "A chronic reaction associated with long-term treatment with nitrofurantoin has also been reported and causes irreversible pulmonary fibrosis"
        }
      ]
    },
    {
      "id": "67e090be18b1e36f2e00006c",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11989131",
        "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
        "http://www.ncbi.nlm.nih.gov/pubmed/24961027",
        "http://www.ncbi.nlm.nih.gov/pubmed/3892050",
        "http://www.ncbi.nlm.nih.gov/pubmed/10361306",
        "http://www.ncbi.nlm.nih.gov/pubmed/16813873",
        "http://www.ncbi.nlm.nih.gov/pubmed/2359181",
        "http://www.ncbi.nlm.nih.gov/pubmed/1732628",
        "http://www.ncbi.nlm.nih.gov/pubmed/21292904",
        "http://www.ncbi.nlm.nih.gov/pubmed/19758621"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11989131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 132,
          "text": "Local immunotherapy with bacillus Calmette-Guerin (BCG) is an effective and frequently used treatment for superficial bladder cancer"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11989131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 205,
          "offsetInEndSection": 351,
          "text": "We describe a 53 year- old man with a disseminated bacillus Calmette-Guerin (BCG) infection after intravescical instillation for bladder carcinoma"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11989131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 353,
          "offsetInEndSection": 410,
          "text": "Recent literature is reviewed for this rare complication."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11989131",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 134,
          "offsetInEndSection": 203,
          "text": "Serious side effects are infrequent but can affect every organ system"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 247,
          "text": "Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976, and has been reported to eradicate disease in more than 70% of patients with in situ and stage I disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 249,
          "offsetInEndSection": 681,
          "text": "To the best of our knowledge, we report the first case of disseminated bacillus Calmette-Guerin infection causing multiple abscesses affecting the pancreatic head and right psoas muscle, diagnosed 5 years after intravesical treatment with bacillus Calmette-Guerin therapy for bladder cancer.\nAn 83-year-old Caucasian man was hospitalized with a 2-month history of back pain, anorexia, generalized weakness and a 47-pound weight loss"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 897,
          "offsetInEndSection": 947,
          "text": "He complained of abdominal pain in his right flank"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1071,
          "offsetInEndSection": 1471,
          "text": "Growth of Mycobacterium bovis was determined in cultures of the purulent material obtained by surgical drainage of the abscesses.\nThis case illustrates the fact that although intravesical administration of bacillus Calmette-Guerin is generally considered to be safe, it is not exempt from complications and these could appear immediately after treatment or as a delayed complication many years later."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 683,
          "offsetInEndSection": 895,
          "text": "He had previously undergone two transurethral resections for high-grade transitional cell carcinoma of the bladder and had received 12 intravesical bacillus Calmette-Guerin instillations without any complications"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19918272",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 949,
          "offsetInEndSection": 1069,
          "text": "A computed tomography scan of the abdomen showed multiple abscesses affecting the pancreatic head and right psoas muscle"
        }
      ]
    },
    {
      "id": "67d7fded18b1e36f2e000042",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
        "http://www.ncbi.nlm.nih.gov/pubmed/20006195",
        "http://www.ncbi.nlm.nih.gov/pubmed/9265274",
        "http://www.ncbi.nlm.nih.gov/pubmed/16771614",
        "http://www.ncbi.nlm.nih.gov/pubmed/25293760",
        "http://www.ncbi.nlm.nih.gov/pubmed/20138347",
        "http://www.ncbi.nlm.nih.gov/pubmed/27490087",
        "http://www.ncbi.nlm.nih.gov/pubmed/17217365",
        "http://www.ncbi.nlm.nih.gov/pubmed/29417387",
        "http://www.ncbi.nlm.nih.gov/pubmed/34482355"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 101,
          "offsetInEndSection": 178,
          "text": "It can be caused by Neisseria gonorrhoeae or Chlamydia trachomatis infections"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 180,
          "offsetInEndSection": 321,
          "text": "FHC syndrome usually presents with pain in the right hypochondrium and fever, associated with symptoms and signs of pelvic infection in women"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 655,
          "offsetInEndSection": 795,
          "text": "The association of arthritis and cutaneous lesions was diagnosed as a syndrome of arthritis-dermatitis, also caused by systemic NG infection"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 860,
          "offsetInEndSection": 994,
          "text": "CONCLUSIONS FHC syndrome should be considered in sexually active young patients, mainly women, with pelvic infection and perihepatitis"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 996,
          "offsetInEndSection": 1049,
          "text": "It may be caused by disseminated gonococcal infection"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "BACKGROUND Fitz-Hugh-Curtis (FHC) syndrome is a perihepatitis linked to inflammatory pelvic disease"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 323,
          "offsetInEndSection": 488,
          "text": "CASE REPORT We present the case of a 22-year-old woman with systemic lupus erythematous (SLE) who presented with polyarthritis, cutaneous lesions, and abdominal pain"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 490,
          "offsetInEndSection": 653,
          "text": "The diagnosis of FHC syndrome was based on the findings of abdominal computerized tomography (CT) and the isolation of Neisseria gonorrhoeae (NG) in blood cultures"
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 1217,
          "offsetInEndSection": 1308,
          "text": "CT images showing the typical findings of perihepatitis allow making the correct diagnosis."
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29284768",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 180,
          "offsetInEndSection": 488,
          "text": "FHC syndrome usually presents with pain in the right hypochondrium and fever, associated with symptoms and signs of pelvic infection in women. CASE REPORT We present the case of a 22-year-old woman with systemic lupus erythematous (SLE) who presented with polyarthritis, cutaneous lesions, and abdominal pain"
        }
      ]
    }
  ]
}